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Abbreviations 
 
a.u. arbitrary units ILAE International League Against Epilepsy 
ACSF artificial cerebrospinal fluid IP immunoprecipitation 
AHS Ammon's horn sclerosis IP3 inositol triphosphate 3 
APS ammonium persulfate kDa kilodalton 
ATP adenosine triphosphate LC MS liquid chromatography mass spectrometry 
BBB blood brain barrier MAPK mitogen activated protein kinase 
BCA bicinchoninic acid assay MTLE mesial temporal lobe epilepsy 
BrdU 5-bromo-2'-deoxyuridine NGS normal goat serum 
CA cornu ammonis NO nitric oxide 
CamKII Ca2+/calmodulin-dependent protein 
kinase II 
PAGE polyacrylamide gel electrophoresis 
cAMP cyclic adenosine monophosphate PBS phosphate-buffered saline 
CDK cyclin-dependent kinase PFA paraformaldehyde 
cGMP  cyclic guanosine monophosphate PKA protein kinase A 
CID collision induced dissociation PKC protein kinase C 
CNS central nervous system PKG protein  kinase G 
CSF cerebrospinal spinal fluid PTM post translational modification 
DCX doublecortin PVDF polyvinylidene fluoride 
DG dentate gyrus RG radial glia 
DKO double knockout SD standard deviation 
EL extracellular loop SDS sodium dodecyl sulfate 
ER endoplasmic reticulum SGZ subgranular zone 
GAPDH glyceraldehyde 3-phosphate 
dehydrogenase 
SR stratum radiatum 
GCD granule cell dispersion TBST tris-buffered saline with Tween-20 
GCL granule cell layer TGFβ  transforming growth factor beta 
GFAP glial fibrially acidic protein TGN trans-golgi network 
HS hippocampal sclerosis TLR toll-like receptor 
IgG immunoglobulin TM trans membrane 
IL interleukin TNF tumor necrosis factor 
TUNEL terminal deoxynucleotidyl transferase  
dUTP nick end labeling  
WT wild type 
ZO zonula occludens 
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1 Introduction 
 
 
Epilepsy is a central nervous system disorder characterized by propensity of the brain to have 
spontaneous seizures. Astrocytes, which are the major non-neuronal cells in the brain, are 
increasingly being recognized as key players in epilepsy. Metabolic and electric coupling is a 
vital property of astrocytic networks in which the distribution of energy metabolites and ions 
takes place. Failure of this buffering function of the astrocytic network can result in seizures 
(Wallraff et al., 2006). Gap junctions formed by connexins are responsible for coupling among 
astrocytes. This coupling is completely absent in human temporal lobe epilepsy with sclerosis 
and its loss has been proposed as a focal contributor to epileptogenesis (Bedner et al., 2015). 
The principal purpose of this study was to find out the mechanism leading to astrocytic 
uncoupling in epilepsy, with a focus on connexins. This section gives a brief introduction to 
various aspects of this topic.  
1.1 Astrocytes 
Non-neuronal cells called glia exist throughout the central nervous system (CNS). Although 
the ratio of glia to neurons varies depending on the region of the brain and the species, 
according to most of the estimates glial number is at least equal to or exceeds that of neurons 
(Khakh and Sofroniew, 2015). Specialized glia called astrocytes constitute approximately 20 
to 40% of the total numbers of cells in the mammalian brain. Astrocytes (from the Greek word 
‘astro’ meaning star) derive their name from their star shaped appearance in Golgi stain. They 
have passive electrophysiological properties and unlike neurons are unable to generate action 
potential (Dallérac et al., 2013). Grey matter astrocytes termed protoplasmic have a roughly 
spherical and bushy appearance. Their processes enwrap numerous synapses and blood vessels. 
White matter astrocytes termed fibrous have long, thin, unbranched processes whose endfeet 
encircle the nodes of Ranvier. There exists a regional variation in the structure and functions 
of astrocytes. Astrocytes are a far more heterogeneous group of cells than was previously 
thought. Their crucial contribution to brain homeostasis and disease is now being progressively 
appreciated. 
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1.1.1 Physiological role of astrocytes 
Glucose transporters present on the astrocytic endfeet enwrapping the blood vessels take up 
the blood glucose. It is converted to pyruvate through aerobic respiration and then to lactate by 
lactate dehydrogenase (Bélanger et al., 2011). Astrocytes convert and store some of the glucose 
into glycogen which acts as an energy substrate in case of hypoglycemia. Lactate is released 
into the extracellular space and then utilized by neurons as an energy substrate. In response to 
synaptic activity, astrocytes increase the uptake and metabolism of glucose to provide lactate 
to neurons. This model of neuroglial metabolic coupling is known as astrocyte-neuron lactate 
shuttle (Pellerin and Magistretti, 2012). In this model (Figure 1.1.1), astrocytes also take up 
glutamate released by neurons and convert it to glutamine using an enzyme glutamine 
synthetase. The uptake of glutamate mediated by specialized transporters on astrocytes is 
essential for the termination of its action in the synaptic cleft. The uptake also triggers 
glycolysis in astrocytes to generate ATP and lactate. Glutamine produced after degradation of 
glutamate in astrocytes can be recycled again for the production of glutamate. Thus, astrocytes 
play a significant role in brain energetics and glutamate turnover. 
Astrocytes maintain the water, ion, pH, and transmitter homeostasis of the synaptic interstitial 
fluid by expressing a variety of channels and transporters (Sofroniew and Vinters, 2010). They 
exert a tight control on the extracellular potassium ion (K+) levels with the help of Na+K+ 
ATPase, inward rectifying K+ channels and gap junctional coupling (introduced in section 
1.1.2). Such a control is essential to prevent the hyper-excitation of neurons following K+ 
accumulation. Astrocytes not only take up neurotransmitters but also metabolize, synthesize 
and release them. The process of neurotransmitter release by astrocytes termed 
gliotransmission, modulates synaptic activity (Parpura and Zorec, 2010). Astrocytes via their 
endfeet constitute a component of the blood brain barrier. They release many vasoactive 
molecules that can influence the blood brain barrier permeability and the blood flow (Serlin et 
al., 2015a). Regulation of the blood flow by astrocytic endfeet is an important aspect of 
neurovascular coupling.   
Glial fibrillary acid protein (GFAP), a component of astrocytic cytoskeleton, has become a 
prototypic marker for astrocytes. The stem cells in the neurogenic niches of the adult brain 
express GFAP (Kriegstein and Alvarez-Buylla, 2009). These GFAP expressing cells have a 
radial morphology and they remain active throughout life in the subventricular zone of the 
lateral ventricles and in the subgranular zone of the hippocampal dentate gyrus (DG), where 
they are the principal source of adult neurogenesis.  
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The newborn neurons generated from these cells integrate into the existing circuitry and are 
believed to play a role in learning and memory (Gonçalves et al., 2016).   
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1.1: Schematic illustration of astrocyte-neuron lactate shuttle. Glutamate uptake by 
astrocytes triggers glycolysis which promotes glucose uptake by glucose transporters.  Lactate and 
glutamine produced by astrocytes are transported to neurons. Figure adopted from (Demetrius et al., 
2015). 
 
1.1.2 Astrocytic coupling 
Astrocytes are connected with each other via structures called gap junctions (introduced in 
section 1.2). Such a connectivity of astrocytes with the surrounding astrocytes results in the 
formation of a huge network through which transport of small molecules (~ 1 kDa) can take 
place (Scemes and Spray, 2009). The astrocytic network is often referred to as a functional 
syncytium. A syncytium is defined as a multinucleated mass of cytoplasm that is surrounded 
by a continuous plasma membrane with no individualized units (cells) (Scemes and Spray, 
2003). According to this definition, astrocytes do not form a structural syncytium mainly 
because even in network, they retain their individual cellular structures. Under physiological 
conditions, there is very little interdigitation between astrocytic processes (Bushong et al., 
2002). In rodent brain, each astrocytic domain includes ~ 140,000 synapses while in the human 
brain the number reaches up to ~2,000,000 synapses. These synapses are not shared with the 
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neighboring astrocytic domains (Oberheim et al., 2008). However, at the border zone between 
two astrocytes, gap junctions pave a way for intercellular transport allowing direct exchange 
of molecules from the cytosol of one cell to that of its coupled neighbours. 
The passage of molecules across astrocytic gap junctions takes place by passive diffusion along 
the concentration gradient. The concentration gradients may be formed either through release 
of molecules at specific sites or through their uptake by subpopulation of cells. The gap 
junctions however exert certain resistance to the permeation. As a result, molecules dissipate 
only gradually through time and space through the networks (Scemes and Spray, 2003). There 
are many possible molecules that can be transported across astrocytic networks e.g. K+, cyclic 
adenosine monophosphate (cAMP), inositol triphosphate (IP3), Ca2+, glucose, glutamate etc. 
Depending on the molecule transported, different functions can be ascribed to astrocytic 
coupling. One of these functions is K+ spatial buffering. The model of astrocyte-mediated K+ 
spatial buffering was first proposed by Dick Orkand, John Nichols and Steve Kuffler (Orkand 
et al., 1966) (Kuffler et al., 1966) and thereafter confirmed by (Wallraff et al., 2006), (Pannasch 
et al., 2011) and (Bazzigaluppi et al., 2016).  Through this mechanism, glial cells are suggested 
to remove the excess K+ released at synaptic sites to regions of low extracellular K+ (Figure 
1.1.2 A). The K+ flux is driven by the difference between the membrane potential (Vm) and the 
local K+ equilibrium potential (EK). In regions of [K+]o increases, there is a net driving force 
causing K+ uptake (Dallérac et al., 2013). This K+ entry causes a local depolarization. K+ is 
released at a location distant from the site of entry. It is important to note here that syncytial 
isopotentiality conferred by gap junctions facilitates all three critical steps in “K+ spatial 
buffering”: K+ uptake, intercellular transfer and release (Ma et al., 2016). Astrocytic spatial 
buffering of K+ has been proposed to be antiepileptic. Indeed, hippocampal slices from mice 
lacking astrocytic coupling were shown to have spontaneous epileptiform activity (Wallraff et 
al., 2006).  
Astrocytic coupling contributes to the distribution of glucose and other metabolites from the 
perivascular space to distal synapses (Figure 1.1.2 B). This property called metabolic polarity 
endows the astrocytic syncytium with the capacity to ensure the transfer of metabolic 
intermediates from areas of production to areas of demand (Pellerin and Magistretti, 2012). In 
the absence of extracellular glucose, the distribution of exogenous glucose or lactate injected 
into an astrocyte maintains glutamatergic synaptic transmission and epileptiform activity only 
when the astrocytes in the network are connected by gap junctions (Rouach et al., 2008). This 
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aspect of astrocytic coupling facilitating the distribution of energy substrates to firing neurons 
has been viewed as pro-epileptic.  
 
 
 
 
 
 
 
 
 
 
Figure 1.1.2: Physiological role of astrocytic coupling. A) K+ buffering. Increase in [K]o produces 
a local depolarization. The local difference in Vm and EK drives the K+ uptake in regions of elevated 
[K]o and K+ outflow at distant regions. The intercellular currents are carried by K+ and extracellular 
currents are facilitated by other ions such as Na+. Figure adopted from (Orkand, 1986). B) Metabolic 
polarity of astrocytic network. Astrocytes have various processes that make contact with capillaries, 
neuronal perikarya, or synapses. The distribution of metabolites through the network takes place in the 
direction of energy demand. Figure adopted from (Pellerin and Magistretti, 2012). 
 
Astrocytic coupling modulates the synaptic strength also by facilitating the removal of 
glutamate and by controlling the extracellular space volume (Pannasch et al., 2011). These 
functions take place synergistically with K+ buffering. The propagation of Ca2+ signal through 
the astrocytic network has also been documented and has been termed  Ca2+ waves (Bazargani 
and Attwell, 2016). IP3 has been shown to mediate Ca2+ waves in astrocytic networks (Boitano 
et al., 1992). The speed of such Ca2+ waves in astrocytic cultures is ~ 20 µm/s while in 
spreading depression it is ~30 to 40 µm/s (Scemes and Giaume, 2006). Ca2+ waves in astrocytic 
cultures can take place even in the absence of neurons. Similarly, Ca2+ waves during spreading 
depression are independent of action potentials (Chuquet et al., 2007). A third, neuronal 
activity-dependent, faster type of Ca2+ wave (60 µm/s) has been shown to propagate through 
astrocytic network in vivo (Kuga et al., 2011). This wave named glissandi has been speculated 
A) B) 
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to mediate the activity-dependent, large-scale modulation of cerebral blood flow (Kuga et al., 
2011). 
There are three methods by which astrocytic coupling can be assessed. Simultaneous patch 
clamp recordings from two astrocytes are used to evaluate electrical coupling between them 
(Kettenmann and Ranson, 1988). In this method, a depolarizing current injected into one 
astrocyte also depolarizes the other if they are connected by gap junctions. For pairs of coupled 
cells, the strength of electrical coupling, termed the coupling coefficient is defined as the ratio 
of voltage changes in the coupled cell to that in the injected cell (Ma et al., 2016). Simultaneous 
patch clamp recordings are technically challenging and while using them, the spatial aspects 
of coupling need to be extracted from multiple recordings. A second method called 
fluorescence recovery after photobleaching (FRAP) involves bleaching of gap junction 
permeable dye in a single astrocyte and recording the recovery of fluorescence caused by 
diffusion of the dyes through gap junctions (Lee et al., 1994). The third and the most commonly 
used method utilizes injection of a tracer dye (for example biocytin) into a single astrocyte and 
measures its spread through the astrocytic network in a given time (Bedner et al., 2015). 
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1.2 Gap junctions 
Gap junctions are specialized pore forming structures at the interface of two apposing 
membranes that connect the cytoplasms of the neighboring cells. The typical distance between 
the two apposing membranes harboring gap junctions is 2 to 4 nm (Oshima, 2014).  In 
vertebrates, membrane proteins called connexins form the gap junctions. They are expressed 
in almost all differentiated cells except red blood cells, spermatozoa, and skeletal muscles 
(Sáez et al., 2003). Twenty one different isoforms of connexins have been detected in humans 
(Bedner et al., 2012). They are commonly named as prefix ‘Cx’ followed by their approximate 
predicted molecular weight in kilo Daltons e.g. Cx39. Cx43 and Cx30 are the main gap 
junctional proteins in astrocytes. Astrocytic expression of Cx26 has been reported but is still 
under debate (Bedner et al., 2012). In mouse hippocampus, the expression of Cx43 and its 
contribution to coupling exceeds that of Cx30.   
1.2.1 Structure of gap junctions 
A single gap junction channel comprises of 12 connexins. A connexin is a tetraspanning 
membrane protein with cytoplasmic N and C terminus and two extracellular loops (Figure 
1.2.1.1). The transmembrane domains (TM1, TM2, TM3 and TM4) and the extracellular loops 
(E1L and E2L) are remarkably similar among connexins. The intracellular loop and C‑terminal 
tail are more variable, with the C‑terminal tail being the major determinant of connexin size, 
which can range from 23 to 62 kDa (Aasen et al., 2016). Six connexins oligomerize to form a 
connexon (also known as a hemichannel) and two connexons from the adjacent cells dock on 
each other to form a gap junction (Figure 1.2.1.1). A gap junction plaque may consist of 100 
to 1000 densely packed gap junction channels. The transmembrane domains of connexins have 
α-helical structures while the extracellular loops are arranged in an anti-parallel β-sheet 
configuration. The extracellular loops are connected by three disulfide bridges considered 
essential for docking. The N terminal tail (aa 1 to 23) with one α-helix is shorter than the C-
terminal tail. The intracellular loop and the C-terminal tails resist crystallographic resolution, 
indicating that they do not have an organized structure and are highly flexible. The C– terminal 
tail of Cx43 begins at aa 230 and ends at aa 382. It has a random coil structure with two short 
α-helices (Thévenin et al., 2013).  
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Figure 1.2.1.1: Structural organization of a gap junction channel. A connexin molecule spans the 
membrane four times (Transmembrane domain, TM 1 to TM 4). N-terminal, cytoplasmic loop (CL) 
and C terminal reside in the cytoplasm while the extracellular loops (E1L and E2L) project outside the 
cell. Six connexins oligomerize to form a connexon. A gap junction is formed when two connexons 
from adjacent cells dock on each other. Figure adopted from (Bosco et al., 2011). 
All connexins in a connexon can be similar (homomeric) or dissimilar (heteromeric). The 
docked connexons in a gap junction can be of similar configuration (homotypic) or different 
configuration (heterotypic). The heteromeric compatibility of connexins can be predicted by a 
signature amino acid motif localized at the interface region where the cytosolic intracellular 
loop domain transitions into the third transmembrane domain (Koval et al., 2014) (Figure 
1.2.1.2). In some connexins (e.g. Cx43), the motif in this region contains a conserved arginine 
or lysine residue (referred to as R type connexins) while other connexins have (e.g. Cx30) a 
di-tryptophan motif (W type connexins). In R type of connexins, because of the presence of 
arginine or lysine at a specific location, interaction with a monomer stabilizing protein Erp29 
is favoured. This interaction delays the oligomerization till the trans-golgi network (Das et al., 
2009). On the other hand, W type of connexins oligomerize in the endoplasmic reticulum. As 
a result, the likelihood of an R type connexin forming a heteromer with W type of connexin is 
very low. This implies that Cx43 and Cx30 are unlikely to form heteromers. The heterotypic 
(docking) compatibility on the other hand is indicated by motifs in the second extracellular 
loop domain (Koval et al., 2014) (Figure 1.2.1.2). There are two types of connexins based on 
the signature motifs in this region: group1 has lysine, arginine and asparagine while group 2 
has only histidine in the signature motif. Thus, group1 connexons are probably incompatible 
in docking with group 2 connexons.  
Connexin Connexon Gap junction channel
E1L E2L 
TM1 TM2 TM3 TM4 
N-terminal 
CL 
C-terminal 
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Cx43 and Cx30 both belong to group1 and hence their connexons can potentially dock to form 
a gap junction. 
 
 
 
 
 
 
 
 
Figure 1.2.1.2: Molecular signatures predicting the heteromeric and heterotypic compatibility of 
connexins. Amino acids at the junction of transition from the cytoplasmic loop into the TM3 determine 
heteromeric compatibility while the amino acids in the extracellular loop 2 determine heterotypic 
compatibility. Accordingly, connexins with the possibility of heteromeric or heterotypic interactions 
are shown in the wheel diagrams. Faint dotted lines indicate weaker compatibility. Figure adopted from 
(Koval et al., 2014). 
A high resolution (3.5˚A) crystal structure of Cx26 has been reported (Maeda et al., 2009). 
According to this model, the shape of a gap junction channel resembles that of a tsuzumi, a 
traditional Japanese drum (Figure 1.2.1.3 A). The structure (without C-terminal tail) has a 
height of 155 Å and an outer maximum diameter of 92 Å. The diameter of the hydrophilic 
channel is widest at the cytoplasmic surface (40 Å), narrows at the membrane/extracellular 
space interface forming the channel vestibule (14 Å), and widens again in the extracellular 
space (25 Å). The extracellular domains have a dual concentric β-barrel configuration with the 
E1L on the inner side of the pore connected through disulfide bridges with corresponding E2L 
on the outer side (Figure 1.2.1.3 B) (Nakagawa et al., 2010). Docking of the extracellular 
regions of opposite hemichannels entails an interdigitation of 6˚A and a rotation of 30˚. Such 
a structural arrangement creates an inter-cellular ‘gap’ of 40˚A (4 nm) between the apposed 
extracellular domains. E1L and E2L loops from one channel dock on to the corresponding E1L 
and E2L loops from another channel to create a tight seal (Nakagawa et al., 2010). All 
interactions in the docking of connexin channels are non-covalent and involve hydrogen bonds 
and salt bridges. N-terminal, TM1 and E1L form lining of the pore-proper. The intracellular 
regions of the TM1 and TM3 domains form the entrance of the channel. The N- terminal resides 
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inside the channel pore giving it a funnel shaped appearance and functions in voltage gating 
(also known as plug gating) (Oshima, 2014).  
 
 
 
 
 
 
 
 
Figure 1.2.1.3: Crystal structure of a gap junction channel. A) Dimensions of a Cx26 gap junction 
channel. Differently coloured helices (tagged A to F) indicate individual Cx26 monomers in a gap 
junction channel. The gap between two membranes harbouring individual connexons is 40˚A (4 nm). 
Figure adopted from (Maeda et al., 2009). B) Top view of a connexon (upper panel) and a cross-
sectional view of a gap junction channel (lower panel). The yellow lines denote disulfide bridges 
connecting two extracellular loops of an individual connexin monomer. Six extracellular loops 1 (E1L) 
line the inside of the channel pore while six extracellular loops 2 (E2L) form the outer wall of the pore. 
Figure adopted from  (Riquelme et al., 2013). 
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1.2.2 Life cycle of connexins 
Some connexin genes tend to cluster together within the genome. For example human 
chromosome 1 alone harbours genes for 8 connexins (Beyer and Berthoud, 2009). Genes for 
Cx43 and Cx30 are located respectively on chromosomes 6 and 13 in humans and on 
chromosomes 10 and 14 in mouse (Söhl and Willecke, 2003). The connexin genes have a 
uniform structure: with a 5’ untranslated region, named exon 1, which is separated by an intron 
of variable length from exon 2 bearing the complete connexin encoding region and the 3’ 
untranslated region (Beyer and Berthoud, 2009). The pattern of synthesis, oligomerization and 
plasma membrane translocation of connexins is similar to that of other membrane proteins 
although certain differences exist for Cx43 (Figure 1.2.2). The transcribed mRNAs are 
translated in rough endoplasmic reticulum into a full length protein. It is then inserted into the 
membrane of the endoplasmic reticulum (ER). Oligomerization takes place in the ER or in the 
trans-Golgi network (TGN). Cx43 is phosphorylated very early in its life cycle and its 
oligomerization takes place in the TGN unlike Cx30 which is oligomerized in ER.  
After oligomerization, connexons can be delivered to the plasma membrane by two 
mechanisms. A minority of the connexons are directly inserted into the plasma membrane, in 
contrast to the majority of the connexons, which follow a secretory pathway (Salameh, 2006). 
The fully formed connexons pass the cisternae of the TGN and are transported in secretory 
vesicles to the plasma membrane. The transport of vesicles takes place along microtubular 
filaments. Once inserted into the plasma membranes, connexons appear to freely diffuse within 
the lipid bilayer (Laird, 2006). By lateral movement in the plane of the plasma membrane, the 
new connexons reach the outer rim of an already existing gap junction plaque causing growth 
of that plaque. The docking of connexons from the neighboring cells is facilitated by cadherins 
in a Ca2+ dependent manner. In case of Cx43, the size of the plaque is negatively regulated by 
its interaction with the zonula occludens -1 (ZO-1) protein. Interestingly, phosphorylation of 
Cx43 (discussed in detail in section 1.2.3) at S373 inhibits this interaction and results in larger 
plaques (Dunn and Lampe, 2014). 
The half-life of connexins is shorter as compared with other structural membrane proteins. 
Cx30 (half-life > 12 h) appears to be more stable than Cx43 (half-life 1.5 to 5 h) (Kelly et al., 
2015). Once a complete dodecameric gap junction channel has been formed, it cannot be 
separated into connexons again because of the tight seal between extracellular loops. Instead, 
it is internalized by one of the neighboring cells resulting in intracellular membrane vesicles 
called annular junctions (Thévenin et al., 2013). The process involves clathrin and other 
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relevant endocytic proteins like dynamin, actin and myosin. Ubiquitination of connexins is a 
vital signal for its internalization. Once internalized, most of the integral membrane proteins 
are degraded via a lysosomal pathway. Although connexins can be degraded by this pathway, 
many researchers have indicated a proteasomal pathway for connexin degradation (Falk et al., 
2014) (VanSlyke and Musil, 2005) (Minogue et al., 2013). An autophagic degradation of 
internalized Cx43-based gap junctions has also been described (Iyyathurai et al., 2016). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2.2: Life cycle of connexins. Connexins are continuously synthesized and degraded resulting 
in a very short half-life. After translation, they are folded and incorporated in the membrane of ER. 
Most of the oligomerized connexins (connexons) are transported to the plasma membrane in secretory 
vesicles guided by microtubules. After cadherin-assisted gap junction formation, many scaffolding 
proteins (like ZO-1) bind to the connexins.  Internalization of gap junctions results in the formation of 
an annular junction (also known as connexosome) which can be degraded by proteasomal or lysosomal 
pathway. Figure adopted from (Laird, 2006). 
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1.2.3 Phosphorylation of Cx43 
Phosphorylation is one of the most extensively studied post translational modifications in 
Cx43. Cx43 is a phosphoprotein presenting three bands on SDS PAGE namely the faster 
migrating P0 band and the slower migrating P1 and P2 bands. The P0 band is relatively non-
phosphorylated as compared with the P1/P2 bands. Treatment with alkaline phosphatase 
merges all the bands at P0 (Musil et al., 1990). The 2-4 kDa shifts in the mobility of 
phosphorylated Cx43 is not caused by mere addition of phosphate groups. It is being gradually 
appreciated that conformational changes caused by specific phosphorylation result in the band 
shifts (Solan and Lampe, 2009).  There are 21 putative phosphorylation sites in the C terminal 
region of Cx43. At least 19 of the 26 serines and 2 of the 6 tyrosines in the C-terminal region 
of Cx43 have been confirmed as sites for potential phosphorylation (Axelsen et al., 2013). Till 
this date, there are no confirmed reports about N-terminal, cytoplasmic loop or extracellular 
loop phosphorylations. Phosphorylation of Cx43 takes place very early in its life cycle. Cx43 
phosphorylation can occur within 15 min after its synthesis in the rough endoplasmic reticulum 
(Crow et al., 1990). This event is deemed to be important for its subsequent oligomerization 
and transport to the plasma membrane. Even the assembly of connexins into gap junctions is 
affected by C-terminal phosphorylation (Cooper and Lampe, 2002). Although phosphorylation 
is an important process in the life cycle of Cx43, it is not absolutely essential for the formation 
of gap junctions. This is highlighted by the fact that C-terminal truncated Cx43 still forms gap 
junctions albeit with different permeability and electrical properties (Fishman et al., 1991). 
Various kinases and their respective target sites are displayed in Figure 1.2.3.1. It is important 
to note here that not all the phosphorylation events take place simultaneously. In fact some of 
the phosphorylated sites prevent the phosphorylation of other sites. Many of the kinases have 
overlapping specificity. Nevertheless, phosphorylation at each site of Cx43 can be viewed as a 
regulatory process affecting a particular aspect of its function. Phosphorylation of S364/S365 
by protein kinase A (PKA) is considered crucial for connexin trafficking towards plasma 
membrane (Solan and Lampe, 2007). Phosphorylation on these residues results in the 
formation of a P1 band on the Western blot. S365 phosphorylation has also been suggested to 
perform a “gatekeeper” function causing a conformational change that prevents protein kinase 
C (PKC)-induced phosphorylation of S368 (Solan et al., 2007). PKC-mediated 
phosphorylation of Cx43 at S368 has been shown to shift the unitary conductance of Cx43 
channels to a lower than normal value (from 100 pS to 50 pS) (Lampe et al., 2000). This is 
known to take place in the S and G2/M phase of the cell cycle leading to reduced gap junctional 
coupling (Solan et al., 2003).  
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Axelsen et al., however have linked dephosphorylation of S368 together with S297 with 
electrical uncoupling in cardiac ischemia (Axelsen et al., 2006). Recently, phosphorylation of 
S368 by PKCδ has been shown to induce gap junction internalization (Cone et al., 2014).  
Casein kinase 1 mediated phosphorylation at S325, S328, and S330 results in increased 
assembly of connexons as gap junctions (Cooper and Lampe, 2002). In fact Cx43 
phosphorylated at these residues has been revealed to be exclusively located in gap junction 
plaques. On Western blot, these changes are reflected in the formation of a P2 band. Consistent 
with this information, phosphorylation at S325, S328, and S330 is drastically reduced in 
ischemic hearts which show Cx43 dislocalization from the intercalated discs (also known as 
gap junction remodeling) (Lampe et al., 2006). To assess the impact of constitutive 
phosphorylation or dephosphorylation of these sites on the gap junctional remodeling, Remo 
et al., developed transgenic mice in which S325, S328, and S330 were replaced either with 
alanine (S3A mice mimicking constitutive dephosphorylation) or with glutamate (S3E mice 
mimicking constitutive phosphorylation) (Remo et al., 2011). S3A mice showed deleterious 
effects on cardiac gap junction formation and functions, developed electric remodeling, and 
were highly susceptible to inducible arrhythmias. On the other hand, S3E mice were resistant 
to acute and chronic pathological gap junction remodeling and displayed diminished 
susceptibility to the induction of ventricular arrhythmias. Interestingly, the S3A construct of 
Cx43 failed to form P2 bands while S3E construct showed prominent P2 bands (Remo et al., 
2011).  
Mitogen activated protein kinase (MAPK)-mediated phosphorylation of Cx43 at S255, S262, 
and S279/S282 is known to hamper gap junctional communication by two mechanisms. These 
phosphorylations either decrease the open probability of gap junction channels or they induce 
gap junction internalization (Thévenin et al., 2013). Some reports also indicate an interplay 
between MAPK and PKC (Sirnes et al., 2009).  Remarkably, S262 which is also 
phosphorylated by cyclin-dependent kinase-2 (CDK-2) during mitosis has been shown to 
regulate DNA synthesis (Doble et al., 2004).  Thus, there exists considerable interplay and 
cross reactivity among kinases phosphorylating Cx43. This is further exemplified by Src 
kinases which phosphorylate Cx43 at T247 and T265 (resulting in reduced channel 
conductance ultimately leading to channel closure) but can also induce phosphorylation at 
S255 and 279/S282 (Axelsen et al., 2013). The conductance of gap junction channels is also 
reduced upon protein kinase G-induced phosphorylation at S257 (Kwak et al., 1995).  
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Akt or protein kinase B phosphorylate S369 and S373 of Cx43. Phosphorylation at S373 
inhibits ZO-1-Cx43 interaction and increases plaque size (Dunn and Lampe, 2014). Apart from 
these kinases, CamK II has been predicted to phosphorylate Cx43 at multiple sites based on in 
vitro assays at Cx43 peptides, but direct in vivo evidence of CamK II-mediated Cx43 
phosphorylation is still lacking (Huang et al., 2011). Although phosphorylation at S296, S297 
and S306 has been shown to take place, there is no clear direct information about kinases 
phosphorylating these sites (Axelsen et al., 2006) (Axelsen et al., 2013) (Pogoda et al., 2016).  
 
 
 
 
 
 
 
 
 
Figure 1.2.2.1: Summary of Cx43 phosphorylation sites. Schematic diagram showing the C-terminal 
tail of Cx43 with putative phosphorylation sites and their respective kinases. Tyrosines are shown in 
blue while serines are shown in red. Figure adopted from (Axelsen et al., 2013). 
There are two principal approaches for investigating phosphorylation of Cx43 in a disease 
state. In a hypothesis driven approach, a specific kinase targetting a particular site of Cx43 is 
postulated based on the available literature. This site then can be assessed with phospho-
specific antibodies or by site directed mutagenesis. Although simple and direct, the hypothesis-
driven approach has severe limitations given the complexity of Cx43 phosphorylation. Another 
strategy is a systems approach involving powerful phosphoproteomics provided by mass 
spectrometry (Chen et al., 2013).  Principal advantage of this strategy is that global changes in 
Cx43 phosphorylation can be detected with a high degree of accuracy. These changes can be 
correlated with the state of gap junctional coupling.  The first step in proteomic analysis 
involves reducing the isolated proteins to peptides with an endoproteinase such as trypsin.  
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Most modern-day MS systems are comprised of 4 major components: 1) High performance 
liquid chromatography (HPLC) 2) ion source, 3) mass analyzer and 4) detector (Figure 1.2.2.2 
A). HPLC separates the peptides based on their retention time in a chromatographic column. 
The peptides are then ionized either by electrospray ionization or matrix associated laser 
desorption. The ionized peptides are fragmented by introducing intermolecular collisions with 
a neutral gas. This process, called collision-induced dissociation (CID) breaks the peptides 
through the lowest energy pathway producing either C-terminal (designated as x-, y- or z- ions) 
or N-terminal ions (a-, b-, or c-ion) (Figure 1.2.2.2 B). The fragment ions are further analyzed 
in a mass analyzer which separates them according to their mass/charge (m/z) ratio. The 
detector records the separated peptide fragments and gives readouts in the form of a mass 
spectrum which is intensity vs. m/z plot. The identification of peptides is based on database 
searches. Any post-translational modification (for example phosphorylation) will alter the m/z 
ratio and therefore can be detected (Chen et al., 2013). 
 
 
 
 
 
 
 
 
Figure 1.2.2.2: Mass spectrometry. A) An overview of a mass analyzer. During a multiple-reaction 
monitoring run, cell Q1 selects peptides based on m/z for transfer to the Q2 CID collision cell. Product 
ions, called transitions, are then specifically selected as they pass through a Q3 isolation window. Each 
set of transitions at a given LC-elution time uniquely identifies a target protein. B)  Peptide fragments 
are named as per the convention shown in the figure. The cleavage results in C- (x-, y-, z-) or N-terminal 
(a-, b-, c-) ions. (Figure adopted from Chen et al., 2013). 
A) 
B) 
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1.3 Epilepsy 
Epilepsy is a brain state that supports repeated, unprovoked seizures which are unusual, 
paroxysmal changes in the electrical activity of the brain (Goldberg and Coulter, 2013). At any 
given time, it is estimated that ~50 million individuals worldwide have a diagnosis of epilepsy 
posing an immense socioeconomic challenge (Birbeck, 2010). Seizures can be classified into 
two clinically useful categories: partial and generalized. The classification of epilepsies has 
been based on whether or not a focal brain abnormality could be identified (localization related 
vs. generalized epilepsies) and whether or not a cause could be identified (symptomatic vs. 
idiopathic) (Shorvon, 2011). Temporal lobe epilepsy (TLE) is the most common form of adult 
localization-related epilepsy. Hippocampal onset accounts for at least 80% of all temporal lobe 
seizures (hence called mesial temporal lobe epilepsy (MTLE)) (Tatum, 2012). In MTLE 
syndrome, ~56% of the cases present a condition termed hippocampal sclerosis (MTLE-HS) 
(Thom, 2014). Although increasingly being understood at the molecular level, epileptogenesis 
is extremely complex process posing a challenge for the effective pharmacotherapy. Indeed, 
~40% of the total epilepsy cases are pharmacoresistant warranting a resective surgery 
(Alexopoulos, 2013). MTLE-HS is the most common feature encountered in epilepsy 
surgeries. 
1.3.1 MTLE-HS 
Hippocampal sclerosis is a combination of atrophy and astrogliosis mainly of the hippocampus 
but may include amygdala, parahippocampal gyrus, and the enterorhinal cortex (Tatum, 2012). 
It is frequently bilateral. Anatomically, the hippocampus is a medial temporal lobe structure 
that runs along a dorsal (septal)-to ventral (temporal) axis in rodents, corresponding to a 
posterior-to‑anterior axis in humans (Figure 1.3.1.1 A) (Strange et al., 2014). The term 
‘hippocampus’ often encompasses the Ammon’s horn and the dentate gyrus (DG) together. 
The Ammon’s horn is separated into three main parts: CA1, CA2, and CA3 (CA stands for 
Cornu Ammonis). Each of these parts consists of four layers: stratum oriens, stratum 
pyramidale, stratum radiatum and stratum lacunosum moleculare. The pyramidal cells in the 
Cornu Ammonis are packed into a layer called stratum pyramidale, in contrast to the neocortex 
in which pyramidal cells are spread over several layers. The DG on the other hand contains no 
pyramidal cells, but is densely packed with smaller granule cells. These granule cells project 
their dendrites into the molecular layer and their axons into the hilus. The axons from the 
neurons of the entorhinal cortex form synapses with dentate granule cells through the perforant 
pathway.  
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The granule cells in turn send signals to the pyramidal cells in CA3 through the mossy fibres. 
CA3 pyramidal neurons transmit the signals to CA1 pyramidal neurons through Schaffer 
collaterals. CA1 pyramidal neurons provide feed-back to deep-layer neurons of the entorhinal 
cortex. The CA3 also receives direct projections from entorhinal cortex (Figure 1.3.1.1 B) 
(Moser et al., 2014). The hippocampus plays a vital role in the formation of episodic and spatial 
memory. Through its interactions with brain structures associated with emotion, it is implicated 
in emotional behaviour as well (Strange et al., 2014). It is also one of the two sites in the mature 
brain where neurogenesis takes place (Gonçalves et al., 2016). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3.1.1: Position and structure of hippocampus. A) Relative positions of human and mouse 
hippocampi in respective brains. Schematic diagram of coronal sections show DG and different 
subdivisions of the Ammon’s horn. Figure adopted from (Strange et al., 2014) B) Schematic diagram 
displaying the hippocampal circuitry. The hippocampus receives inputs from entorhinal cortex (EC) via 
the perforant and temporoammonic pathway and also sends signals to the EC from CA1 pyramidal 
A) 
B) 
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neurons. Mossy fibres originate in the hilus and form synapses with CA3 pyramidal neurons which 
through Schaffer collaterals relay information to CA1 pyramidal neurons.  Figure adopted from (Deng 
et al., 2010). 
It has been long recognized that the hippocampus has a low threshold for seizures (McIntyre 
and Racine, 1986). Animal experiments and clinical observations congregate to support the 
concept that the hippocampus plays a critical role in the generation of epileptiform activities 
(Schwartzkroin, 1994). This is especially evident in drug resistant MTLE in which surgical 
resection of hippocampus results in seizure control in 60 to 80% of the patients within 2 years 
(Blümcke et al., 2013). Most of these patients display HS.  The striking characteristic of HS 
seen in histopathologic examination is loss of pyramidal neurons which can take place in any 
subdivision of the Ammon’s horn. This cell loss is associated with strong astrogliosis, 
appearing as a dense intermingled network of intensely immunostained GFAP-positive 
processes. The International league against epilepsy (ILAE) has classified MTLE-HS into three 
categories (Blümcke et al., 2013). ILAE type 1 displays severe neuronal cell loss mainly in the 
CA1 and CA4 regions, ILAE type 2 has neuronal cell loss only in CA1, while loss of only CA4 
neurons is termed ILAE type 3 (Figure 1.3.1.2). Type 1 represents the classical or typical 
MTLE-HS while type 2 and 3 are atypical. All of these types demonstrate intense gliosis which 
together with hippocampal atrophy hardens the tissue. Granule cell dispersion (GCD) is 
another remarkable feature observed in 40-50% of MTLE-HS patients (Thom, 2014). GCD has 
been associated with early onset of epilepsy and febrile seizures as well as with longer duration 
of seizures (Blümcke et al., 2009). There is conflicting data about the predictive value of GCD 
for post-surgical success (da Costa Neves et al., 2013) (Blümcke et al., 2009a) (Thom et al., 
2010). Experimental models of epilepsy suggest that deficiency of reelin rather than seizure-
induced neurogenesis contributes to GCD (Haas and Frotscher, 2010). Somatic translocation 
of already existing mature granule cells has also been proposed as a mechanism of GCD 
(Murphy and Danzer, 2011). In HS, mossy fibre collaterals send recurrent projections into the 
molecular layer to make excitatory synaptic contact with apical dendrites and spines of granule 
cells (Sutula et al., 1989). This ‘mossy-fibre sprouting’ has a potential to synchronize the firing 
neurons during seizures. It has been correlated with the extent of neuronal loss and GCD 
(Schmeiser et al., 2017). Although mossy fibre sprouting is observed extensively in HS, its 
contribution to epileptogenesis is still not clear (Thom, 2014). 
 
 
   Introduction  
  
32 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3.1.2: ILAE classification of MTLE-HS. NeuN immunohistochemistry with hematoxylin 
counterstaining in surgically resected human hippocampi demonstrating subtypes of MTLE-HS. The 
non-sclerotic tissue serves as a control. All MTLE-HS subtypes display neuronal loss that differs in 
pattern of location. Type 1 (also known as classical or typical HS) shows neuronal loss in the CA1 and 
CA4 regions. Type 2 (prominent neuronal loss only in CA1) and type 2 (prominent neuronal loss only 
in CA4) are atypical MTLE-HS. Scale bar 1mm. Figure adopted from (Blümcke et al., 2013). 
 
1.3.2 Role of astrocytes in epilepsy 
The contribution of astrocytes to epileptogenesis can be envisaged from the physiological 
functions played by them. Astrocyte-mediated metabolic supply sustaining neuronal firing is 
viewed as pro-epileptic (Rouach et al., 2002). On the other hand, astrocytic contribution to ion, 
water and neurotransmitter homeostasis is perceived as anti-epileptic. Remarkably, this 
homeostatic function of astrocytes is perturbed in epilepsy (Figure 1.3.2). Seizure activity leads 
to an upsurge in extracellular K+ which in MTLE-HS is ineffectively regulated partly because 
of the downregulation of astrocyte Kir4.1 channels and reduction in extracellular space volume 
(Heuser et al., 2012). This downregulation of Kir4.1 channels is reflected in reduced inward 
rectifying currents (Hinterkeuser et al., 2000). The resultant accumulation of extracellular K+  
is expected to exacerbate seizures (Walz, 2000).  Interestingly, mutations in the Kir4.1 
encoding gene (KCNJ10) along with mutations in the aquaporin 4 gene have been linked with 
MTLE (Heuser et al., 2010). Aquaporins facilitate water movement across the membrane along 
the osmotic gradients.  
Type 1 Type 2 
Type 3 Non-sclerotic 
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Aquaporin 4, a predominant water channel in the brain is dislocalized from its position in 
perivascular end feet due to dystrophin down regulation in MTLE-HS (Eid et al., 2005). Its 
total expression is however increased (Lee et al., 2004). These alterations in aquaporin 
expression pattern are expected to disturb not only water but also K+ homeostasis owing to the 
fact that the uptake of K+ drives water flux into the cell. Furthermore, in experimental epilepsy, 
the perivascular dislocalization of aquaporin takes place even before the chronic phase 
indicating that it is not mere a consequence but rather can be a contributing factor to the process 
of epileptogenesis (Alvestad et al., 2013).  
 
 
 
 
 
 
 
 
 
 
Figure 1.3.2:  Disruption of astrocytic functions in epilepsy. Schematic representation of various 
aspects of astrocytic changes labelled in numbers. 1) Downregulation of Kir 4.1 channels. 2) Reduced 
astrocytic gap junctional coupling. Cx43 gap junctions under physiological conditions distribute ions 
and metabolites in the astrocytic network. 3) Dislocalization of aquaporin 4 4) Upregulation of 
adenosime kinase (ADK) resulting in reduced extracellular adenosine. However Ca2+   induced ATP 
release can result in increased adenosine levels by endonucleases (EN). 5) Downregulation of glutamate 
transporters (EAAT1 and EAAT2). 6) Reduced supply of glutamine by astrocytes due to reduced 
glutamine synthetase (GS). 7) Upregulation of metabotropic glutamate receptors causing increased Ca2+ 
mediated glutamate release. Figure adopted from (Steinhäuser et al., 2016). 
 Astrocytic glutamate transporters are mainly responsible for removal of synaptic glutamate 
and cessation of its action on neurons which would otherwise continue to fire (Tanaka et al., 
1997).  
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Uncontrolled glutamate-induced neuronal excitation would ultimately result in their death 
termed as excitotoxicity (Gl, 1992). Thus, through glutamate transporters, astrocytes prevent 
excitotoxicity. The reports on expression levels of these transporters in epilepsy however are 
inconsistent (Steinhäuser et al., 2016). Nevertheless, increased glutamate levels in epilepsy 
have unequivocally been reported (During and Spencer, 1993) (Glass and Dragunow, 
1995)(Cavus et al., 2005). These increased glutamate levels can be partially explained by the 
loss of astrocytic glutamine synthetase that converts glutamate into glutamine (Eid et al., 2004). 
Such an impairment of the glutamate–glutamine cycling in astrocytes can lead to cytosolic 
glutamate buildup which can impede the operation of glutamate transporters, ultimately 
leading to extracellular glutamate accumulation. Another explanation for increased 
extracellular glutamate can be astrocytic Ca2+ -mediated release of glutamate (Carmignoto and 
Haydon, 2012). Astrocytes respond to synaptic activity by increasing intracellular Ca2+ through 
various ionotropic and metabotropic receptors many of which are upregulated after seizures 
(Aronica et al., 2000). The elevation of astrocytic Ca2+ is then reflected in gliotransmission of 
glutamate, ATP, D-serine, prostaglandins and cytokines, all of which are known to modulate 
synaptic activity (Bezzi and Volterra, 2001). 
 Astrocytes in MTLE-HS undergo dramatic changes and acquire an atypical phenotype 
suggesting their crucial role in the pathogenesis of epilepsy. The most apparent astrocytic 
change in MTLE-HS is the morphology. Astrocytes in physiological state retain their 
anatomical domains and there is very little interdigitation in their processes (Bushong et al., 
2002). However, seizure induced abolition of astrocytic domains have been demonstrated in 
mice (Oberheim et al., 2008). In human MTLE-HS, astrocyte-like cells expressing the markers 
GFAP and S100β show atypical morphology. Their intense GFAP labelling with a mesh-like 
network makes identification of a cell body difficult without co-labelling with S100β. Although 
these cells display a complex current pattern resembling that of an NG2 cell, they do not 
express the NG2 cell marker PGFRα (Bedner et al., 2015). In response to glutamate, they show 
linear current voltage relationship, indicating the presence of ionotropic receptors. The 
glutamate induced inward currents in these astrocytes are incompletely blocked by glutamate 
receptor blockers indicating co-expression of glutamate receptors and transporters. They are 
also completely devoid of astrocytic coupling (discussed in section 1.3.3) supporting the notion 
of lack of bona fide astrocytes in MTLE-HS (Bedner et al., 2015). 
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1.3.3 Astrocytic uncoupling in epilepsy 
A tracer injected into an astrocyte spreads throughout the astrocytic network if individual cells 
of the network are gap junction coupled. Such a coupling although present in MTLE without 
sclerosis, is completely absent in MTLE-HS (Bedner et al., 2015). In order to investigate the 
time course of this phenomenon in epileptogenesis, a mouse model of epilepsy involving 
intracortical injection of kainate over the right hippocampus was developed. Such an injection 
resulted in status epilepticus (0 to 12 h) followed by a seizure free latent phase (till ~5 d) and 
thereafter a phase of spontaneous seizures (chronic phase). In this mouse model, three months 
after the kainate injection, the hippocampus on the injected side (ipsilateral) displayed many 
features of MTLE-HS. Importantly, the ipsilateral astrocytes were devoid of gap junctional 
coupling. Uncoupling continued to exist at 6 months and 9 months post injection.  This 
uncoupling of astrocytes was however found to evolve gradually. As early as 4 h after kainate 
injection, the astrocytes lost ~50% of their coupling network when compared with the 
astrocytes from the non-injected side (contralateral). Interestingly, at this time point, late stage 
apoptosis in neurons was absent. As expected, astrocytic uncoupling in the ipsilateral 
hippocampus resulted in dysregulation of extracellular K+ (Bedner et al., 2015). 
After losing 50% of coupling at 4 h post injection, the ipsilateral astrocytes continued to remain 
so till 5 d. At this time point, the majority of mice were still in the latent phase. Thus, astrocytic 
uncoupling observed initially, preceded the phase of spontaneous seizures highlighting its role 
in epileptogenesis. An important mechanistic insight into the uncoupling phenomenon was 
obtained when kainate injection failed to cause uncoupling in toll-like receptor 4 (TLR-4) 
knock-out mice (Bedner et al., 2015). Toll-like receptor 4 is expressed in astrocytes and is 
known to mediate downstream effects of inflammation. Indeed, the inflammatory cytokines 
tumor necrosis factor α (TNFα) and interleukin 1β (IL-1β) were able to uncouple astrocytes 
(Bedner et al., 2015). It was not though clear how these changes affected the gap junctions in 
astrocytes.  
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Figure 1.3.3: Astrocytic uncoupling in human and experimental epilepsy. Astrocytic coupling was 
assessed with biocytin-spread in human and mouse hippocampi. Human MTLE-HS (A) and mouse 
ipsilateral hippocampus 3 months post kainate injection (B1) were completely devoid of coupling. 4 h 
post kainate injection, coupling in the ipsilateral hippocampus was reduced by ~50% (B2). However, 
there were no TUNEL positive cells, indicating absence of late stage apoptosis (B3). TUNEL-positive 
cells begin to appear at 6 h post injection (B3). Figure adopted from Bedner at al., 2015.
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2 Aims of the study  
 
Gap junction-mediated astrocytic coupling which plays an important role in the physiological 
functions of astrocytes, is lost in epilepsy (Bedner et al., 2015). An obvious implication of the 
widespread uncoupling in astrocytes is disturbed ion and neurotransmitter homeostasis. 
Accumulation of extracellular K+ and glutamate as a result of astrocytic uncoupling is expected 
to generate and sustain spontaneous epileptiform activity. Accordingly, strategies targeting a 
prevention of astrocytic uncoupling or rescue of astrocytic coupling in epilepsy have 
therapeutic potential. In order to devise such a strategy, an understanding of the molecular 
modifications in gap junctions leading to uncoupling is indispensable. Cx43 and Cx30, which 
form gap junctions in astrocytes, are subject of dynamic regulation throughout their life cycles. 
Little is known about the seizure induced alterations in astrocytic connexins resulting in 
uncoupling. Knowledge of these alterations can shed a light on the molecular basis of astrocytic 
uncoupling and thereby help in formulating preventive or rescue strategies for the same.  
Therefore, the main aim of this study was to unravel seizure induced modifications in astrocytic 
connexins which lead to uncoupling. In order to achieve this goal, the study was divided into 
three main objectives. 
(I) Pattern of connexin expression, distribution and phosphorylation in hippocampi from 
epilepsy patients: This part of the study was intended at exploring connexins in the context of 
hippocampal sclerosis. Previous studies assessing astrocytic connexin expression in epilepsy 
patients were inconsistent and inconclusive regarding the functional outcome (Coulter and 
Steinhäuser, 2015) as they did not consider the distribution and phosphorylation of connexin. 
The present study was designed to overcome these limitations by utilizing cellular 
fractionation, phospho-specific antibodies and expansion microscopy techniques.  
(II) Evaluating whether the abovementioned parameters from human specimens are 
recapitulated in the mouse model of epilepsy: An experimental animal of epilepsy in mouse 
can be extremely useful for examining the time course of events in epileptogenesis. The 
relevance of an animal model is depicted by its resemblance with the human condition. The 
mouse model involving intracortical injection of kainate employed by Bedner et al., was used 
for the present study as well. In this model, three months after kainate injection, the 
morphological features and astrocytic uncoupling in the mouse hippocampus are similar to 
those observed in human epilepsy (Bedner et al., 2015). Consequently, to mimic the findings 
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from human specimens (Objective I), the three months’ time point was assessed in the mouse 
model. 
(III) Investigating connexins in the early phase of the mouse model of epilepsy: In the mouse 
model, astrocytic uncoupling is observed as early as 4 h post injection without any detectable 
neuronal death. The level of uncoupling remained at approximately the same level in mice 
which were in the latent phase at day 5 post injection (Bedner et al., 2015). Thus, the 
uncoupling takes place before the onset of spontaneous seizures, indicating its potential role in 
epileptogenesis. Understanding molecular mechanisms of astrocytic uncoupling in the early 
phase of epilepsy might be useful in the understanding of epileptogenesis itself. In order to 
unravel these mechanisms, astrocytic connexins were investigated in the early phase of the 
mouse model of epilepsy. 
All these three objectives were aimed at finding out what seizure does to astrocytic connexins. 
Another objective was aimed to evaluate how astrocytic connexins contribute to post seizure 
GCD and neurogenesis. For this purpose, mice with astrocytic deletion of connexins and fate 
mapping techniques were utilized. 
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3 Materials and Methods 
 
 
3.1 Biological specimens 
3.1.1 Hippocampal specimens from patients 
A total of 38 hippocampal specimens were obtained from patients with pharmacoresistant 
MTLE and were divided into two broad categories based on prior histopathological diagnosis. 
The first category involved 19 specimens, hereafter referred to as the sclerotic group, and 
revealed hippocampal sclerosis characterized by severe neuronal loss, atrophy and intense 
GFAP immunoreactivity in the Ammon’s horn. The other 19 patients constituted the ‘non-
sclerotic group’ as they did not show any significant hippocampal atrophy or neuronal death. 
However, mild to moderate astrogliosis and/or microglia activation was present in many of the 
specimens in the non-sclerotic group (Table 3.1.1). In all patients, the generation of temporal 
lobe seizures had been traced to the hippocampus as shown by non-invasive and invasive 
diagnostics described elsewhere (Elger et al., 1993)(Behrens et al., 1994). Informed consents 
were obtained from all patients for additional morphological studies. All procedures were 
approved by the ethics committee of Bonn University Medical center and conform to standards 
set by the Declaration of Helsinki (1989). For immunohistochemistry, specimens were fixed 
in 4% paraformaldehyde (PFA) (pH 7.4) for 12 h at 4˚C. For Western blotting, specimens were 
snap frozen in liquid nitrogen for 5 min and then were stored at -80˚C until further use. 
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Table 3.1.1:  Patient information 
AHS: Ammon’s Horn Sclerosis,  F: female, M: male 
Category Patient Gender Age (Years) Diagnosis 
Sclerotic 
1 F 28 AHS  
3 F 11 AHS  
5 F 20 AHS 
7 F 27 AHS  
9 M 21 AHS 
11 M 18 AHS + Dysembryoplastic neuroepithelial tumour 
13 M 24 AHS  
15 M 17 AHS (Endfolium sclerosis) 
17 M 31 AHS 
19 M 35 AHS 
21 M 48 AHS 
23 F 50 AHS 
25 F 22 AHS 
27 F 48 AHS 
29 M 40 AHS 
31 F 41 AHS 
33 M 26 AHS 
35 F 17 AHS 
37 M 51 AHS 
Non-
sclerotic 
2 M 16 Middle cerebral artery infarction right 
4 M 10 Multifocal dysplasia of the left hemisphere 
6 F 43 Glioblastoma multiforme 
8 F 8 Rasmussen encephalitis 
10 F 47 Rasmussen encephalitis 
12 M 3 Rasmussen encephalitis  
14 M 19 Loss of grey-white matter differentiation 
16 M 11 Rasmussen encephalitis 
18 M 21 Loss of grey-white matter differentiation 
20 M 48 Non-AHS  
22 M 11 Dysembryoplastic neuroepithelial tumour 
24 F 30 Rolando-epilepsy  
26 M 38 Focal cortical dysplasia 
28 M 13 Ganglioglioma 
30 M 18 Reactive astrogliosis 
32 M 22 Focal cortical dysplasia 
34 M 47 Cavernous hemangioma 
36 F 24 Dysembryoplastic neuroepithelial tumour 
38  Glioblastoma multiforme, no epilepsy 
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3.1.2 Animals 
Maintenance and handling of animals was according to the local government regulations. 
Experiments were approved by the state office of North-Westphalia, (LANUV approval 
number 84-02.04.2015.A393). Mice were kept under standard housing conditions (12 h/12 h 
dark-light cycle, food and water ad libitum). Wild-type mice (FVB and Black 6 background) 
and transgenic mice lacking Cx30 and Cx43 in GFAP-positive cells (Cx30–/–/Cx43fl/fl-
hGFAP-Cre mice) of 90-120 d age were used. The MTLE animal model was established by 
unilateral intracortical kainate injection as described before (Bedner et al., 2015). All kainate 
injections were performed by Dr. P. Bedner, Institute of Cellular Neurosciences, Bonn. Briefly, 
the mice were anesthetized (medetomidine (0.3 mg/kg, i.p.) and ketamine (40 mg/kg, i.p.)) and 
placed in a stereotaxic frame equipped with a manual microinjection unit (TSE Systems 
GmbH, Bad Homburg, Germany). Seventy nl of a 20 mM solution of kainate (Tocris, Bristol, 
UK) in 0.9% sterile NaCl were stereotactically injected into the neocortex just above the right 
dorsal hippocampus. The stereotactic coordinates were 1.9 mm posterior to bregma, 1.5 mm 
from midline and 1.7 mm from the skull surface. Control mice were given injections of 70 nl 
saline under the same conditions. After injection the scalp incision was sutured and anesthesia 
stopped with atipamezol (300 mg/kg, i.p.).  Brains from these mice were perfusion fixed with 
4% PFA at the following time points: 4 h, 5 d, 1 month and 3 months. For Western blotting, 
entire hippocampi from the dorsal region of the temporal lobe were harvested at the following 
time points post kainate injection: 4 h, 5 d, and 3 months.  The harvested tissues were snap 
frozen in liquid nitrogen followed by storage at -80 ºC until further use. 
 
 
 
 
 
Figure 3.1.2: Schematic diagram illustrating intracortical kainate injection 
 
Stereotactical coordinates 
Anteroposterior (AP) = -1.9 
mm Lateral (Right) = 1.5 mm 
Dorsoventral = 1.7 mm 
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3.2 Materials 
3.2.1 Chemicals, solutions and reagents  
Product Company 
Acetic acid Sigma Aldrich, Munich, Germany  
Acetonitrile Sigma Aldrich, Munich, Germany  
Acrylamide solution (Rotiphorese Gel 30 (37, 5:1) Carl Roth, Karlsruhe, Germany 
Albumin fraction V AppliChem, Darmstadt, Germany 
Ammonium bicarbonate Sigma Aldrich, Munich, Germany 
5-Bromo-2′-deoxyuridine (BrdU) Sigma Aldrich, Munich, Germany 
Dithiothreitol (DTT) Carl Roth, Karlsruhe, Germany 
Ethanol Carl Roth, Karlsruhe, Germany 
Gel Code blue safe protein stain Pierce (Now Thermo Scientific 
Waltham, MA, USA) 
Hoechst 33258 Sigma Aldrich, Munich, Germany 
Iodoacetamide Sigma Aldrich, Munich, Germany 
Isopropanol Carl Roth, Karlsruhe, Germany 
Ketamine 10% Bela Pharma, Vechta, Germany 
Methanol Carl Roth, Karlsruhe, Germany 
Milk powder (non-fat) Carl Roth, Karlsruhe, Germany 
NativeMark™ Unstained Protein Standard Invitrogen (Now Thermo Scientific 
Waltham, MA, USA) 
Normal Goat Serum (NGS) Chemicon (Now Merck Millipore, 
Darmstadt, Germany) 
Normal Donkey Serum (NDS) Carl Roth, Karlsruhe, Germany 
PageRuler Thermo Scientific Waltham, MA, USA 
Paraformaldehyde Sigma Aldrich, Munich, Germany 
Permafluor mounting medium  Thermo Scientific Waltham, MA, USA 
Phosphate Buffered Saline  Gibco (Now Thermo Scientific 
Waltham, MA, USA) 
Protease and phosphatase inhibitor cocktail Pierce (Now Thermo Scientific 
Waltham, MA, USA) 
Protein A beads Invitrogen (Now Thermo Scientific 
Waltham, MA, USA) 
Roti-Load buffer (Laemli buffer 4x) Carl Roth, Karlsruhe, Germany 
TritonX-100 Sigma Aldrich, Munich, Germany 
Tween-20 AppliChem, Darmstadt, Germany 
Tetramethylethylenediamine (TEMED) Carl Roth, Karlsruhe, Germany 
Xylazine Ceva, Dusseldorf, Germany 
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3.2.2 Kits  
Product (Company) Purpose  
BCA assay kit (Pierce, now Thermo Scientific) Estimation of protein concentration 
Plasma membrane protein extraction Kit (Abcam) Isolation of plasma membrane proteins 
Click-iT® TUNEL Alexa Fluor® Imaging Assay 
(Invitrogen, now Thermo Scientific) 
Detection of apoptosis  
WesternBright® Sirius HRP substrate (Advansta) Substrate for visualizing HRP activity 
 
3.2.3 General materials 
Material Company 
Gloves Ansell ltd, Staffordshire, UK 
Mice surgery equipment  Fine Science Tools (F.S.T), Germany 
Microscopic slides Thermoscientific, Braunsweig, Germany 
Pasteur pippetts Carl-Roth, Karlsruhe, Germany 
Pipette tips Greiner GmbH, Frickenhausen, Germany 
Native Protein gels (4-16 %) Invitrogen/Thermo Scientific, Waltham, MA, USA 
PVDF membrane Millipore, Schwalbach, Germany 
Sterile filters Millipore, Schwalbach, Germany 
Syringes, Venofix safety Braun, Melsungen, Germany 
Whatman paper Whatman International, Maidstone, UK 
 
3.2.4 Softwares  
Software Application Company 
Gene Tools Quantification of Western blots Genegnome , UK 
ImageJ Image analysis NIH,  USA 
Proteome Discoverer  MS Raw data processing  Thermo Fisher Scientific, USA 
Mascot Peptide identification Matrix Science Ltd, UK 
Huygens Essential Deconvolution Scientific Volume Imaging 
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3.2.5 Instruments 
Instrument Company 
Centrifuge 5424 Eppendorf, Hamburg, Germany  
DynaMag magnet Invitrogen (Now Thermo Scientific Waltham, 
USA) 
Gene Gnome Imaging system Synaptics ltd. Cambridge, England 
Heat block VWR, Darmstadt, Germany 
SP8® Laser Scanning Microscope Leica Microsystems, Wetzlar, Germany 
Mini-Protean 3 Cell Biorad, Munich, Germany 
Mini-Trans blot Cell Biorad, Munich, Germany 
pH meter Mettler Toledo, Giessen, Germany 
Rotator PTR-30 Grant Bio 
SDS gel electrophoresis power supply Bio-Rad 
Shaker Grant-Bio, UK 
Vibratome VT1200S Leica, Nussloch, Germany 
Vortexer VWR, Darmstadt, Germany 
Weighing balance Acculab, Sartorius group, Germany 
Western Blotting power supply Biorad, Munich, Germany 
4˚C  Refrigerator Liebherr, Biberach, Germany 
-20˚C Freezer Liebherr, Biberach, Germany 
-80˚C Freezer Thermo Scientific, Bonn, Germany 
 
3.2.6 Buffers for polyacrylamide gel 
   Contents for two gels of 
1.55 mm thickness 
Stacking gel              Resolving gel 
4% 10% 12.50% 
Rotiphorese gel 30 1.66 ml 6.66 ml 8.33 ml 
50 mM Tris buffer  (pH 6.8) 2.5 ml     
150 mM Tris buffer (pH 8.8)   5 ml 5 ml 
Distilled water 5.63 ml 7.92 ml 6.25 ml 
TEMED 10 µl 20 µl 20 µl 
APS (10 %) 100 µl 200 µl 200 µl 
SDS 100 µl 200 µl 200 µl 
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3.2.7 Buffers for electrophoresis and Western blotting 
Buffer  Concentration Composition 
Protein lysis buffer (RIPA buffer, 
modified) (pH adjusted to 7.4) sterile-
filtered, stored at -20°C 
50 mM Tris-base 
150 mM NaCl 
0.5 % v/v Nonidet P-40 (NP40) 
0.5 % w/v Sodium Deoxycholate 
1 % v/v TritonX-100 
   
Plasma membrane protein buffer (4 % 
Dodecyl maltoside) (pH adjusted to 7.4) 
50 mM Bis-Tris 
40 mM  NaCl 
4% Dodecyl maltoside 
   
SDS-running buffer  (pH 8.3) 0.25 M Tris-base 
1.92 M Glycine 
1 % v/v SDS  
   
Transfer buffer  (pH 8.3) 0.25 M Tris-base 
1.92 M Glycine 
   
Tris-buffered saline with Tween-20 
(TBST) (pH adjusted to 7.4) 
0.25 M Tris-base 
150 mM NaCl 
0.05 % v/v Tween 20 
 
3.2.8 Buffers for Blue Native PAGE 
Buffer  Concentration Composition 
Anode buffer (pH adjusted to 7) 50 mM Bis-Tris 
   
Cathode buffer (pH adjusted to 7) 50 mM Tricine 
15 mM Bis-Tris 
0.02% Coomassie G 250 
   
Cathode buffer/10 (pH adjusted to 7) 50 mM Tricine 
15 mM Bis-Tris 
0.002% Coomassie G 250 
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3.2.9 Buffers for expansion microscopy 
Monomer solution 
Chemicals Concentration (%) Volume (ml) for 9.4 ml 
38 % Sodium acrylate 8.6 2.25 
50% Acrylamide 2.5 0.5 
2 % N,N′-Methylenebisacrylamide 0.15 0.75 
29.2% Sodium chloride 11.7 4 
1x PBS 10 1 
Deionized water   0.9 
Gelling solution 
Chemicals Concentration (%) Volume (µl) for 300 µl) 
Monomer solution 282 
0.5% 4-hydroxy-TEMPO 0.01 6 
10% TEMED 0.2 6 
10% APS 0.2 6 
Digestion buffer 
Chemicals Concentration Volume (µl) for 5 ml 
Tris pH 8.0 50 mM 250 
0.5M EDTA 1 mM 10 
10% Triton X-100 0.50% 250 
8 M Guanidine-HCl 0.8 M 500 
Proteinase K 16 units/mL 100 
Deionized water 3890 
   
3.2.10 Primary antibodies 
IF: Immunofluorescence, IB: Immunoblotting 
Antigen Species Dilution ratio Company/Reference 
BrdU rat IF 1: 500 AbD Serotec 
CD31 Mouse IF 1: 200 Abcam 
Goat IF 1: 200 R&D systems 
Cx43 360-382 rabbit IF 1: 500 Custom  made (Perbioscience) 
IB 1: 1000 
Cx43 363-382 rabbit IF 1: 500 Sigma 
IB 1: 1000 
Cx43NT1 mouse IB 1: 200 FHCRC 
Cx43 phospho S262 rabbit IB 1: 1000 Santa Cruz Biotech 
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Cx43 phospho S255 rabbit IB 1: 1000 Santa Cruz Biotech 
Cx43 phospho S368 rabbit IB 1: 1000 Invitrogen 
Cx30 rabbit IF 1: 500 Invitrogen 
IB 1: 250 
DCX goat IF 1: 100 Santa Cruz Biotech 
GAPDH mouse IB 1: 5000 Abcam 
GFAP mouse IF 1: 500 Chemicon 
rabbit IF 1: 500 Dako 
IB 1: 1000 
Iba1 rabbit IF 1: 500 Dako 
Prox1 rabbit IF 1: 2500 Chemicon 
NG2 Mouse IF 1: 100 Millipore 
PDGFR β Goat IF 1: 600 RD systems 
S100 β Mouse IF 1: 1000 Abcam 
Rabbit IF 1: 500 Abcam 
   
3.2.11 Secondary antibodies 
IF: Immunofluorescence, IB: Immunoblotting 
Product Species Dilution ratio Company 
Anti-mouse HRP sheep IB 1: 6000 GE Healthcare 
Anti-rabbit HRP donkey IB 1: 6000 GE Healthcare 
Anti-rat biotinylated donkey IF 1: 500 Jackson Immunoresearch 
Alexa fluor 488 donkey anti-goat IF 1: 200 Invitrogen 
Alexa fluor 488 goat anti-mouse IF 1: 500 Invitrogen 
Alexa fluor 488 goat anti-rabbit IF 1: 500 Invitrogen 
Alexa fluor 488 donkey anti-rabbit IF 1: 500 Invitrogen 
Alexa fluor 594 goat anti-mouse IF 1: 500 Invitrogen 
Alexa fluor 594 goat anti-rabbit IF 1: 500 Invitrogen 
Alexa fluor 594 donkey anti-goat IF 1: 500 Invitrogen 
Alexa fluor 647 donkey anti-rabbit IF 1: 300 Invitrogen 
Alexa fluor 647 goat anti-mouse IF 1: 500 Invitrogen 
Alexa fluor 647 goat anti-rabbit IF 1: 500 Invitrogen 
Alexa fluor 568 donkey anti-goat IF 1: 200 Jackson ImmunoResearch 
Biotin donkey anti-rabbit IF 1: 200 Jackson ImmunoResearch 
Streptavidin (Alexa 
Fluor 647) 
 IF 1: 500 Jackson ImmunoResearch 
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3.3 Methods 
3.3.1 Fixation and sectioning of brains  
Mice were perfusion fixed as follows. They were first anesthetized with intraperitoneal 
injection (100 µl each) of Xylazine and Ketamine (in the ratio 3:2). Using small scissors, the 
ribcage was opened up and the pericardium was exposed.  A 25-G needle connected with PBS 
and PFA sources was inserted into the left ventricle. An incision was made into the right 
ventricle in order to make an exit for the blood flow. 20 ml PBS (pH 7.4) was slowly injected 
into the left ventricle to remove blood, followed by further pumping of 20 ml 4% PFA for 
fixation. After perfusion, the brains were isolated by opening up the skull and then were fixed 
again in 4% PFA overnight at 4°C. The next day, brains were transferred in vials containing 
PBS and stored until further use. They were cut into 40 µm thick coronal sections with the help 
of a vibratome. The sections were stored in PBS containing 0.01% sodium azide. 
Human hippocampal specimens obtained during surgeries (performed at the Department of 
Neurosurgery, University Clinic, Bonn) were fixed in 4% PFA overnight followed by storage 
in PBS. They were cut into 20 µm thick sections with the help of a vibratome. For expansion 
microscopy, 60 µm thick sections were made. The sections were stored in PBS containing 
0.01% sodium azide. 
3.3.2 General procedure for immunohistochemistry  
Brain slices prepared as described in 3.3.1 were washed 3 times (5 min each time) with PBS to 
remove the sodium azide and residual PFA. After permeabilization and blocking (2 h, room 
temperature) with 0.5% Triton X-100 and 10% normal goat serum (NGS) (or 10% normal 
donkey serum, NDS) in PBS, the sections were incubated overnight (4°C) in 5% NGS (or 
NDS) in PBS containing 0.1% Triton X-100 and primary antibodies (listed in Table 3.2.10). 
After washing  three times with PBS (5 min each time), the sections were incubated with 
secondary antibodies conjugated with Alexa Fluor® 488, Alexa Fluor® 594 or Alexa Fluor 
®647 (Invitrogen, dilution 1:500 each) in PBS with 2% NGS (or 2% NDS)  and 0.1% Triton 
X-100  for 1.5 h at room temperature. For immunostaining of PDGFRβ and CD31, NGS in the 
blocking solutions was replaced by NDS, and the secondary antibodies were also changed 
accordingly. For the immunostaining of albumin, no serum was used in the blocking solutions.  
For the histochemical detection of the vasculature in the hippocampus, biotinylated 
lycopersicon esculentum (tomato) lectin (Vector laboratories) was used. In brief, after 
overnight incubation with primary antibodies, the diluted lectin (dilution 1:100) was added to 
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the sections and incubated for 30 min at room temperature, then the mixture of streptavidin 
coupled with Alexa Fluor ®647 (1:500, Invitrogen) and other appropriate secondary antibodies 
was added to the sections. Sections were washed three times after each incubation. 
Alternatively, CD31 was used to visualize the vasculature. 
3.3.3 Expansion microscopy  
(Performed in collaboration with Dr. M. Herde, Institute of Cellular Nuerosciences, Bonn). 
The expansion microscopy protocol with conventional primary and secondary antibodies was 
adopted from Chen et al., 2015 and Chozinski et al., 2016 (Chen et al., 2015)(Chozinski et al., 
2016). A schematic procedure is depicted in Figure 3.3.3. Hippocampal slices were stained as 
described in section 3.3.2. For Cx43 labelling, biotinylated anti-rabbit secondary antibody was 
used. The sections were then incubated with 1 mM methylacrylic acid-NHS (Sigma Aldrich) 
linker for 1 h. After washing in PBS 3 times, sections were incubated with monomer solution 
containing 8.6% sodium acrylate, 2.5% acrylamide, 2% N, N′-Methylenebisacrylamide and 
29.2% sodium chloride in PBS for 45 min. A gelling solution was prepared by adding APS 
(0.2 %), TEMED (0.2 %) and 4-hydroxy-TEMPO (0.01 %) to the monomer solution. Slices 
were placed in the gelling solution on a glass slide and the preparation was covered with a 
coverslip. After 2 h of incubation at 37°C, the coverslip was removed and the excess gel around 
the slice was removed. The gel pieces containing the tissue slices were incubated overnight at 
37˚C in a digestion buffer containing 50 mM Tris, 0.5 % Triton-X100, 1 mM EDTA, 0.8 M 
guanidine hydrochloride and 16 U/ml of proteinase K (pH 8). The next day, the digestion buffer 
was removed and the gel pieces were incubated with streptavidin coupled with Alexa 647 for 
1.5 h. They were then washed with deionized water. After five washes (2.5 h), slices were 
transferred to a custom mounting chamber filled with distilled water, mounted by superglueing 
its edges to the chamber’s bottom and sealed with a coverslip on the top. All imaging was 
performed on a Leica SP8 confocal microscope using a 40x/1.1NA objective and hybrid 
detectors. The expansion factor was determined by measuring gel sizes before and after 
expansion. Images were deconvolved with Huygens Essential® (Scientific Volume Imaging). 
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Figure 3.3.3: Schematic diagram describing expansion microscopy. Prior to the linking step, a 
standard protocol for immunohistochemistry was followed. Expansion was carried out by washing the 
gel-containing tissue slices in deionized water. F stands for the fluorophore attached to a secondary 
antibody. 
3.3.4 TUNEL assay for detection of apoptotic cells 
Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) was performed with 
the Click-iT® TUNEL Alexa Fluor Imaging Assay (Invitrogen) according to the 
manufacturer’s instructions. Briefly, 15 µm cryostat cut sections were placed on Superfrost® 
plus glass slides. They were then fixed with acetone for 2 min at room temperature 
(alternatively with 4% PFA for 15 min), air dried and a hydrophobic barrier (Roti-Liquid 
Barrier Marker, Roth) was applied around the sections, followed by wash with PBS. Sections 
were permeabilized with 0.25% Triton X-100 in PBS.  A positive control was prepared by 
incubating some of the sections with DNAse I for 30 min at room temperature. TdT reaction 
cocktail was prepared by mixing the following components: 
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                                                TdT reaction buffer (Component A):     94 µl 
    EdUTP (Component B):                 2 µl 
    TdT (Component C):         4 µl 
    --------------------------------------------------- 
    Total:      100 µl 
The reaction was allowed to take place for 1 h at 37˚C after which it was terminated by 
removing the reaction cocktail and washing the sections twice with 3% BSA in PBS for 2 min 
each time. Click-iT® reaction cocktail, in which the sections were incubated for 30 min at 
room temperature, was prepared as follows:  
 
Click-iT reaction buffer (Component D):    97.5 µl 
Click-iT reaction buffer additive (Component E):     2.5 µl 
-------------------------------------------------------------------------------------- 
         100 µl 
The reaction was terminated by removing the reaction cocktail and washing the sections 3 
times with 3% BSA in PBS for 2 min each time. 
For GFAP staining, sections were blocked with 5% NGS, 0.125% TritonX-100 in 1x PBS (pH 
7.4) for 1 hr at room temperature and incubated with mouse GFAP antibody (1:400) in 2% 
NGS, 0.125% TritonX-100 in 1x PBS (pH 7.4) for 1h at RT. The sections were washed three 
times for 5 min each with 1x PBS followed by incubation with goat anti mouse Alexa Fluor 
488 (1:500) secondary antibody in 2% NGS, 0.125 % TritonX-100 in 1x PBS (pH 7.4) for 1h 
at room tempreature. Sections were washed three times with 1x PBS for 5 min each, followed 
by staining for nuclei with Draq5 (1:1000, Biostatus ltd, Leicestershire, UK) in 1x PBS for 10 
min at room temperature followed by two short washes, drying of the sections and mounting 
using Permafluor® mounting medium. 
3.3.5 BrdU administration and staining procedure 
Mice were given BrdU (1 mg/ml) through drinking water containing 1% sucrose for 14 days 
post intracortical kainate injection. BrdU administration was started 24 h after the kainate 
injection. From the 16th day after kainate injection, mice were given normal drinking water 
(Figure 3.3.5). They were perfused and the brains were processed as described in 3.3.1. Before 
immunostaining an antigen retrieval procedure was performed. Briefly, sections were 
incubated with 2 N HCl for 30 min. After washing with PBS, any remaining HCl in the sections 
was neutralized by incubating the sections in 0.1 M borate buffer for 10 min. The sections were 
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immunostained as outlined in section 3.3.2. Normal donkey serum was used as a blocking 
agent in all solutions. Rat anti- BrdU antibody was used at the concentration of 1:500. Donkey 
anti-rat secondary antibody coupled with Alexa 594 was used to visualize BrdU incorporated 
into the nuclei. 
 
 
 
 
 
Figure 3.3.5: Design of the experiment for BrdU-based assessment of cell proliferation. BrdU 
solution was freshly prepared every 5 days and it was protected from light. 
3.3.6 Image acquisition and cell counting 
A laser confocal microscope (Leica SP8®) was used to acquire all the images. For cell 
counting, 63x or 40x magnification images were taken while for Cx43 stereology, only 63 x 
magnification was used with an optical thickness of 1 µm. 1024 x 1024 pixel frame was used 
in all of the images. Images intended for fluorescence intensity and stereological analysis were 
acquired with the Leica HyD hybrid® detector in a standard mode. Other images were acquired 
with a photo-multiplier tube (PMT) detector. 184.52 X 184.52 X 30 µm3 counting boxes (boxes 
1, 2 and 3 in Figure 3.3.6) were positioned in the SR region of CA1 for cell counting (for 
example astrocytes, microglia, and endothelial cells) or for Cx43 stereology. Cell counting in 
the DG (for example granule cells, newly generated neurons and astrocytes) was performed in 
290 x 290 x 8 µm3 counting boxes (boxes 4, 5 and 6 in Figure 3.3.6). The first counting box in 
the DG was positioned 250 µm away from the tip of the granule cell layer as shown in Figure 
3.3.6. The cell numbers (or values for any other parameter) were averaged across all boxes in 
the same region.  
 
 
 
 
Kainate 
injection 
Normal 
water 
BrdU 1 mg/ml (in 1 % sucrose) 
Day 0 Day 1 Day 15 Day 30 
Normal water 
Perfusion 
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Figure 3.3.6: Positions of the counting boxes. Hoechst fluorescence image showing cell nuclei in the 
hippocampus. Boxes with the dotted lines represent the region of interests in which cell counting or 
Cx43 stereological analysis was performed. Values from the boxes 1, 2 and 3 were used to get the mean 
value for the CA1 region. Similarly, values from the boxes 4, 5 and 6 were used to get the mean value 
for the DG region.  
 
3.3.7 Stereology 
A point counting method was used to quantify the vascular density (Rigau et al., 2007). The 
resulting parameter called ‘point count’ is influenced not only by the number of vessels present 
in a given area but also by the size and tortuosity of the vessels. Briefly, a 5 x 5 grid was 
superposed onto the digitized image of the CA1 region (including all layers of the CA1) (Figure 
3.3.7 A). The numbers of intersections made by blood vessels with this grid were counted. At 
least three sections (slices) were used per mouse or patient. The point counts were first 
averaged across sections and then across mice or patients. Cx43 immunostaining was analyzed 
to extract the plaque dimensions. Confocal images acquired at constant settings were used to 
extract the following parameters using the image analysis software Fiji (Schindelin et al., 
2012): average fluorescence intensity, the area occupied by the Cx43 signal, average plaque 
size, plaque number and the distribution ratio. Images were converted into 8-bit format and 
were thresholded at 3 different values 55-255, 75-255 and 90-255. All of these thresholding 
conditions maintained the statistical inference between the experimental groups. Therefore, the 
intermediate thresholding condition (75-255) was used for further analysis. The values were 
recorded for each optical plane and then averaged across all the planes in a slice from mouse 
or a patient. Mean pixel intensity and the distribution ratio was measured in non-thresholded, 
12-bit images. Pixel intensities or grey values were measured in arbitrary units (a.u.).  
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The distribution ratio was calculated as the ratio of average Cx43 intensities around the blood 
vessels to the intensities in the rest of the tissue. The region around the blood vessel was defined 
as a 5 µm wide rim from the innermost margin of Cx43 around blood vessel into the brain 
parenchyma (Figure 3.3.7 B). For each mouse or patient, these values were obtained from 3 
slices and then they were averaged. 
 
 
 
 
 
 
 
 
 
Figure 3.3.7: Examples of point count and distribution ratio estimation. A) A 5 x 5 grid 
superimposed on an image displaying CD31 positive blood vessels in the CA1 region. A point count is 
the number of intersections made by the blood vessels with the superimposed grid. B) CD31-Cx43 
immunostaining displaying the regions of interests, A (5 µM thick rim around the blood vessel) and B 
(rest of the image without region A). The distribution ratio is defined as the ratio of mean Cx43 
fluorescence intensity in region A to that in region B. 
3.3.8 Preparation of total cellular protein lysates (whole-cell protein 
lysates) 
Dorsal hippocampi from mice or surgically resected hippocampal specimens from epilepsy 
patients were snap frozen in liquid nitrogen and stored at -80˚C until further use. The tissues 
were homogenized with the help of a plastic or glass pestle in a modified RIPA buffer 
(containing 150 mM NaCl, 50 mM Tris, 1% Triton X-100, 0.5% sodium Deoxycholate, 0.5% 
NP-40, pH 7.4). Halt® protease and phosphatase inhibitor cocktail was added in 1:10 v/v ratio. 
The resultant cell suspension was sonicated in a bath sonicator three times for 30 s each, with 
incubation on ice for one min after each sonication.  The lysates were then passed through a 
prechilled 27 gauge syringe 5 times. Protein concentration was measured using a BCA assay 
kit (Pierce/Thermo Scientific). Proteins were aliquoted and stored at -80˚C.  
CD31 Cx43  CD31 
A) B) 
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3.3.9 Plasma membrane protein isolation 
Plasma membrane-associated proteins were isolated from mouse or human hippocampi using 
‘Plasma Membrane Protein Extraction Kit’ (Abcam) as per the manufacturer’s instructions. 
Halt® protease and phosphatase inhibitor cocktail was added to all buffers in the kit (1:10 v/v 
ratio). The tissues were homogenized in the homogenization buffer supplied with the kit. The 
homogenized tissue suspension was sonicated in supersonic bath 3 times for 30 s each. The 
sonications were interspaced with incubations on ice for 1 min. The resultant lysate was 
centrifuged at 11000xG for 30 min. The supernatant contained the cytoplasmic fraction while 
the pellet contained the total membrane fraction. The pellet was then extracted with the two 
partially miscible polymer solutions provided with the kit. The plasma membrane proteins are 
enriched in the upper phase of the polymer mixture. After series of extractions and 
centrifugations, a final pellet enriched in plasma membrane proteins was obtained.  This pellet 
was dissolved in 4% didodecyl maltoside in 50 mM Bis-Tris buffer containing ‘Halt® Protease 
and Phosphatase Inhibitor Single-Use Cocktail’ (Thermo Scientific) and then stored at -80˚C. 
3.3.10  SDS PAGE and Western blotting 
Five µg (plasma membrane fraction) or 30 µg (total cellular lysate) of protein from each sample 
was subjected to 4-12.5% SDS PAGE. The separated proteins were transferred to PVDF 
membranes by the electrophoretic wet transfer method (100 V for 2 h). The blotted membranes 
were blocked with 5% non-fat milk in TBST for 1 h followed by overnight incubation with 
primary antibodies in 2.5% milk. The next day, after 3 times washings in TBST, the membranes 
were probed with ECL™ anti-rabbit or anti-mouse IgG, HRP-linked F(ab)₂ fragment 
(Amersham, dilution 1:5000) in 2.5% milk for 1 h. For phospho-specific antibodies, the 
albumin fraction V (pH 7) was used as a blocking agent in all the steps at the same 
concentrations as that of milk. WesternBright Sirius® Chemiluminescent substrate (Advansta) 
was used to visualize the blots by GeneGnomeXRQ® imager (Syngene). Densitometry was 
performed using GeneTools (Syngene). Band intensities of proteins of interest were 
normalized with loading control intensities (GAPDH for total cellular proteins and cadherin 
for plasma membrane fraction). 
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3.3.11  Blue Native PAGE 
A Blue native PAGE protocol as reported by Wittig et al., (Wittig et al., 2006) was adopted 
with some modifications. Five µg of plasma membrane protein lysate (prepared in 4% dodecyl 
maltoside) was suspended in 10% glycerol and 5% coomassie G 250. The ratio of detergent 
(dodecyl maltoside) to dye (coomassie G 250) was adjusted to 4:1 with diluent 4% dodecyl 
maltoside. Native gels with a gradient of 4 to 16% and a XCell SureLock® Mini-Cell apparatus 
were used for electrophoresis. The inner chamber of the apparatus was filled with cathode 
buffer containing 0.02% coomassie G 250 while the outer chamber was filled with anode 
buffer. A constant voltage of 75 V was applied across the electrodes. After the dye front 
reached 1/3 of total gel length, the inner chamber was refilled with cathode buffer containing 
0.01% coomassie G 250. The run was allowed to continue until the dye front reached the end 
of the gel. Separated proteins on the gel were blotted on PVDF membranes as described in 
section 3.3.10. 
3.3.12  Immunoprecipitation and isolation of Cx43 
The sample preparation workflow is illustrated in figure 3.3.12. Homogenization buffer 
supplied with the ‘Plasma Membrane Protein Extraction Kit’ (Abcam) was used to homogenize 
the dorsal hippocampi (one dorsal hippocampus is equal to approximately half of the whole 
hippocampus from one hemisphere). Halt® protease and phosphatase inhibitor cocktail was 
added to all buffers in the kit (1:10 v/v ratio). The homogenized tissue suspension (350 µl/half 
hippocampus) was sonicated in supersonic slat 3 times for 30 s each. The sonications were 
interrupted with incubations on ice for 1 min. The resultant lysate was centrifuged at 11000 G 
for 30 min. The supernatant contained the cytoplasmic fraction while the pellet contained the 
total membrane fraction. The total membrane fraction pellet was dissolved in 200 µl of 
modified RIPA buffer (containing 150 mM NaCl, 50 mM Tris, 1% Triton X-100, 0.5% sodium 
Deoxycholate, 0.5% NP-40, pH 7.4). The membrane fractions of dorsal hippocampi from two 
mice were pooled together. Membrane fractions from the ipsilateral dorsal hippocampus from 
one mouse were always pooled with the corresponding ipsilateral hippocampus of another 
mouse. Similar pooling was followed for contralateral hippocampi. Such pooled membrane 
lysates were stored at -80˚C until immunoprecipitation. 
One-hundred µl of custom-made anti-Cx43 antibody was coupled with 6 mg of Protein A 
magnetic beads for 1 h.  Membrane lysates from two dorsal hippocampi (total volume 400 µl) 
were added to the bead-antibody mixture and the total volume was adjusted to 700 µl with 
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modified RIPA buffer. All buffers used for immunoprecipitation contained Halt® protease and 
phosphatase inhibitor cocktail in a 1:10 v/v ratio. The bead-antibody-lysate mixture was 
incubated on a rotar for 1 h. The supernatant was then removed with magnetic separation and 
stored at -80˚C. The beads were washed 5 times with PBS.  
The washed beads were heated with 12 µl Laemmli buffer and 36 µl modified RIPA buffer for 
10 min at 65˚C.  The eluate was separated from beads with the help of a magnet. The entire 48 
µl of eluate was subjected to SDS PAGE (4-10% gel). After electrophoretic separation of 
proteins, the gel was washed 3 times in distilled water and then was stained with colloidal 
coomassie G 250 (Gel Code blue, Pierce/ Thermo Scientific) with overnight incubation. The 
next day, the gel was photographed with the help of a GeneGnomeXRQ® imager (Syngene). 
Bands corresponding to 40 kDa were excised with the help of a scalpel blade and then were 
submitted to mass-spectrometric analysis.  
 
 
 
  
 
 
 
 
 
 
 
Figure 3.3.12: Schematic diagram showing sample preparation workflow for mass-spectrometry. 
The eluates obtained from immunoprecipitation reaction were subjected to SDS PAGE and the gel was 
stained with Coomassie G250. The strong band between 40 and 55 kDa represents the heavy chain of 
IgG antibody that was used for immunoprecipitation. Bands at 40 kDa were carved out and were 
subjected to tryptic digestion. (Brain image adapted and modified from Amaral and Witter, 1995) 
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3.3.13  In-gel digestion 
(Performed by Dr. B. Gehrig, Institute of Biochemistry and Molecular Biology, Bonn 
University) 
Gel slices in the molecular weight range of Cx43 were cut into smaller pieces and then were 
subjected to tryptic in-gel digestion. In brief, proteins were reduced with 20 mM DTT, slices 
were washed with 100 mM ammonium bicarbonate, and proteins were alkylated with 40 mM 
iodoacetamide. The slices were washed again and dehydrated with acetonitrile. Slices were 
dried in a vacuum concentrator and incubated with 400 ng sequencing grade trypsin (at 37°C) 
overnight. The peptide extract was dried in a vacuum concentrator and stored at -20°C. 
3.3.14 Liquid chromatography-Mass-Spectrometry (LC-MS) analysis 
(Performed by Dr. M. Sylvester, Institute of Biochemistry and Molecular Biology, Bonn 
University) 
Dried peptides were dissolved in 10 µl of 0.1% formic acid (solvent A). Three µl were injected 
onto a C18 trap column (self-packed, 20 mm length, 100 µm inner diameter, ReproSil-Pur 120 
C18-AQ, 5 µm, Dr. Maisch GmbH, Ammerbuch-Entringen, Germany). Bound peptides were 
eluted onto a C18 analytical column (200 mm length, 75 µm inner diameter, 1.9 μm particles, 
NanoSeparations, Nieuwkoop, Netherlands). Peptides were separated over a linear gradient 
from 6% to 35% solvent B (80% acetonitrile, 0.1% formic acid) within 87 min at a flow rate 
of 320 nl/min. The nanoHPLC was coupled online to an LTQ Orbitrap Velos mass 
spectrometer (Thermo Fisher Scientific, Bremen, Germany). Peptide ions between 330 and 
1600 m/z were scanned in the orbitrap detector with a resolution of 30,000 (maximum fill time 
400 ms, AGC target 106). The 25 most intense precursor ions (threshold intensity 3000) were 
subjected to collision induced dissociation with multiple stage activation and fragments 
analyzed in the linear ion trap. Fragmented peptide ions were excluded from repeat analysis 
for 15 s. 
Raw data processing and analysis of database searches were performed with Proteome 
Discoverer software 2.1.0.81 (Thermo Fisher Scientific). Peptide identification was done with 
an in-house Mascot server version 2.5.1 (Matrix Science Ltd, London, UK) from Proteome 
Discoverer. MS2 data were searched against mouse sequences from SwissProt (release 
2012_07) and a minimized Cx43 database for increased sensitivity. Precursor Ion m/z tolerance 
was 9 ppm, fragment ion tolerance 0.5 Da. b- and y-ion series were included. Tryptic peptides 
with up to two missed cleavages were searched. Carbamidomethylation was set as a static 
modification of cysteines. The following dynamic modifications were allowed: 
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phosphorylation of serine, threonine, and tyrosine, oxidation of methionine, and the acetylation 
of the protein N-terminus. The ptmRS1.4 node was used for scoring of the phospho site 
assignments. Spectra without high confident matches were sent to a second round Mascot 
search with semitryptic specificity and 11 ppm mass tolerance.  
Mascot results from searches against SwissProt were sent to the percolator algorithm version 
2.05 as implemented in Proteome Discoverer 2.1. Low scoring identifications and phospho-
localizations were inspected manually. Chromatographic peak areas of phosphopeptides were 
calculated in Proteome Discoverer. Peak areas of peptides with the same assigned site were 
summed and normalized to total Cx43 (the sum of the top 3 Cx43 peptides’ chromatographic 
peak areas). 
3.3.15  Statistics 
Data are given as mean ± standard deviation (SD). All error bars represent standard deviation. 
The difference between groups was tested for significance using the Student’s t-test or 
ANOVA followed by Tukey’s post hoc analysis.  Non-normal data sets (determined by 
Grubb’s test) were analyzed by non-parametric tests, followed by post hoc Dunn’s test. The 
level of significance was set at P <0.05. 
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4 Results 
 
Short half- life and extensive post-translational modification of connexins have profound 
influence on the extent of gap junctional coupling mediated by them. Cx43 and Cx30 mediate 
gap junctional coupling in astrocytes. In order to investigate the molecular mechanism leading 
to astrocytic uncoupling in epilepsy, it is imperative to study these connexins at various stages 
of epilepsy.  Since the contribution of Cx43 to the astrocytic coupling in hippocampus is more 
than that of Cx30 (Gosejacob et al., 2011), the former was the major focus of this investigation. 
4.1 Molecular alterations associated with astrocytic 
uncoupling in human hippocampal specimens 
Lack of intercellular coupling is a prominent feature of astrocytes in the sclerotic hippocampus 
(Bedner et al., 2015). There have been inconsistent reports about the expression pattern of 
connexins in hippocampal specimens obtained from epileptic patients (Steinhäuser et al., 
2012). Therefore, total connexin expression levels could not be correlated with the observed 
astrocytic uncoupling. Moreover, previous studies lacked the information about cellular 
distribution and phosphorylation of Cx43 in human specimens (Mylvaganam et al., 2014). 
These aspects of connexin expression along with their functional relevance were investigated 
in hippocampal specimens obtained from 38 patients suffering from pharmacoresistant 
temporal lobe epilepsy. These specimens were divided into two groups: sclerotic (total 19) and 
non-sclerotic (total 19), based on histological diagnosis.  
4.1.1 Number S100β-positive cells are increased in the sclerotic 
hippocampus 
Astrocytes in the sclerotic hippocampus are known to undergo profound alterations (Coulter 
and Steinhäuser, 2015). The term astrogliosis encompasses increases in both, the number and 
size of astrocytes (Sofroniew and Vinters, 2010). The numbers of astrocytes in the CA1 region 
were counted and compared between sclerotic and non-sclerotic hippocampi. Coronal sections 
of the brain were stained with mouse monoclonal anti-S100β and rabbit polyclonal anti-GFAP 
antibodies. Identification of an astrocyte was based on colocalization of GFAP and S100β 
immunolabelling. Confocal images revealed that most of the GFAP-positive cells were co-
labelled with S100β (Figure 4.1.1 A).  
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However, not all S100β-positive cells were GFAP-positive.  In the sclerotic hippocampus, 
GFAP immunoreactivity was intense and diffuse with intermingled fibres. In this case, 
recognition of a putative astrocytic cell body was possible only with S100β labelling. Numbers 
of S100β-positive cells per counting box were significantly higher in the sclerotic group (26.4 
± 2 in non-sclerotic vs. 38.22 ± 3.5 in sclerotic hippocampus, N = 3, p < 0.01) (Figure 4.1.1 
B). 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.1: Astrocytic markers in human hippocampal specimens. A) S100β and GFAP co-
immunostaining. Representative images from the sclerotic and non-sclerotic CA1 regions of human 
specimens are shown. All GFAP positive cells were also S100β positive.  Scale bar, 25 µm. B) The bar 
graph shows that the numbers of S100β positive cells per counting box were significantly higher in the 
sclerotic hippocampus. Three counting boxes of dimension 184.52 x184.52 x20 µm3 were positioned 
in the stratum radiatum of each specimen for counting. (** p < 0.01, N = 3 per group). 
 
4.1.2 Cx43 expression is augmented and is preferentially located around 
blood vessels in sclerosis 
Plasma membrane associated connexins are essentially hexamers which can dock with 
hexamers from neighboring cells to form gap junctions or remain in un-docked (hemichannel) 
configuration. They are present not only at the junctions between two astrocytic processes, but 
also in the astrocytic end-feet surrounding blood vessels where they facilitate transport of 
metabolites from perivascular space to distal places of neuronal activity (Rouach et al., 2008). 
Connexins in the astrocytic end-feet whether in hemichannel or in gap junctional assemblies, 
are important components of neurovascular coupling.  
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Therefore, their distribution at the vascular interface was examined. Antibody staining showed 
higher Cx43 immunoreactivity in the sclerotic vs. non-sclerotic CA1 region (non-sclerotic, 
99.75 ± 40.26 a.u.; sclerotic, 183.03 ± 64.15 a.u.). The enhanced expression was also reflected 
in the total area occupied by Cx43 immunolabeled structures, which were much larger in the 
sclerotic CA1 region (468.01 ± 426.55 µm2) as compared with non-sclerotic (37.88 ± 30.31 
µm2) (N = 6 per group). Thus, the area occupied by Cx43 in sclerotic CA1 was 1235.51 ± 
1126.06% that of Cx43 in non-sclerotic (Figure 4.1.2 B). In sclerosis, Cx43 expression was 
non-uniformly distributed. Immunoreactivity was preferentially seen around blood vessels 
(Figure 4.1.2 A). To get a quantitative measure of the distinctive pattern of Cx43 
immunoreactivity, a distribution ratio was defined as the ratio of the mean Cx43 staining 
intensity around blood vessels to the mean intensity of the remaining CA1 area (Chapter 3, 
section 3.3.7). In non-sclerotic specimens this ratio was 1.07 ± 0.24 (N = 6), suggesting a 
uniform distribution of Cx43. In contrast, a ratio of 1.83 ± 0.47 (N = 6) was obtained in the 
sclerotic CA1 region, confirming the non-uniform immunoreactivity pattern. Most of the 
perivascular Cx43 immunoreactivity was not co-localized with the blood vessel marker lectin 
(Figure 4.1.2 A). To further characterize the Cx43 staining patterns, Cx43 plaque number and 
average size were determined. In sclerotic CA1, both of these parameters exceeded those in 
the non-sclerotic CA1 region (plaque numbers, 5493.84 ± 3992.15 vs. 885.05 ± 708.49; 
average plaque size, 0.06 ± 0.09 µm2 vs. 0.04 ± 0.004 µm2, respectively).  
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Figure 4.1.2: Cx43 expression and stereology in human hippocampal specimens. A) Lectin and 
Cx43 immunostaining. Single stack images were taken from the CA1 region of sclerotic and non-
sclerotic hippocampi. Note the up-regulation and distribution of Cx43 around the lectin positive blood 
vessels. Cx43 was not co localized with lectin. Scale bar, 10 µm. B) Bar graph showing the 
quantification of the Cx43 plaques. There was a significant increase in the total number of plaques 
(620.74 ± 451.06%), area occupied by plaques (1235.51 ± 1126.06%), average plaque size (156.43 ± 
42.86%) and average fluorescence intensity (183.49 ± 64.31%) in the sclerotic hippocampus. The 
distribution ratio was also significantly elevated in the sclerotic hippocampus (170.88 ± 43.55%) 
indicating altered distribution of Cx43. All values are expressed as a percentage over non-sclerotic (* 
p < 0.05, N = 6 per group). 
 
4.1.3 Cellular localization of Cx43 in the human epileptic hippocampus 
In the central nervous system, Cx43 is expressed mainly in astrocytes. Pericytes, which are part 
of the brain-vascular interface have been described to express Cx43 at least in retinal pericyte 
cultures (Li et al., 2003). Therefore, co-localization Cx43 with pericyte markers NG2 and 
PDGFRβ was assessed. Most of the Cx43 immunoreactivity was not found to be co-localized 
with either of these markers (Figure 4.1.3 A and B). Cx43 accumulation around the endothelial 
cells observed earlier (Figure 4.1.2) was also evident around pericytes as both of these cells 
have the same basement membrane (Abbott et al., 2006). Thus, majority of perivascular Cx43 
puncta were not localized in endothelial cells or pericytes, leaving the possibility of its 
expression in astrocytic endfeet only. Indeed, the redistributed Cx43 around the vasculature 
was present in close proximity with S100β (Figure 4.1.3 C).  Although S100β, which is a 
cytosolic protein, has mainly been used to visualize the cell body and main processes of 
astrocytes, this protein can also be used to visualize end-feet (Söderqvist et al., 2015) (Steiner 
et al., 2007).  
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Altogether, this data indicated that the up-regulated Cx43 in the vicinity of vasculature is not 
extra-astrocytic but it is present in astrocytic endfeet. 
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Figure 4.1.3: Cellular localization of Cx43 in the CA1 region.  A) Cx43 and NG2 immunostaining. 
Cx43 was not co-localized with NG2. Some Cx43 puncta were seen in close contact with NG2 positive 
pericytes. B) Cx43 and PDGFRβ immunostaining. Note the distribution of Cx43 around PDGFRβ 
positive pericytes. Cx43 did not co-localize with PDGFRβ. C) Cx43, S100β and Lectin 
immunostaining. S100β positive astrocytic end-feet surround the lectin positive blood vessels in both 
non-sclerotic and sclerotic hippocampi. In the sclerotic hippocampus, Cx43 expression around the 
blood vessels was increased and it was in close proximity with S100β. Scale bar, 10 µm. 
 
4.1.4 Expansion microscopy revealed a detailed structure of the blood 
vessel–gap junction interface 
As described in section 4.1.1 and 4.1.2, the sclerotic CA1 region was characterized by a mesh-
like appearance of diffuse GFAP staining and enhanced accumulation of Cx43 around blood 
vessels, respectively. Confocal microscopy images shown in Figure 4.1.3 indicated that most 
of the Cx43 immunoreactivity was astrocytic. However, this conventional diffraction limited 
microscopy was unable to resolve the fine details of blood vessel-gap junction interface. In 
order to circumvent this limitation, a recently developed expansion microscopy (ExM) 
technique was employed (Chen et al., 2015)(Chozinski et al., 2016). Briefly, this technique 
involves embedding the immunostained tissue slices in a polyacrylamide gel followed by 
enzymatic digestion and expansion in deionized water. An expansion factor defined as the ratio 
of gel dimensions after and before expansion was determined for each specimen (average 
expansion factor 4.57 ± 0.67, N = 16). There was no difference in the average expansion factors 
of sclerotic and non-sclerotic specimens (4.36 ± 0.75, N =8 for sclerotic vs. 4.74 ± 0.53, N =8 
for non-sclerotic). ExM allowed assignment of the location of Cx43 with respect to the vessel 
and endfoot in much detail than with the standard confocal microscopy (Figure 4.1.4.1). Most 
of the Cx43 in the perivascular space was found to be present on the parenchymal side of the 
astrocytic endfoot (Figure 4.1.4.1, arrows) as GFAP or S100β separated the Cx43 signal from 
the vessel wall. Cx43 formed large plaques around blood vessels in both, the sclerotic and the 
non-sclerotic CA1 regions. However, in the sclerotic CA1, the accumulation of Cx43 was more 
pronounced as compared to that in the non-sclerotic condition. Importantly, many of the Cx43 
puncta were found to be hemmed between GFAP positive processes (solid arrows, Figure 
4.1.4.2) even in the sclerotic specimens. A minor proportion of Cx43 immunoreactivity of 
relatively smaller puncta size was found to be present in close association with endothelial cells 
(dotted-arrows, Figure 4.1.4.2 and Figure 4.1.4.3). Pericytes on the other hand faced large Cx43 
plaques mainly on the parenchymal side (solid arrows, Figure 4.1.4.3). 
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 It can be concluded that, although the majority of perivascular Cx43 immunoreactivity was 
astrocytic, a minor endothelial and pericytic expression of Cx43 cannot be ruled out. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.4.1: Expansion microscopy images displaying S100β-GFAP-Cx43 immunostaining in 
the CA1 region.  Panel A) shows individual channels while panel B) shows merged images. Blood 
vessels (BV) were identified by observing each specimen in bright-field mode of the microscope. 
Astrocytic cell bodies with endfeet approaching a blood vessel can be seen in non-sclerotic and sclerotic 
specimens. Cx43 formed large plaques near endfeet. Their accumulation in perivascular space was 
increased in the sclerotic tissue. In both of the hippocampi, majority of the Cx43 plaques were localized 
on the parenchymal sides of the endfeet (arrows). The scale bars show expansion adjusted distances in 
µm. 
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Figure 4.1.4.2: Expansion microscopy images displaying GFAP-CD31-Cx43 immunostaining in 
the CA1 region. Individual channels can be seen in panel A). Panel B) shows merged images while 
panel C) shows enlarged view of images indicated in the dashed boxes. CD31 positive endothelial cells 
can be seen surrounded by GFAP positive astrocytic endfeet. GFAP and Cx43 immunoreactivities were 
increased in the sclerotic specimens. Some of the Cx43 positive puncta were found to be present 
between astrocytic processes (solid arrows) in both groups. Although the majority of the Cx43 
immunoreactivity was associated with GFAP, some relatively smaller Cx43 puncta were seen in the 
perivascular space, in close association with CD31 (dotted arrows). The scale bars show expansion 
adjusted distances in µm. 
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Figure 4.1.4.3: Expansion microscopy images displaying NG2-CD31-Cx43 immunostaining in the 
CA1 region. Individual channels can be seen in panel A). Panel B) shows merged images while panel 
C) shows enlarged view of images indicated in the dashed boxes. NG2 positive pericytes can be seen 
surrounding CD31 positive endothelial cells. The majority of the Cx43 immunoreactivity did not 
colocalize with NG2 or CD31. Some of the Cx43 plaques on the parenchymal side of the vessel were 
in close contact with pericytes (solid arrows) in both specimens. A minority of relatively smaller Cx43 
puncta were seen in close association with CD31 (dotted arrows). The scale bars show expansion 
adjusted distances in µm. 
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4.1.5 Plasma membrane Cx43 levels are similar between sclerotic and non-
sclerotic hippocampi 
Dislocalization of connexin or its removal from the plasma membrane has been hypothesized 
as one of the mechanisms of loss of gap junction coupling (Malone et al., 2007). Tissue lysates 
from human specimens were enriched for the plasma membrane fractions (Chapter 3, section 
3.3.9). These fractions were analyzed by Western blotting for expression of Cx43 and Cx30 
(Figure 4.1.5 A). Cx43 immunoblot showed 3 distinct bands around 40 kDa representing 
different phosphorylation and conformational states while Cx30 showed a single band at 30 
kDa. E-cadherin levels are indicative of total protein amounts which were loaded onto the gel.  
Plasma membrane Cx43 levels were similar in non-sclerotic and sclerotic hippocampi 
(Cx43/E-cadherin ratio 4.43 ± 2.22, N = 5 and 3.35 ± 0.90, N= 6, respectively), despite 
complete loss of functional coupling in sclerotic specimens (Bedner et al., 2015). The fractional 
contribution of the different phospho-bands of Cx43 (P0, P1 and P2) was also not different 
between sclerotic and non-sclerotic conditions, suggesting a similar phosphorylation status of 
the C-terminus. Similarly, the normalized expression levels of Cx30 were not different between 
sclerotic (Cx30/E-cadherin ratio 0.14 ± 0.04, N = 6) and non-sclerotic hippocampi (Cx30/E-
cadherin ratio 0.16 ± 0.14, N = 5). In conclusion, the enhanced total Cx43 levels in human 
sclerotic specimens as seen in immunofluorescence analysis did not lead to increased assembly 
of Cx43 channels in the plasma membrane, indicating its impaired translocation. 
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Figure 4.1.5: Plasma membrane associated connexins. A) Representative immunoblots showing 
Cx43, Cx30 and loading control E- cadherin. Plasma membrane associated proteins were selectively 
isolated from the human hippocampal specimens. Five µg of protein were loaded in each well. B) The 
bar graph shows the quantification of total Cx43 and Cx30 levels which were not significantly altered 
in the sclerotic hippocampus as compared with non-sclerotic hippocampus. C) Quantification of the 
phospho-bands. All phospho-bands (P2, P1 and P0) were similar between sclerotic and non-sclerotic 
hippocampi. 
 
4.1.6 Total (whole-cell) Cx43 levels are increased in sclerosis 
Stereological analysis performed on immuno-stained sections revealed increased Cx43 plaque 
size in sclerotic hippocampus when compared with the non-sclerotic hippocampus. There was 
also an increase in the intensity of the Cx43 immuno-labelling, indicating increase in the 
overall expression of Cx43 (Figure 4.1.2 B). However, Western blot analysis of plasma 
membrane proteins displayed no difference in the Cx43 levels (Figure 4.1.5 B). In order to 
assess the discrepancy, total (whole-cell) Cx43 protein levels were checked by Western 
blotting. Whole-cell protein lysates were obtained by homogenizing hippocampal specimens 
from epileptic patients. These lysates were subjected to SDS PAGE followed by Western 
blotting. The resultant blotted membranes were probed for Cx43, Cx30, E-cadherin and 
GAPDH (as a loading control) (Figure 4.1.6A). GAPDH was used as a loading control since 
its protein levels are proportional to the total protein present in the sample and are known to be 
unchanged in epilepsy (Becker et al., 2002). GAPDH normalized Cx43 protein levels were 
significantly higher (N = 4 per group, p < 0.01) in the sclerotic hippocampus as compared with 
the non-sclerotic hippocampus (7.89 ± 1.79 vs. 4.43 ± 0.94) (Figure 4.1.6 B). The increased 
Cx43 level in the sclerotic hippocampus was 178.12 % of the non-sclerotic hippocampus. 
There was no significant difference in phospho-band levels between the two groups. Similarly, 
Cx30 (sclerotic: 0.46 ± 0.22; non-sclerotic: 0.55 ± 0.20) and E-cadherin (sclerotic: 0.12 ± 
0.027; non-sclerotic: 0.10 ± 0.013) levels were not significantly different between the two 
groups. Thus, total Cx43 expression is enhanced in the sclerotic hippocampus. On the other 
hand, the plasma membrane Cx43 levels were similar between sclerotic and non-sclerotic 
hippocampi. The data thus indicate that there was an inefficient or disproportional localization 
of Cx43 to the plasma membrane. 
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Figure 4.5.6: Western blot of total connexins, in sclerotic and non-sclerotic human hippocampus. 
A) Representative immunoblots showing E-cadherin, Cx43, GAPDH (loading control) and Cx30. Total 
(Whole-cell) protein lysates were obtained by homogenizing hippocampal specimens surgically 
resected from epileptic patients, in a lysis buffer containing detergents (section 3.3.8). Thirty µg of the 
proteins from each sample were subjected to SDS-PAGE followed by Western blotting. B) The bar 
graph shows that the total amount of Cx43 in the sclerotic hippocampus was significantly higher than 
that in the non-sclerotic hippocampus (178.12% ± 40.6 %, p < 0.01, N = 4 each group). No significant 
difference was found in E-cadherin and Cx30 protein levels in the two groups. C) The Cx43 blot was 
further analyzed for the phospho-isoforms which did not differ between the two groups. 
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4.1.7 Phosphorylation of the plasma membrane Cx43 is altered 
The total gap junctional conductance between any two cells is influenced by the total number 
of gap junctions channles between them and unitary conductance and open probability of those 
channels (Moreno, 2005). The total Cx43 present at the plasma membrane as assessed by 
Western blotting and the plaque number as assessed by immunofluorescence are indicative of 
the possibility of gap junction formation. There was an increase in the Cx43 plaques (Figure 
4.1.2 B) despite of lack of coupling in the sclerotic hippocampus (Bedner et al., 2015). 
Moreover, the plasma membrane connexin levels were similar between the two groups (Figure 
4.4.3). Therefore, phosphorylation of Cx43 which is known to affect the gap junctional 
coupling was investigated. Phosphorylation of Cx43 by MAPKs on serine 255 is known to 
reduce the open probability of channels (Cottrell et al., 2003). On the other hand, when Cx43 
is phosphorylated on serine 368, gap junctional conductance is reduced (Lampe et al., 2000). 
To evaluate the phosphorylation on these two sites, 5 µg of the plasma membrane lysates were 
subjected to SDS-PAGE followed by Western blotting and then probed with phospho-specific 
antibodies directed against P-Cx43 S255 and P-Cx43 S368. P-Cx43 S255 and P-Cx43 S368 
antibodies identified 3 bands between 40 and 55 kDa, similar to the bands obtained by 
phosphorylation unspecific Cx43 antibody (Figure 4.1.7 A). Phospho-Cx43 band intensities 
were divided by total Cx43 band intensities to get the fraction of total Cx43 that is 
phosphorylated on the given serine residue. The P-Cx43 S255 fraction was significantly 
elevated in the sclerotic hippocampus (0.15 ± 0.043 (N = 6)) as compared with non-sclerotic 
hippocampus (0.09 ± 0.041 (N = 5), p < 0.05). There was no significant difference in P-Cx43 
S368 fraction between the two groups (Figure 4.1.7 B). Thus, phosphorylation of Cx43 at 
serine 255 but not at serine 368 is increased in human hippocampal sclerosis. This change in 
the phosphorylation might contribute to the observed uncoupling possibly via a reduced open 
probability of the Cx43 channels. 
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Figure 4.1.7: Western blot using phospho-specific antibodies. A) Plasma membrane protein lysates 
form human hippocampi were investigated for Cx43 phosphorylated on serine 255 and serine 368. The 
membrane used for detection with phospho-specific antibodies was further probed with 
phosphorylation unspecific Cx43 antibody. B) Quantification of Western blots performed using total 
Cx43 as a loading control. Phospho-Cx43 band intensities were divided by total Cx43 band intensities 
and expressed as a percentage of non-sclerotic mean values. The P-Cx43 S255 fraction was significantly 
elevated (169.72 ± 48.47 %) in sclerotic hippocampi. However, P-Cx43 S368 fractions were not 
significantly different between the two groups. (* p < 0.05, N = 5 for non-sclerotic and N = 6 for 
sclerotic group). 
 
4.1.8 Cx43 distribution is associated with albumin extravasation in the 
sclerotic hippocampus 
BBB breakdown characterized by albumin extravasation has been implicated in 
epileptogenesis (Vliet et al., 2007) (Ivens et al., 2007a). Therefore, albumin immunoreactivity 
in the vicinity of blood vessels was checked in human epileptic hippocampi. Albumin leakage 
around the vasculature was found to be a prominent feature of hippocampal sclerosis only. 
Extra-vascular immunoreactivity was almost absent in non-sclerotic hippocampi indicating 
intact BBB in contrast with the leaky vasculature of sclerotic hippocampi (Figure 4.1.8). 
Intraventricular albumin administration has been shown to disrupt astrocytic coupling 
(Braganza et al., 2012). It remains to be demonstrated whether the observed astrocytic 
uncoupling in the sclerotic hippocampus is due to albumin in the brain parenchyma.  
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Nevertheless, albumin immunoreactivity around the blood vessels followed a pattern similar 
to that of Cx43 distribution observed earlier (Figure 4.1.2). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.1.8: Albumin extravasation in human hippocampal specimens. CD31 and albumin 
immunostaining in the CA1 region of human hippocampi. Sclerotic hippocampi displayed prominent 
extra-luminal albumin immunoreactivity indicating BBB disruption. Scale bar, 10 µm.  
Albumin Merged CD31 
N
on
-s
cl
er
ot
ic
 
Sc
le
ro
tic
 
    Results  
 
75 
 
4.2 Molecular alterations associated with astrocytic 
uncoupling, 3 months post kainate injection 
Three months post kainate injection, the ipsilateral hippocampus recapitulates many features 
of human temporal lobe epilepsy with hippocampal sclerosis. These features include loss of 
CA1 pyramidal neurons, pronounced astrogliosis, granule cell dispersion and lack of inter-
astrocytic coupling (Bedner et al., 2015). Possible mechanisms behind astrocytic uncoupling 
were investigated using immunohistochemistry and Western blotting. Since coupling is still 
present in the contralateral hippocampus, it was used as a pseudo-control. Data from human 
epileptic hippocampal specimens indicated possible roles of Cx43 phosphorylation and 
albumin extravasation, in disruption of astrocytic coupling (Section 4.1.7 and 4.1.8). Therefore, 
these two aspects were also investigated at the 3 months’ time point. 
4.2.1 Ipsilateral hippocampus 3 months post kainate injection has 
increased number of astrocytes 
Astrocytic proliferation in epilepsy has been well documented (Niquet et al., 1994) (Hüttmann 
et al., 2003). The numbers of S100β positive cells were increased in the CA1 region of human 
sclerotic hippocampus (section 4.1.1). Therefore, for the 3 months’ time point, the total number 
of astrocytes were counted in the CA1 region and compared between ipsilateral and 
contralateral hippocampi. Coronal sections of the brain were stained with either rabbit 
polyclonal anti-S100β (Figure 4.2.1 A) or rabbit polyclonal anti-GFAP antibodies (Figure 4.2.1 
C). Confocal images from the CA1 region were used for cell counting. There was a significant 
increase in the total number of S100β-positive cells in the ipsilateral hippocampus (21.33 ± 
3.78 in contralateral vs. 45.66 ± 6.65 in ipsilateral hippocampus, N = 3) (Figure 4.2.1 B).  The 
morphology of S100β- and GFAP-positive cells was drastically altered in the ipsilateral 
hippocampus. The astrocytes in the ipsilateral hippocampus showed enlarged cell bodies and 
very few primary branches as compared with the astrocytes in the contralateral hippocampus 
(Figure 4.2.1 A and C). 
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Figure 4.2.1: Astrocytic markers 3 months post kainate injection. A) S100β immunostaining with 
Hoechst as a nuclear marker. Representative images from the CA1 region, 3 months after kainate 
injection. Scale bar, 25 µm. B) The bar graph shows the number of astrocytes per counting box (184.52 
x184.52 x30 µm3). There was significant increase in the number of astrocytes in the ipsilateral 
hippocampus as compared with the contralateral hippocampus.  (* p < 0.01, N = 3 per group). C) GFAP 
immunostaining with Hoechst as a nuclear marker. Note the hypertrophied astrocytes with few primary 
processes in the ipsilateral hippocampus. Scale bar, 25 µm. 
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4.2.2 Cx43 expression is augmented 3 months post kainate injection 
Cx43 expression and stereology was assessed by immunolabeling with an antibody targeting 
amino acids 360 to 382 of the Cx43 C-terminal domain. Confocal images from the CA1 region 
revealed punctate staining patterns in the contralateral hippocampus while the ipsilateral 
hippocampus showed intense labelling with large aggregates (Figure 4.2.2 A). Indeed, 
quantification of fluorescence intensity and plaque size showed a significant increase in these 
two parameters in the ipsilateral hippocampus (203.94 ± 47.07 a.u. and 0.075 ± 0.018 µm2 
respectively) when compared with the contralateral hippocampus (112.41 ± 19.49 a.u. and 
0.045 ± 0.002 µm2 respectively). The increased plaque size was also reflected in the total area 
occupied by Cx43 and the number of Cx43 plaques (Contralateral: 132.78 ± 49.72 µm2 and 
2696.81 ± 928.18 vs. Ipsilateral: 1131 ± 456.02 µm2 and 9287.39 ± 3489.04, respectively).  
Interestingly, Cx43 was found to be preferentially distributed around the blood vessels. This 
pattern of Cx43 expression was quantified by means of a distribution ratio (defined in section 
3.3.7 and 4.1.2). The distribution ratio of Cx43 in the ipsilateral CA1 (1.49 ± 0.13) was 
significantly higher than that in the contralateral CA1 (1.09 ± 0.17) (Figure 4.2.2 B). The 
redistributed Cx43 was not co-localized with CD31, indicating its absence in the endothelial 
cells. 
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Figure 4.2.2: Cx43 expression and stereology 3 months post kainate injection.  A) CD31 and Cx43 
immunostaining in the CA1 region, 3 months post kainate injection. Cx43 signal in the contralateral 
hippocampus is punctate and evenly distributed around the blood vessels and in the rest of the tissue. 
The ipsilateral hippocampus displays intense, large aggregates of Cx43 preferentially around the blood 
vessels. B) The bar graph shows quantification of Cx43 plaques. There was a significant increase in the 
total number of plaques (344.38 ± 129.37%), area occupied by plaques (851.77 ± 343.44%), average 
plaque size (167.18 ± 41.43%) and average fluorescence intensity (181.42 ± 41.87%) in the ipsilateral 
hippocampus (all values normalized to contralateral). The distribution ratio in ipsilateral hippocampus 
was 136.97 ± 12.53% of the contralateral hippocampus, indicating altered Cx43 distribution. * p < 0.05, 
N = 3 per group. Scale bar, 25 µm. 
 
4.2.3 Plasma membrane associated connexins, 3 months post kainate 
injection 
Cx43 has a very short half-life of 1.5 to 5 h as compared with other membrane proteins (Laird 
et al., 1991)(Beardslee et al., 1998). It is continuously removed from the plasma membrane 
and replaced by newly synthesized Cx43. Increased total Cx43 levels in the human sclerotic 
hippocampus did not result in the increased assembly of these proteins at plasma membrane, 
indicating impaired translocation (Figure 4.1.5 and 4.1.6). Therefore, mouse hippocampi 3 
months post kainate injection, were also assessed for plasma membrane associated connexins. 
The E-cadherin normalized intensities of total Cx43 and Cx30 did not differ between the 
contralateral and ipsilateral hippocampi (Figure 4.2.3 A and B). However, in the ipsilateral 
hippocampus, there was a significant increase in the P2 band levels (E-cadherin normalized 
protein levels, 0.12 ± 0.024 contralateral vs. 0.27 ± 0.053 ipsilateral, p < 0.01, N= 4 per group) 
(Figure 4.2.3 C). It is important to note here that this increase in the ipsilateral P2 band fraction 
was associated with increased P0 contribution on the contralateral side.  
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Taken together, the Western blotting data 3 months post kainate not only indicate similar 
plasma membrane connexin levels between the contralateral and ipsilateral hippocampi but 
also point out the altered phosphorylation of Cx43. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.3: Western blot of plasma membrane associated connexins, 3 months post kainate 
injection. A) Plasma membrane associated proteins were isolated from dorsal hippocampi. Five µg of 
protein was loaded in each well. Immunoblots shows Cx43, Cx30 and E-cadherin (as a loading control). 
B) The bar graph shows E-cadherin- normalized protein levels expressed as a percentage of the E-
cadherin normalized mean protein value of the contralateral group. Total Cx43 and Cx30 levels were 
not statistically different between contralateral and ipsilateral hippocampi. C) Phospho-bands P2, P1 
and P0 were normalized to E-cadherin and then expressed as a percentage of the contralateral group. 
The P2 band in the ipsilateral hippocampus was 219.5 ± 43.35 % of the contralateral hippocampus (p 
< 0.01, N= 4 in each group). The other isoforms did not differ significantly between the two groups.  
 
 
0
50
100
150
200
250
300
P2 P1 P0
E-
ca
dh
er
in
 n
or
m
al
iz
ed
 p
ro
te
in
 
le
ve
sl
 (%
 o
f C
on
tra
la
te
ra
l) 
** 
C) 
Ipsilateral 
Contralateral 
0
50
100
150
200
250
300
Cx43 Cx30
E-
ca
dh
er
in
 n
or
m
al
iz
ed
 p
ro
te
in
 
le
ve
ls
 (%
 o
f C
on
tra
la
te
ra
l) 
B) 
kDa 
135 
170 
100 
70 
55 
40 
35 
25 
Contralateral  Ipsilateral 
C
x4
3 
E-
C
ad
he
rin
 
C
x3
0 
P2 
P1 
P0 
A) 
    Results  
 
80 
 
4.2.4 Total Cx43 is increased ipsilaterally, 3 months post kainate injection 
Stereological analysis performed on immuno-stained sections revealed an increased Cx43 
plaque size in the ipsilateral hippocampus, 3 months post kainate injection. There was also an 
increase in the intensity of the Cx43 immuno-labelling, indicating increase in the overall 
expression of Cx43 (Figure 4.2.2 B). However, Western blot analysis of plasma membrane 
proteins displayed no difference in the Cx43 levels (Figure 4.2.3 B). In order to assess the 
discrepancy between plasma membrane and global Cx43 expression, the total (whole-cell) 
Cx43 protein levels were checked by Western blotting. Dorsal hippocampi were harvested 
from mice, 3 months after kainate injection. Whole-cell protein lysates obtained by 
homogenizing the hippocampi were subjected to SDS PAGE followed by Western blotting. 
The resultant blotted membranes were probed for Cx43, Cx30, E-cadherin and GAPDH (as a 
loading control) (Figure 4.2.4 A). GAPDH-normalized Cx43 protein levels were significantly 
higher (N = 4 per group, p < 0.01) in the ipsilateral hippocampus (3.19 ± 0.50) as compared 
with contralateral hippocampus (2.18 ± 0.38) (Figure 4.2.4 B). The increased Cx43 levels in 
the ipsilateral hippocampus were 146.63 ± 23.14% of the contralateral hippocampus. This 
increase was primarily provided by significantly enhanced P2 band levels (0.21 ± 0.07 
contralateral vs. 0.48 ± 0.16 ipsilateral, N= 4, P < 0.05) (Figure 4.4.4 C). In contrast, Cx30 
(contralateral: 0.22 ± 0.04; ipsilateral: 0.31 ± 0.13) and E-cadherin (contralateral: 1.52 ± 0.73; 
ipsilateral: 1.44 ± 0.30) levels were not significantly different between the two groups. Thus, 
only the total Cx43 (and not the plasma membrane Cx43) expression is enhanced in the 
ipsilateral hippocampus. The data also indicate that there was an inefficient or disproportional 
localization of Cx43 to the plasma membrane, since the latter showed unchanged expression 
of Cx43 despite of enhanced total cellular Cx43 expression. 
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Figure 4.2.4: Western blot of total connexins, 3 months post kainate injection A) Total (Whole-
cell) protein lysates were obtained by homogenizing dorsal hippocampi 3 months post kainate injection, 
in a lysis buffer containing detergents. Thirty µg of the proteins from each sample were subjected to 
SDS-PAGE followed by Western blotting. Representative immunoblots showing E-cadherin, Cx43, 
GAPDH (loading control) and Cx30. B) The bar graph shows that the total amount of Cx43 in the 
ipsilateral hippocampus  was significantly higher than the contralateral hippocampus (146.6 ± 23.14% 
of the contralateral hippocampus, p < 0.01, N = 4 each group). No significant difference was found in 
E-cadherin and Cx30 protein levels between the two groups. C) Cx43 blot was further analyzed for 
phosphorylated bands. There was a significant increase in the P2 band of the ipsilateral hippocampus 
(225.03 ± 79.39 % of the contralateral hippocampus, p < 0.05, N= 4 in each group). 
 
4.2.5 Ipsilateral Cx43 displays enhanced phosphorylation on serine 255 
and 368, 3 months post kainate injection 
There was an increase in Cx43 plaques despite of lack of coupling in the ipsilateral 
hippocampus; 3 months post kainate injection (Figure 4.2.2). The plasma membrane connexin 
levels were unaffected at this time point (Figure 4.2.3 B). However, Western blot indicated a 
change in the phosphorylation of Cx43 (Figure 4.2.3 C). Earlier analyses on human 
hippocampal samples had shown increased phosphorylation on S255 (but not on S368) of 
Cx43. Therefore, these sites were further investigated in the mouse model. 5 µg of plasma 
membrane lysates from mouse hippocampi, 3 months post kainate injection were subjected to 
SDS-PAGE followed by Western blotting and then probed with phospho-specific antibodies 
directed against P-Cx43 S255 and P-Cx43 S368. P-Cx43 S255 and P-Cx43 S368 antibodies 
identified one band between 40 and 55 kDa contrary to phosphorylation unspecific Cx43 
antibody which identified 3 characteristic bands around 40 kDa (Figure 4.2.5 A).  
 
B) C) 
0
50
100
150
200
250
300
Cx43 Cx30 E-cadherin
    ** 
G
A
PD
H
 n
or
m
al
iz
ed
 p
ro
te
in
 
le
ve
ls
 (%
 o
f c
on
tra
la
te
ra
l) 
0
50
100
150
200
250
300
350
P2 P1 P0
  * 
G
A
PD
H
 n
or
m
al
iz
ed
 p
ro
te
in
 
le
ve
ls
 (%
 o
f c
on
tra
la
te
ra
l) 
Ipsilateral Contralateral 
    Results  
 
82 
 
Phospho-Cx43 band intensities were divided by total Cx43 band intensities to get the fraction 
of total Cx43 that is phosphorylated on the given serine residue. Both P-Cx43 S255 (0.067 ± 
0.023 vs. 0.033 ± 0.004, N = 4 per group, p < 0.05) and P-Cx43 S368 (0.059 ± 0.018 vs. 0.012 
± 0.005, N = 4 per group, p <0.01) fractions were significantly elevated in ipsilateral 
hippocampi (Figure 4.2.5 B). This altered phosphorylation profile of Cx43 might account for 
the observed uncoupling via reduced open probability and unitary conductance of the gap 
junction channels. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.5: Western blot using phospho-specific antibodies.  A) Three months after kainate 
injection, plasma membrane protein lysates form mouse hippocampi were investigated for Cx43 
phosphorylated on serine 255 and serine 368. The membrane used for detection with phospho-specific 
antibodies was further probed with phosphorylation unspecific Cx43 antibody. P-Cx43 S255 and P-
Cx43 S368 antibodies identified 1 band between 40 to 55 kDa contrary to phosphorylation unspecific 
Cx43 antibody which identified 3 bands around 40 kDa. B) Quantification of Western blots using total 
Cx43 as a loading control. Phospho-Cx43 band intensities were divided by total Cx43 band intensities 
and expressed as a percentage of contralateral mean values. Both P-Cx43 S255 and P-Cx43 S368 were 
significantly elevated in the ipsilateral hippocampus when compared with the corresponding 
contralateral hippocampus. Percentage of these two phospho-Cx43 proteins in the ipsilateral 
hippocampus over the contralateral group were 200.05 ± 68.83% and 412.4 ± 150.62% respectively (** 
p < 0.01, *** p <0.001, N = 4 per group). 
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4.2.6 BBB disruption and albumin extravasation differs between 
ipsilateral and contralateral hippocampi 
Even a single episode of epileptic seizure is sufficient to transiently open the BBB (Vliet et al., 
2007). Serum proteins thus leak out of the vasculature and diffuse into the brain parenchyma. 
Local differences in inflammation might modulate the BBB permeability (Phares et al., 2006). 
Ipsilateral and contralateral hippocampi 3 months post kainate injection were shown to differ 
in the degree of astrogliosis (Figure 4.2.1). Therefore, it was evaluated whether these 
hippocampi also differ in BBB disruption and subsequent albumin extravasation. Coronal 
sections of the brain were stained with goat polyclonal anti-albumin antibody. Confocal images 
from the CA1 region revealed that the albumin immunoreactivity was present only in ipsilateral 
hippocampi of kainate injected mice while contralateral hippocampi in the same mice were 
devoid of any albumin signal (Figure 4.2.6). Interestingly, the blood vessels themselves lacked 
albumin immunoreactivity as the mice brains were perfused with PBS prior to fixation. 
Importantly, the albumin immunoreactivity was not restricted to perivascular space in the 
ipsilateral hippocampus. It was observed throughout the CA1 region indicating diffusion of 
albumin into the region away from the vasculature.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.6: Albumin extravasation 3 months post kainate injection. CD31 and albumin 
immunostaining in the CA1 region. Ipsilateral hippocampi showed noticeable albumin 
immunoreactivity indicating BBB disruption. Scale bar, 10 µm.  
 
Albumin Merged 
C
on
tra
la
te
ra
l 
Ip
si
la
te
ra
l 
CD31 
    Results  
 
84 
 
4.2.7 Oligomerization of Cx43 
Connexins as monomers do not form gap junctions. 6 connexins oligomerize to form a structure 
called connexon and two connexons from the neighbouring cells dock on each other to form a 
gap junction. There are various mechanisms that control the gating of a gap junctional channel. 
These mechanisms are functional only on a fully formed gap junction. Therefore, 
oligomerization of connexin was studied to check whether fully formed gap junctions exist in 
an epileptic hippocampus. For this purpose, a technique called ‘blue native PAGE’ (BN PAGE) 
was employed. Briefly, plasma membrane associated proteins from dorsal hippocampi were 
isolated and solubilised in a buffer that preserves protein interactions (Materials and methods, 
Section 3.3.11). Five µg of proteins were loaded on a native gradient gel. Proteins were given 
a uniform negative charge by the dye coomassie G250. As a result, the protein complexes got 
separated based on their molecular weights. After separation, proteins from the gel were 
electrophoretically transferred to a PVDF membrane and visualized with anti-Cx43 antibody. 
Line scans of the resultant blot revealed 4 peaks corresponding to 4 bands at different molecular 
weights (Figure 4.2.7 A and B). These bands represented different possible oligomerization 
states of Cx43. When molecular weights of 146, 240 and 516 kDa were plotted against the 
possible number of Cx43 molecules forming oligomers, 3, 6 and 12 respectively, it resulted in 
a straight line (Figure 4.2.7 C). Thus, band at 516 kDa represented a putative dodecameric 
configuration of Cx43. A horizontal line scan through this band showed a significant reduction 
in the ipsilateral hippocampus (Figure 4.2.7 D). The data indicated that the docking of 
connexon pairs might be impaired in the ipsilateral hippocampus. 
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Figure 4.4.7: Blue Native PAGE followed by Western blot. A) Plasma membrane preparations of 
the dorsal hippocampi were obtained from mice 3 months after kainate injection. Cx43 immunoblots 
shows a spread across the lane with prominent bands at 240 and 500 kDa. B) Vertical line scans with 
Cx43 intensity on Y axis and distance in pixel units on the X axis. Note the peaks in the plot, 
representing putative oligomers. C) Plot of observed molecular weight of peaks and possible number 
of Cx43 molecules forming oligomer. D) Horizontal line scans through the 500 kDa (dodecamer) band, 
showing decreased intensity in the ipsilateral hippocampus. 
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4.3 Molecular alterations associated with astrocytic 
uncoupling 4 h post kainate injection 
In the human sclerotic hippocampus and the mouse ipsilateral hippocampus 3 months post 
kainate injection, both of which represent chronic epilepsy, astrocytic coupling is completely 
absent (Bedner et al., 2015). In contrast, the coupling is only partially lost at 4 h post kainate 
injection.  At this time point, astrocytic coupling is reduced by ~50 % (Bedner et al., 2015). 
However, apoptotic neurons are absent in ipsilateral and contralateral hippocampi. Thus, 4 h 
after kainate injection represents an early phase of epileptogenesis in which loss of astrocytic 
coupling might contribute to the neuronal death in subsequent phases. Possible mechanisms 
behind this observed uncoupling were investigated using immunohistochemistry and Western 
blotting. The underlying hypothesis was - seizure-induced alterations in astrocytic connexins 
lead to uncoupling. In addition to the effects on connexins, changes in astrocyte morphology 
were analyzed using stereological techniques. 
4.3.1 Astrocytic markers at the onset of seizures 
S100β and GFAP are two widely used markers for astrocytes (Sofroniew and Vinters, 2010). 
Two antibodies targeting distinct epitopes were used to label each of these proteins.  One of 
these antibodies was monoclonal while the other one was polyclonal. The purpose of using two 
antibodies was to enhance the probability of detection of the target proteins, in case one of the 
antibodies failed to bind to its epitope. 
 
4.3.1.1 S100β immunoreactivity is lost following kainate injection 
Coronal sections of the brain 4 h post kainate injection were stained with mouse monoclonal 
and rabbit polyclonal anti-S100β antibodies. Confocal images revealed almost complete 
mutual co-localization of the signals from these two antibodies in the contralateral 
hippocampus (Figure 4.3.1.1 A). On the ipsilateral side, none of the antibodies labelled any 
cellular structures, especially in the SR region of the hippocampus (Figure 4.3.1.1 A). 
However, other regions of the brain, for example cortex and thalamus, showed normal S100β 
labelling (images not shown). Interestingly, the loss of immunoreactivity was specific to the 
ipsilateral hippocampus underneath the injection site (dorsal hippocampus). S100β signal was 
regained in the ipsilateral hippocampus distal from the injection site (Figure 4.3.1.1 B). 
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Figure 4.3.1.1: S100β immunostaining 4 h post kainate injection using antibodies targeting two 
different epitopes. A) S100 β immunostaining using monoclonal and polyclonal antibodies. In the 
contralateral hippocampus, there was an almost complete overlap of the signals from the two anti-S100 
β antibodies. The signal was absent in the SR region of the ipsilateral hippocampus. B) S100β signal 
was regained in the ipsilateral hippocampus distal from the injection site. Scale bar, 100 µm. 
 
4.3.1.2 Reduced number of astrocytes and altered astrocyte morphology, 4 h post kainate 
In order to check if the absence of S100β immunoreactivity indicated loss of astrocytes, GFAP 
immunostaining was performed. As mentioned earlier, antibodies with two different epitopes 
were used to probe GFAP in the coronal sections. Signals from mouse monoclonal and rabbit 
polyclonal antibodies showed mutual co-localization (Figure 4.3.1.2 A) in both contralateral 
and ipsilateral hippocampi. Thus, astrocytes were indeed present in the ipsilateral 
hippocampus, contrary to the findings from S100β immunostaining (see Discussion, section 
5.4). Further, GFAP positive structures co localizing with the nuclear marker Hoechst were 
counted in 184.52 x 184.52 x 30 µm3 counting boxes in the SR region (Figure 4.3.1.2 B). There 
was a reduction of 27.9 % in the total number of astrocytes (15.1 ± 1.6 in contralateral 
hippocampus vs. 10.9 ± 1.4 in ipsilateral hippocampus, N = 6). This decline in the number of 
astrocytes paralleled a similar 24.4 % decrease in the number of nuclei in the same region (35.9 
± 3.9 in contralateral hippocampus vs. 27.1 ± 2.7 in ipsilateral hippocampus, N = 6). The 
number of primary branches per astrocyte was also significantly reduced on the ipsilateral side 
as compared with the contralateral side (7.2 ± 1.4 in contralateral hippocampus vs. 3.9 ± 1.1 in 
ipsilateral hippocampus, total 24 cells from 3 mice) (Figure 4.3.1.2  C). Thus, the overall 
morphology of astrocytes was drastically altered. However, the area occupied by GFAP signal, 
Rb Polyclonal Ms Monoclonal Merged
C
on
tra
la
te
ra
l 
Ip
si
la
te
ra
l 
Rb Polyclonal
A) B) 
    Results  
 
88 
 
was similar between the two groups (Figure 4.3.1.2 C), indicating reorganization of the 
cytoskeleton without reduction in GFAP protein levels. This was further confirmed with 
Western blot which revealed no significant difference in the GFAP protein levels (Figure 
4.3.1.2 D, N =6). 
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Figure 4.3.1.2: Astrocyte number and morphology 4 h post kainate. A) GFAP immunostaining 
using monoclonal and polyclonal antibodies in the SR region. In both hippocampi, there is a complete 
overlap of the signals from the two anti-GFAP antibodies with different clonalities. Scale bar, 100 µm.  
B) Number of GFAP positive astrocytes and total number of cells were significantly reduced in the 
ipsilateral hippocampus (*** p < 0.001, ** p < 0.01, N = 6). C) The number of primary branches per 
astrocyte were reduced in the ipsilateral hippocampus (** p < 0.01, 24 cells from 3 mice) even though 
the area occupied by GFAP signal remained unchanged. D) Western blot showing GFAP with GAPDH 
as a loading control. Total GFAP levels were similar in the two groups (N = 6). The graph shows the 
quantification of the Western blot. 
 
4.3.2 Assessing astrocytic death by TUNEL assay 
Apoptosis is a programmed cell death characterized by DNA fragmentation, cellular blebs and 
vesicular release (Elmore, 2007). Since GFAP immunostaining indicated reduced cell 
numbers, a TUNEL assay was performed to assess apoptosis in astrocytes. This assay is based 
on the incorporation of modified dUTPs by the enzyme terminal deoxynucleotidyl transferase 
(TdT) at the 3’-OH ends of fragmented DNA. A click reaction was employed to detect the 
incorporated dUTPs. DNAse treated sections were used as a positive control. Co-
immunostaining with GFAP revealed that none of the astrocytes in the ipsilateral and 
contralateral hippocampi were TUNEL positive. In fact, no TUNEL positive signal was 
detected in either of these hippocampi (Figure 4.3.2 (A) and (B)), in contrast to a positive 
control which showed TUNEL positive astrocytes in addition to TUNEL positive pyramidal 
neurons (Figure 4.3.2 (C)).  Thus lack of TUNEL signal ruled out the possibility of late stage 
apoptosis in astrocytes following kainate induced seizures. 
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Figure 4.3.2: TUNEL assay to detect apoptotic cells, 4 h post kainate. TUNEL, GFAP and Hoechst 
co-staining to detect apoptotic astrocytes. DNAse treated brain section (A) was used as a positive 
control. Confocal images from the CA1 region revealed apoptotic cells in positive control. No TUNEL 
positive cells were detected in the contralateral (B) and ipsilateral (C) CA1 the regions, 4 h post kainate 
injection. Scale bar, 100 µm. 
 
4.3.3 Cx43 expression and stereology 
Cx43 is the most important gap junctional protein in hippocampal astrocytes. Its deletion 
resulted in 50% loss of astrocytic coupling despite a compensatory increase in Cx30 protein 
levels (Theis et al., 2003). Expression and distribution of Cx43 have been correlated with gap 
junctional coupling in many studies (Rouach et al., 2002)(Collignon et al., 2006)(Koulakoff et 
al., 2012). Cx43 expression and stereology was assessed by immunolabeling with an antibody 
targeting amino acids 360 to 382 of the Cx43 C-terminal domain. Cx43 showed a punctate 
staining pattern (Figure 4.3.3) in both, ipsilateral and contralateral hippocampi. Quantification 
of fluorescence intensity in the SR region revealed no significant difference in the mean 
intensity (91.25 ± 15.38 a.u. in contralateral vs. 91.07 ± 28.86 a.u. in ipsilateral, N = 3) 
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indicating similar expression levels between the two groups. Further analysis indicated similar 
size (0.04 ± 0.002 µm2 in contralateral vs. 0.05 ± 0.007 µm2 in ipsilateral, N = 3), number (89.1 
± 47.53 in contralateral vs. 80.09 ± 24.62 in ipsilateral, N = 3) and area occupied by Cx43 
plaques (4.09 ± 2.17 µm2 in contralateral vs. 4.01 ± 0.8 µm2 in ipsilateral, N = 3). It can be 
concluded that Cx43 expression and plaque patterns are unaltered in the ipsilateral SR as 
compared with contralateral SR.  
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.3: Cx43 immunostaining and stereology. A) Cx43 immunostaining in the stratum 
radiatum displaying punctate labelling. Scale bar, 25 µm. B) Bar graph shows the quantification of 
Cx43 plaques in 184.52 x 184.52 x 30 µm3 boxes positioned in stratum radiatum. There was no 
significant difference in the total number of plaques, area occupied by plaques, average plaque size and 
average fluorescent intensity between contralateral and ipsilateral hippocampi. N = 3 per group. 
 
4.3.4  Phosphorylation status of Cx43  
Cx43 undergoes extensive post-translational modification, for example phosphorylation which 
is known to regulate its distribution, channel forming properties and gating (Axelsen et al., 
2013). On SDS-PAGE, the protein is characterized by three bands namely the fast migrating 
P0 isoform and slows migrating P1 and P2 isoforms. The nomenclature P1 and P2 does not 
correlate with the extent of phosphorylation but it is rather the result of complex conformations 
arising from phosphorylation at different residues (Solan and Lampe, 2009). Changes in the 
relative levels of these isoforms indicate changes in the phosphorylation of the protein, which 
may affect gap junctional coupling.  
C
on
tra
la
te
ra
l 
Ip
si
la
te
ra
l 
0
25
50
75
100
125
150
175
200
Number of
Plaques
Area occupied Average
plaque size
Mean
fluorescence
intensity
C
ha
ng
es
 n
or
m
al
iz
ed
 to
 c
on
tra
la
te
ra
l s
id
e 
(%
) 
Contralateral 
Ipsilateral 
A) B) 
    Results  
 
92 
 
In earlier experiments using immunofluorescence methods, Cx43 expression was found to be 
unaltered (Figure 4.3.3). Therefore, Cx43 phosphorylation was assessed by Western blotting. 
Total membrane preparations from the dorsal hippocampi of kainate and sham injected mice 
were subjected to SDS PAGE followed by blotting on to PVDF membranes. The membranes 
were probed with antibodies against Cx43 and the loading control E-cadherin (Figure 4.3.4 A, 
B). The normalized intensities revealed no difference in the total protein levels, as anticipated. 
However, in the kainate injected group, there was significant increase in the P2 band levels on 
the ipsilateral side as compared with contralateral side (increased to 165.02 ± 11.78 %) (Figure 
4.3.4 C). In contrast, in sham injected mice all isoform levels were similar (Figure 4.3.4 D).  
Cx30 is another gap junctional protein found in astrocytes in the hippocampus. Its contribution 
to astrocytic coupling is considered marginal, with 20% reduction in the network size when 
Cx30 is knocked out (Gosejacob et al., 2011). There has been no report of phosphorylation 
mediated regulation of Cx30. In order to check if the expression level of Cx30 was changed in 
epilepsy, Western blot was performed on total membrane preparations obtained from 
hippocampi of kainate injected mice. E-cadherin-normalized protein levels indicated no change 
in the expression of Cx30 in both, kainate and saline injected mice (Figure 4.3.4 C and D).  
Altogether, these data demonstrate that, the phosphorylation status of Cx43 is altered 4 h after 
kainate injection. It is important to note that there are 21 potential phosphorylation sites on the 
cytoplasmic tail of Cx43. Phosphorylation at some of these sites has been postulated as a 
constitutive requirement for coupling while phosphorylation at other sites has been correlated 
with loss of coupling (Lampe and Lau, 2004)(Solan and Lampe, 2009). The bands seen on the 
Western blots are combined results of many possible combinations of these phosphorylation 
sites and they do not reveal exactly which amino residues were phosphorylated. These details 
can be identified with the help of mass spectrometry. 
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Figure 4.3.4:  Immunoblot of Cx43 with E-cadherin as a loading control, 4 h after kainate (panel 
A) or saline injection (panel B).  Total membrane preparations from the dorsal hippocampi were 
subjected to SDS PAGE followed by Western blotting. Cx43 antibody detected 3 bands that represent 
the different phosphorylation forms of Cx43 (P0, P1 and P2). C) and D) Bar graphs showing 
quantification of E-cadherin-normalized protein levels expressed as % of corresponding mean levels in 
the contralateral hippocampus.  There was no difference in the total Cx43 and Cx30 levels across all 
the groups. However, the P2 bands was significantly elevated in the ipsilateral hippocampus of kainate 
injected mice (165.02 ± 11.78%) while the other bands were similar when compared with corresponding 
bands from the contralateral hippocampus.  All isoforms were similar between contralateral and 
ipsilateral hippocampi in saline injected group. *** p < 0.001, N = 6 per group. 
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4.4 Mass spectrometry-based characterization of Cx43 
phosphorylation 
Mass spectrometry-based phosphoproteomics requires that the target protein is isolated in 
sufficient and pure amounts, posing an immense importance on sample preparation. 
Immunoprecipitation (IP)  is the most widely used method to isolate a protein of interest from 
a complex mixture of tissue proteins. Successful immunoprecipitation requires a highly 
specific antibody coupled to a solid support (like protein A sepharose beads) and a buffer to 
solubilize the precipitated protein. Cx43, which is a membrane protein is not soluble in aqueous 
solutions without detergents. Therefore, a sample preparation protocol for the isolation of Cx43 
from mouse hippocampi was systematically optimized. There were three main requirements: 
To obtain an optimum ratio for bead and antibody coupling 
To estimate the volume of antibody required for complete extraction of Cx43 from the lysate 
Scaling up the optimized IP protocol and confirmation of the complete removal of Cx43 
4.4.1  Optimization of the sample preparation protocol 
4.4.1.1 Optimization of the bead antibody ratio 
The concentration of custom made anti-Cx43 antibody as measured by UV spectrophotometer 
was found to be 0.82 µg/µl. ‘Protein A’ magnetic beads (30µg/µl) were used to non-covalently 
couple with this antibody. The minimum volume of beads required to adsorb 100 µl of the 
antibody was estimated as follows. 10 µl of the beads were sequentially added to 100 µl of the 
antibody. After each addition, the mixture was incubated for 30 minutes followed by magnetic 
separation. The concentration of the separated supernatant was measured and the supernatant 
was added back to the beads. Another 10 µl of the beads were added to the mixture and the 
process was repeated. After 6 such additions and subsequent measurements, 3 parameters were 
calculated and plotted for correlation analysis. The three parameters were i) cumulative amount 
of beads ii) cumulative amount of antibody adsorbed on to the beads and iii) adsorption 
efficiency. The last parameter is the ratio of the first two parameters and is defined as the µg 
of antibody adsorbed by per mg of beads. Plotting cumulative amounts of beads vs. cumulative 
amounts of antibody adsorbed on to the beads resulted into a zero intercept straight line 
according to the equation y = 0.023x (R2= 0.95) (Figure 4.4.1.1 A). From this equation, the 
minimum volume of beads required to adsorb 100 µl of the antibody was estimated to be 93.5 
µl.  
    Results  
 
95 
 
Further, the adsorption efficiency was plotted against the cumulative amount of antibody 
adsorbed. It resulted into a non-linear relationship, with adsorption efficiency declining over 
the adsorbed antibody amount (Figure 4.4.1.1 B). This indicates that, adsorption efficiency is 
directly proportional to the availability of the free antibody. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.1.1:  Optimization of the bead-antibody ratio. A) A linear plot of the antibody adsorbed 
to the beads against the cumulative amount of beads (in mg). Extrapolation yields a minimum required 
ratio of 0.023 between the beads and the antibody. B) Logarithmic plot of the cumulative amount of 
antibody adsorbed (µg) against the adsorption efficiency (µg of antibody/mg of beads). The latter 
decreases as the amount of free antibody depletes. AB = antibody, amt = amount 
 
4.4.1.2 Estimation of the volume of antibody required for complete extraction of Cx43 
Complete extraction of Cx43 from the tissue is necessary to obtain sufficient amount for 
phospho-site detection. 2.5, 5 and 10 µl of antibody was used to immunoprecipitate Cx43 from 
50 µg of the protein lysate of mouse hippocampus. After overnight incubation, the eluates and 
the respective supernatants were subjected to SDS PAGE and subsequent Western blotting. 
Direct probing of the membrane with the secondary antibody alone revealed bands at 55 kDa 
representing the heavy chain of the antibody used for immunoprecipitation (Figure 4.4.1.2, 
upper panel). The same membrane was later probed with anti-Cx43 antibody to visualize the 
Cx43 band at 40 kDa. 2.5 µl of antibody gave partial extraction of Cx43 while 5 and 10 µl of 
antibody resulted in complete extraction from the 50 µg of lysate (Figure 4.4.1.2, lower panel).  
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Thus, a minimum 5 µl of the antibody is required to extract the entire pool of Cx43 from 50 ug 
of the lysate. This can be extrapolated to a 100 µl of antibody for complete extraction of Cx43 
from 1000 µg of protein lysate, which is an average amount of protein obtained from one mouse 
hippocampus. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.1.2: Optimization of the lysate-antibody ratio. Western blot showing 
immunoprecipitation efficiency of various volumes of the antibody in 50 µg of the protein lysate. The 
upper panel represents signal from direct incubation of secondary antibody. The band representing the 
heavy chain of IgG is visible at around 55 kDa. After primary antibody incubation and subsequent 
detection with secondary antibody, all Cx43 related bands were visible (lower panel). 2.5 µl of antibody 
resulted in partial extraction of Cx43 while 5 and 10 µl resulted in complete extraction as indicated by 
absence of Cx43 signal in the supernatant lane. SP = Supernatant.   
 
4.4.1.3 Scaling up the optimized IP protocol and confirmation of the complete removal of 
Cx43 
Based on the optimized bead-antibody and antibody-lysate ratio (4.4.1.1 and 4.4.1.2), a scaled 
up IP reaction was undertaken. 100 µl of the antibody was coupled with 100 µl of the magnetic 
protein A beads. The bead-antibody conjugate was then incubated with either 1000 µg of total 
cellular lysate or 1000 µg of the total membrane lysate overnight at 4 0C with shaking. The 
next day, the immunoprecipitated Cx43 was eluted with glycine buffer (pH 2.8). Eluates and 
the corresponding supernatants were subjected to SDS PAGE followed by Western blotting. 
The resultant blots were probed with mouse anti Cx43 antibody directed against the N-terminal 
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domain of Cx43 (NT-1 antibody). It is important to note here, that the antibody used for probing 
the blot recognized a different epitope than the antibody that used for immunoprecipitation, 
which targets the last 23 amino acids of the C terminal region of Cx43. The entire C terminal 
tail of Cx43 has many Serine, Tyrosine and Threonine residues with potential for undergoing 
phosphorylation. On the other hand the NT-1 antibody used for detection targets the N-terminal 
region of Cx43 which is not phosphorylated. The use of two different antibodies for 
immunoprecipitation and detection helped in the unbiased evaluation of immunoprecipitation 
efficiency. Indeed, no left over Cx43 was detected in the supernatant lane (Figure 4.4.1.3) while 
the eluate was enriched in Cx43. Interestingly, total membrane preparations gave better yield 
of Cx43 phospho-isoforms as compared with total cellular preparations. 
 
 
 
 
 
Figure 4.4.1.3:  Western blot using antibody targetting the N-terminal of Cx43. The blot shows the 
immunoprecipitation efficiency of a scaled up reaction on the entire hippocampal lysate (equivalent to 
1000 µg of protein). The antibody used for immunoprecipitation was raised against amino acids 360 to 
380 of Cx43. The antibody used for detection recognized amino acids 1 to 20 of Cx43.  There was 
complete extraction of Cx43 as indicated by the absence of Cx43 signal in the SP lane. Total membrane 
preparation gave better yield of phosphorylated Cx43 as indicated by the P2 band. Lysate from the 
hippocampus of the Cx43 knock out mouse was used as a negative control. Control lysate was not 
subjected to immunoprecipitation. SP = Supernatant. 
 
4.4.2 Identification of the phosphorylation sites 
(In collaboration with Dr. M. Sylvester, Institute of Biochemistry and Molecular Biology, 
Bonn)  
The eluate obtained after IP reaction is a mixture of the target protein and the antibody. It is 
essential to separate them before mass spectrometric analysis. Therefore, eluate from the scaled 
up IP reaction was subjected to SDS PAGE. The gel was stained with colloidal coomassie (G 
250). The band corresponding to 40 kDa was excised and subjected tryptic digestion. The 
peptides thus obtained were spin dried and analyzed with LC MS. The resultant spectra were 
then examined for the presence of phosphorylated residues with the help of a computer 
program. An example of such an analysis is presented in Figure 4.4.2 B. The sequence coverage 
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shown in the figure is the fraction of total sequence of Cx43 protein detected by the mass 
analyzer (corresponding sequences highlighted in green). The phosphorylated residues are 
designated with the letter P. As shown in this figure, there were 8 phospho-sites detected with 
99 to 100% confidence. Some of these sites are considered to be constitutively phosphorylated 
and essential for gap junctional coupling (see discussion).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.2: Identification of the phosphorylation sites. A) Representative image of a coomassie 
stained gel. The eluates obtained from immunoprecipitation reaction were subjected to SDS PAGE. 
The strong band between 40 and 55 kDa represents the heavy chain of the IgG antibody that was used 
for immunoprecipitation. Bands at 40 kDa were carved out and subjected to tryptic digestion. B) 
Sequence coverage obtained after a typical mass-spectrometric analysis. Percentage coverage indicates 
the percentage of total protein sequence identified by a mass analyzer in the form of peptide fragments 
(highlighted in green). Colour code on the left corner represents the confidence in predicting the 
phosphorylation sites. P = phosphorylated residue. 
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4.4.3 Phosphorylation profile of Cx43 4 h after kainate induced seizures 
(In collaboration with Dr. M. Sylvester, Institute of Biochemistry and Molecular Biology, 
Bonn).  
Dorsal ipsilateral and contralateral hippocampi were resected from mice subjected to unilateral 
kainate injections. Ipsi- and contralateral hippocampi from 2 mice were pooled. In total, 
hippocampi from 30 mice were pooled to obtain 9 samples for kainate injected contralateral 
group (Kainate C), 9 samples for kainate injected ipsilateral group (Kainate I), 6 samples for 
saline injected contralateral group (Sham C) and 6 samples for saline injected ipsilateral group 
(Sham I). The IP reaction was performed as described in section 4.4.2.3, except for the elution 
procedure. Immunoprecipitated Cx43 was eluted by heating the beads in Laemli buffer at 65 
0C for 10 min.  Separation of antigen and antibody, protein digestion and detection of 
phosphorylated residues on the resultant peptides were carried out illustrated in section 4.4.2. 
In total, 14 phosphorylation sites were detected with a post translational modification (PTM) 
score of more than 95% (Table 4.4.3.1). On 2 of these 14 positions, threonine was present. 11 
residues were serines while only one phosphorylated tyrosine was detected.  
In order to quantify the extent of phosphorylation on each of these sites, chromatographic peak 
areas of their corresponding peptides were measured. These areas were normalized with 
chromatographic peak areas of the non-phosphorylated peptides. These area ratios were 
calculated for each site and then used for statistical analyses. There was no significant 
difference in the area ratios for any of the phosphorylation sites between Sham I (i.e. ipsilateral) 
and Sham C (i.e. contralateral) (Mann-Whitney test, N = 6 per group). Thus, there was no effect 
of saline injection on the phosphorylation profile of Cx43. Therefore, the area ratios from these 
two groups were pooled together for further comparison with Kainate I (i.e. ipsilateral) and 
Kainate C (i.e. contralateral) groups.  
 
 
 
 
 
 
 
 
 
 
    Results  
 
100 
 
Table 4.4.3.1: Phosphorylated amino acid residues detected with a PTM score of more than 95%. 
Small letters in the sequence motif represent the phosphorylated residues. In total, 14 phosphorylation 
sites were detected.  On 2 of these 14 positions, threonine was present. 11 residues were serines while 
one phosphorylated tyrosine was detected. 
 
Position Target  PTM Localization probability Sequence Motif
244 Serine 98.71 DRVKGRsDPYHAT
257 Serine 99.97 TGPLSPsKDCGSP
262 Serine 100 PSKDCGsPKYAYF
290 Threonine 99.3 PGYKLVtGDRNNS
296 Serine 99.07 TGDRNNsSCRNYN
297 Serine 99.75 GDRNNSsCRNYNK
301 Tyrosine 97.19 NSSCRNyNKQASE
306 Serine 100 NYNKQAsEQNWAN
325 Serine 99.37 RMGQAGsTISNSH
326 Threonine 97.54 MGQAGStISNSHA
328 Serine 99.98 QAGSTIsNSHAQP
330 Serine 99.99 GSTISNsHAQPFD
364 Serine 95.8 IVDQRPsSRASSR
365 Serine 98.75 VDQRPSsRASSRA  
 
Kruskal-Wallis followed by post hoc Dunn’s test revealed differential phosphorylation on 4 
sites, namely S328, S330, S257 and S262 (Table 4.4.3.2). Representative spectra for these sites 
are displayed in Figure 4.4.3.1 (below). 
 
 
 
 
 
 
 
 
 
 
Fragment ion spectrum demonstrating evidence for pS328 from ipsilateral tissue of kainate-
injected mice. RT: 53.61 min, precursor m/z= 986.75934 Da, (z=3, MH+= 2958.26346 Da), 
match tolerance =0.5 Da. Mascot ion score = 68, Percolator PEP = 1.1E-07 
(A) S328 
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(B) S330 
Fragment ion spectrum demonstrating evidence for pS330 from ipsilateral tissue of sham-injected 
mice. RT: 51.90 min, precursor m/z= 744.32166 Da, (z=4, MH+= 2974.26479 Da), match tolerance 
=0.5 Da. Mascot ion score = 38, Percolator PEP = 1.1E-04 
(C) S257 
Example of a fragment ion spectrum demonstrating evidence for pS257 from ipsilateral tissue of 
kinate-injected mice. RT: 39.90 min, precursor m/z=766.00299 Da, (z=3, MH+=2295.99442 Da), 
match tolerance =0.5 Da. Mascot ion score = 42, Percolator PEP = 5.3E-04.  Not all matching fragment 
ions are annotated due to space restraints. Fragmentation pattern of the peptide sequence generated 
with GPMAW10 (Lighthouse Data, Odense, Denmark). 
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Figure 4.4.3.1: Representative spectra of the distinctly phosphorylated serines, 4 h post kainate 
injection. Phosphorylations at S328 (A), S330 (B), S257 (C) and S262 (D) of Cx43 were altered in 
hippocampus following kainate induced seizures. 
 
S328 and S330 are the targets of Caseine kinase 1 and are considered to be constitutively 
phosphorylated. Their phosphorylation is required for gap junctional assembly (Lampe et al., 
2006). Indeed, in all samples of the saline injected group, S328 and S330 were phosphorylated. 
Interestingly, in the Kainate group (both C and I) S330 phosphorylation is reduced when 
compared with the Sham group (Figure 4.4.3.2 B). On the other hand S328 phosphorylation is 
reduced only in the Kainate C group when compared with the Sham group (Figure 4.4.3.2 A).  
S257 can be phosphorylated by protein kinase G (PKG) (Kwak et al., 1995) or CamK II (Huang 
et al., 2011). Phosphorylation of S257 has been associated with reduced gap junctional 
conductance (Kwak et al., 1995). Phosphorylation at this site was increased the in Kainate I 
group when compared with the Sham group. Surprisingly, there was no significant difference 
between I and C subgroups of the Kainate group (Figure 4.4.3.2 C). 
S262 can be phosphorylated by MAPK or CDK-2 and this phosphorylation is known to reduce 
the open probability of the gap junction channels (Thévenin et al., 2013). Phosphorylation of 
S262 was increased in Kainate I group when compared with Kainate C  and Sham groups 
(Figure 4.4.3.2 D). It is worth noting here that S262 was the only phospho-site that was 
differentially regulated in the ipsilateral (kainate I) hippocampus when compared with the 
contralateral hippocampus (kainate C). Qualitative analysis also revealed increased occurrence 
of S262 phosphorylation in the ipsilateral hippocampus of the kainate group (found in 8 out of 
(D) S262 
Fragment ion spectrum demonstrating evidence for pS262 from contralateral tissue of sham-injected 
mice. RT: 35.48 min, precursor m/z= 837.04230 Da, (z=3, MH+= 2509.11234 Da), match tolerance 
=0.5 Da. Mascot ion score = 56, Percolator PEP = 4.5E-07 
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9 samples) when compared with ipsilateral and contralateral hippocampi of the sham group 
(found in 2 out of 6 samples per group) (Table 4.4.3.2).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4.3.2: Box-whisker plots showing normalized chromatographic peak areas of the 
phospho-peptides, 4 h after kainate or saline injection. Chromatographic peak areas of the phospho-
peptides were normalized with the chromatographic peak areas of complete Cx43 in the same sample 
to obtain ‘area ratios’. Peptide forms that contained the same phospho-site but different peptide 
boundaries, oxidation states or charge states were summed up. The area ratios were calculated for each 
site and then used for statistical analyses. There was no significant difference in the area ratios for any 
of the phosphorylation sites between Sham I (i.e. Ipsilateral Sham) and Sham C (i.e. Contralateral 
Sham) (Mann-Whitney test, N = 6 per group). Thus, there was no effect of the saline injection on the 
phosphorylation profile of Cx43. Therefore, the area ratios from these two groups were pooled together 
for further comparison with Kainate I (i.e. Ipsilateral Kainate) and Kainate C (i.e. Contralateral Kainate) 
groups. The boundaries of the boxes encompass the lower (25 %) and the upper (75%) quartiles  of the 
samples. The horizontal line inside the box represents the median. Each dot denotes a sample.** p < 
0.01, * p < 0.05, Kruskal-Walis followed by Dunn’s test for pairwise comparison. N = 9 each for 
Kainate I and Kainate C group. N = 12 for sham C + I group. A) pS328 The area ratio of the sham 
group was significantly higher than that of the Kainate C and Kainate I groups. There was no difference 
between Kainate I and Kainate C group. B) pS330 Phosphorylation on S328 was significantly decreased 
in the Kainate groups when compared with the Sham group. There was no difference between kainate 
I and C groups. C) pS257 The area ratio for pS257 was significantly higher in the Kainate I group when 
compared with Sham group. There was no significant difference between Kainate I and Kainate C 
groups. The median for the sham group was 0. D) pS262  This was the only phospho-site which differed 
significantly between Kainate I and Kainate C groups. The area ratio for pS262 was significantly higher 
in the Kainate I group when compared with Kainate C and Sham C + I groups. The median for the sham 
group was 0. 
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In conclusion, phosphorylation at S262 and 257 was increased after kainate injection. This 
increase was more pronounced in the ipsilateral hippocampus of the kainate group when 
compared with the sham group. Out of these two sites, S262 was more phosphorylated in 
ipsilateral hippocampus of the kainate group when compared with the contralateral 
hippocampus of the same group (p < 0.05, N = 9 per group). Therefore, S262 phosphorylation 
was investigated further. 
 
Table 4.4.3.2: Occurrences of the distinctly phosphorylated serines, 4 h after kainate or saline 
injection. The numbers represent the number of samples in which the respective site was found to be 
phosphorylated. Each sample was obtained by pooling the cognate hippocampi from two mice. S262 
phosphorylation was more frequently observed in the kainate I group when compared with other groups. 
 
  Groups
Site Putative kinase Kainate R Kainate L Sham R Sham L 
S328 Caseine kainase I 6 out of 9 8 out of 9 6 out of 6 5 out of 6 
S330 Caseine kainase I 6 out of 6 6 out of 6 3 out of 3 3 out of 3 
S257 PKG 7 out of 9 7 out of 9 3 out of 6 1 out of 6 
S262 MAPK/CDK-2 8 out of 9 6 out of 9 2 out of 6 2 out of 6 
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4.4.4 Western blot using antibody against phospho-S262  
Mass-spectrometric analysis of Cx43 revealed increased kainate-induced phosphorylation of 
S262. In order to confirm this finding, phospho-specific antibody against a peptide targetting 
phosphorylated S262 of mouse Cx43 was used for Western blotting. Hippocampi were 
harvested from mice 4 h after kainate or saline (Sham group) injection. Total membrane 
preparations from the dorsal hippocampi were subjected to SDS PAGE followed by Western 
blotting. The blotted membranes were probed with anti-pS262 Cx43 followed by 
phosphorylation-unspecific Cx43 antibody. Cadherin was used as a loading control (Figure 
4.4.4 B). The phosphorylation-unspecific antibody recognized 3 characteristics bands namely 
P2, P1 and P0 with an additional lower molecular weight band. The phospho-specific anti-
S262 antibody identified many bands between 35 to 40 kDa. Bands co-localizing with those 
identified by phosphorylation-unspecific antibody were considered as specific signals (Figure 
4.4.4 A). Phospho-S262 intensities were normalized by two methods: 1) with cadherin protein 
intensity which is indicative of the total protein present in the membrane fractions. This method 
gave a ratio of S262 phosphorylation to the total protein loaded on to the gel. 2) With total 
Cx43 intensity obtained by probing with phosphorylation-unspecific Cx43 antibody. This 
method gave a fraction of total Cx43 that is phosphorylated on S262. Both of these methods 
revealed an increased proportion of phosho-S262 in the ipsilateral hippocampus of the kainate 
group when compared with the contralateral hippocampus of the same group and both 
hippocampi of the sham group (Figure 4.4.4 C and D). Further, phospho-isoforms obtained by 
probing the membranes with phosphorylation-unspecific Cx43 antibody indicated increased 
P2 isoform levels in the ipsilateral hippocampus of the kainate group when compared with all 
other three groups (Figure 4.4.4 E). However, there was no significant difference in the total 
Cx43 levels (i.e. P2 + P1 + P0) between any of the groups. Thus, there was a shift in bands 
towards P2, without any significant change in the total protein levels. The data indicate that 
this shift towards P2 band was caused by kainate injection and was not merely an injection 
artefact. Moreover, the data confirm the increased phosphorylation of S262 previously 
suggested by mass-spectrometric analysis.   
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Figure 4.4.4: Phosphorylation at S262 of Cx43, 4 h post kainate.  A) Immunoblot with 
phosphorylation-unspecific and phospho-specific (pS262 Cx43) Cx43 antibody. The phosphorylation-
unspecific antibody (also used for all previous Western blots and immunoprecipitations) recognized 3 
characteristics bands namely P2, P1 and P0 with an additional lower molecular weight band. The 
phospho-specific anti-S262 antibody identified many bands between 35 to 40 kDa. Bands co-localizing 
with those identified by phosphorylation-unspecific antibody were considered as specific signals. B) 
Hippocampi were harvested from mice, 4 hr after kainate or saline (Sham group) injection. Total 
membrane preparations from the dorsal hippocampi were subjected to SDS PAGE followed by Western 
blotting. The blotted membranes were probed with anti- pS262 Cx43 followed by phosphorylation-
unspecific Cx43 antibody. Cadherin was used as a loading control. C) Histogram showing pS262 levels 
normalized with cadherin and then expressed as a percentage of contralateral hippocampus of the 
kainate group.  Phosphorylation of S262 was increased in ipsilateral hippocampus (181.72 ± 6.9) of the 
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kainate group when compared with other three groups (Contralateral hippocampus of the kainate group: 
100 ± 7.87, Contralateral hippocampus of the sham group: 96.56 ± 33.92, Ipsilateral hippocampus of 
the sham group: 89.35 ± 22.14).  These three groups did not differ with each other in pS262 
phosphorylation. D) Histogram showing pS262 levels normalized with total Cx43 (identified by 
phosphorylation-unspecific Cx43 antibody) and then expressed as a percentage of contralateral 
hippocampus of the kainate group.  Phosphorylation of S262 was increased in ipsilateral hippocampus 
(166.74 ± 13.13) of the kainate group when compared with other three groups (Contralateral 
hippocampus of the kainate group: 100 ± 11.09, Contralateral hippocampus of the sham group: 99.80 
± 26.75, Ipsilateral hippocampus of the sham group: 99.02 ± 29.99).  These three groups did not differ 
with each other in pS262 phosphorylation.  E) Quantification of total Cx43 and Cx43 phospho-isoforms 
(identified by phosphorylation-unspecific Cx43 antibody) normalized with pan-cadherin and then 
expressed as a percentage of contralateral hippocampus of the kainate group. Total Cx43 did not differ 
between any of the groups. Among phospho-isoforms, only P2 isoform was significantly elevated in 
ipsilateral hippocampus (154.11 ± 13.39) of the kainate group when compared with the other three 
groups (Contralateral hippocampus of the kainate group: 100 ± 5.16, Contralateral hippocampus of the 
sham group: 104.46 ± 26.93, Ipsilateral hippocampus of the sham group: 103.1 ± 8.05).  These 
remaining three groups did not differ with each other in any of the phospho-isoform levels. ** p < 0.01, 
* p < 0.05, N = 3 per group. 
 
4.4.5 Cytokines mediated phosphorylation of Cx43 at S262  
Incubation of mouse hippocampal slices in cytokines namely TNFα and IL-1β has been shown 
to reduce the astrocytic gap junctional coupling (Bedner et al., 2015). The phosphorylation of 
Cx43 was assessed in hippocampal slices incubated under following conditions: ACSF (as a 
control), TNFα + IL-1β (10 ng/ml) or TNFα + IL-1β (10 ng/ml) with XPRO 1595 (10 µg/ml) 
for 3.5 hr. XPRO 1595 is a dominant negative inhibitor of the soluble TNFα  (Fischer et al., 
2015).  Total membrane preparations from the slices incubated in above-mentioned conditions 
were subjected to SDS PAGE followed by Western blotting. The blotted PVDF membranes 
were probed with anti- pS262 Cx43 followed by phosphorylation-unspecific Cx43 antibody. 
The phosphorylation-unspecific antibody recognized three characteristics bands namely P2, P1 
and P0 with an additional faint lower molecular weight band. The phospho-specific anti-S262 
antibody identified strong bands at 40 kDa (Figure 4.4.5 A). Bands co-localizing with those 
identified by phosphorylation-unspecific antibody were considered as specific signals. 
Densitometry was performed as described in 4.4.4. Cytokine treatment increased the extent of 
S262 phosphorylation on Cx43. This increase was attenuated by co-treatment with XPRO 1595 
(Figure 4.4.5 B, C). Remarkably, phospho-bands seen after probing the membranes with 
phosphorylation-unspecific Cx43 antibody indicated increased P2 band levels in the cytokine-
treated group when compared with control and XPRO 1595 treated groups (Figure 4.4.5 D). 
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Figure 4.4.5: Cytokines mediated phosphorylation of Cx43 at S262. A) Immunoblot with 
phosphorylation-unspecific and phospho-specific (pS262 Cx43) Cx43 antibody. Hippocampal slices 
incubated in ACSF (as a control), TNFα + IL-1β (10 ng/ml) or TNFα + IL-1β (10 ng/ml) with XPRO 
1595 (10 µg/ml) for 3.5 h, were homogenized in a lysis buffer to obtain total membrane preparations. 
Five µg of proteins from each sample were subjected to SDS PAGE followed by Western blotting. The 
blotted membranes were probed with anti- pS262 Cx43 followed by phosphorylation-unspecific Cx43 
antibody. The phosphorylation-unspecific antibody recognized 3 characteristics bands namely P2, P1 
and P0. The phospho-specific anti-S262 antibody identified strong bands at 40 kDa. B) Bar graphs 
showing pS262 levels normalized with pan-cadherin.  pS262/cadherin ratio was increased in cytokine 
treated slices (0.9 ± 0.03) when compared with control slices (0.64 ± 0.05) or XPRO 1595 treated slices 
(0.73 ± 0.03). C) Bar graphs showing pS262 levels normalized with total Cx43.  The pS262/total Cx43 
ratio was increased in cytokine treated slices (0.104 ± 0.003) when compared with control slices (0.082 
± 0.009) or with XPRO 1595 treated slices (0.083 ± 0.008). D) Quantification of Cx43 phospho-
isoforms (identified by phosphorylation-unspecific Cx43 antibody) normalized with pan-cadherin. 
Only P2 isoform is significantly elevated in cytokine treated slices (1.93 ± 0.03) when compared with 
the other two groups (Control group: 1.62 ± 0.09, XPRO 1595 group: 1.65 ± 0.06). *** p < 0.001, ** 
p < 0.01, * p < 0.05, N = 3 per group. 
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4.5 Molecular alterations in astrocytes 5 days post 
kainate injection 
Status epilepticus is typically followed by a latent phase in which the brain is virtually seizure 
free but is undergoing molecular changes that increase its propensity to have seizures (Wong, 
2009). This enduring predisposition to generate seizures is the characteristic feature of chronic 
epilepsy. In our animal model of temporal lobe epilepsy, the latent phase typically lasts for 
about 5 days after kainate injection. At this time, astrocytic coupling in the ipsilateral 
hippocampus continues to be at 50% of the level in the contralateral hippocampus (Bedner et 
al., 2015). Possible mechanisms behind this observed uncoupling were investigated using 
immunohistochemistry and Western blotting. Astrocyte number, proliferation and connexin 
expression were examined for their association with uncoupling. Further, changes in the blood 
brain barrier permeability were studied with the help of albumin immunohistochemistry.  
4.5.1 Astrocytic markers 5 days post kainate injection 
Immunohistochemistry and stereology had indicated reduced number of astrocytes in the 
stratum radiatum of the ipsilateral hippocampus 4 h after kainate injection. However, no 
apoptotic astrocytes could be detected (section 4.3). Therefore, astrocytic markers were 
assessed 5 days after kainate injection. Coronal sections of the brain were stained with mouse 
monoclonal anti-S100β and rabbit polyclonal anti-GFAP antibodies. Confocal images revealed 
almost complete mutual co-localization of the signals from these two antibodies (Figure 4.5.1 
A). Numbers of astrocytes were not statistically different in contralateral (17.91 ± 0.62) and 
ipsilateral (18.08 ± 1.75) hippocampi (N = 3 per group) (Figure 4.5.1 B).  
 
 
  
 
 
 
 
 
 
A) Contralateral
Ipsilateral
S100β GFAP Merged
C
on
tra
la
te
ra
l 
Ip
si
la
te
ra
l 
N
um
be
r o
f a
st
ro
cy
te
s p
er
 c
ou
nt
in
g 
bo
x 
0
5
10
15
20
25
30
B) 
SP 
SR 
SO 
   Results  
 
110 
 
Figure 4.5.1: Astrocytic markers, 5 days after kainate injection. A) S100β and GFAP co-
immunostaining. Representative images from the CA1 region 5 days after kainate injection. All GFAP-
positive cells were also S100β-positive. Dashed curved line represents lower border of the pyramidal 
cell layer. Three counting boxes (184.52 x184.52 x30 µm3) were positioned in the SR region. SO = 
stratum oriens, SR = stratum radiatum, SP = stratum pyramidale. Scale bar, 100 µm. B) The bar graph 
shows the number of astrocytes per counting box. There was no significant difference in the number of 
astrocytes in the two groups. N = 3 per group. 
 
4.5.2 Astrocyte proliferation 5 days post kainate injection 
Since the difference in astrocyte numbers at 4 h (4.1.1.2) was abolished on day 5 post kainate 
(4.5.1), astrocytes were assessed for proliferative activity. BrdU was administered through 
drinking water from day 2 till day 5 after kainate injection. Coronal sections of the brain were 
stained with anti S100β and anti BrdU antibodies. Confocal images from the CA1 region 
revealed newly (post kainate injection) generated or dividing nuclei with BrdU signal (Figure 
4.5.2 A, red channel). Newly generated or dividing astrocytes were identified by co-
localization of S100β with BrdU. The number of such cells was significantly higher in the 
contralateral hippocampus as compared the ipsilateral hippocampus (6.85 ± 1.98 in 
contralateral vs. 3.52 ± 0.96 in the ipsilateral hippocampus, N = 3 per group).  However, the 
total number of S100β cells in the two groups was not statistically different (19.69 ± 1.24 in 
contralateral vs. 15.97 ± 3.37) (Figure 4.5.2 B).  
 
 
 
 
 
 
 
 
 
 
Figure 4.5.2: Astrocytic proliferation 5 days post kainate injection.  A) BrdU and S100β co-
immunostaining. Representative images from the CA1 region 5 days after kainate injection. S100β cells 
co-labelled with BrdU indicate newly generated or proliferating astrocytes. Dashed curved line 
represents lower border of the pyramidal cell layer. 3 counting boxes of the dimension 
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184.52x184.52x30 µm3 were positioned in the SR region. SO = stratum oriens, SR = stratum radiatum, 
SP = stratum pyramidale. Scale bar, 100 µm. B) Bar graph shows total number of S100β -positive cells 
and the number of S100β-positive BrdU cells per counting box. There was no significant difference in 
the total number of astrocytes in the two groups. The number of newly generated or proliferating 
astrocytes was significantly higher in the contralateral hippocampus.  (* p < 0.05, N = 3 per group). 
 
4.5.3 Cx43 expression and stereology 5 days post kainate injection 
Cx43 expression was assessed by immunolabeling with an antibody targeting amino acids 360 
to 382 of the Cx43 C-terminal (360-382 antibody). Cx43 showed punctate staining pattern in 
the SR of the ipsilateral hippocampus.  Surprisingly, Cx43 immunoreactivity was drastically 
reduced in the same region of the contralateral hippocampus (Figure 4.5.3 A). It is noteworthy 
here that any modification in the epitope of the antibody might result the loss of signal. 
Therefore, another antibody targeting a totally different epitope (250-270) was used to verify 
the staining pattern observed with 360-382 antibody. The 250-270 antibody detected Cx43 in 
both contralateral and ipsilateral hippocampi, indicating epitope masking of 360-382 antibody 
in the contralateral hippocampus. Therefore, the 250-270 antibody was used for stereological 
analysis. Quantification of the fluorescence intensity in the SR revealed no significant 
difference in the mean intensity indicating similar expression levels between the two groups 
(Contralateral: 69.73 ± 8.49 a.u. vs. Ipsilateral: 66.01 ± 5.31 a.u.). Further, plaque analysis 
indicated similar size (Contralateral: 0.046 ± 0.002 µm2 vs. Ipsilateral: 0.048 ± 0.001 µm2), 
number (Contralateral: 371.1 ± 176 vs. Ipsilateral: 371.3 ± 106.8) and area occupied by Cx43 
plaques (Contralateral: 17.78 ± 8.89 µm2 vs. Ipsilateral: 18.73 ± 5.77 µm2) (Figure 4.5.3 B). 
The data indicated that 5 days post kainate injection, Cx43 expression and plaque stereology 
was unaltered in ipsilateral SR as compared with contralateral SR, although epitope masking 
for the region 360 to 382 of Cx43 was observed in the contralateral hippocampus. 
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Figure 4.5.3: Cx43 expression and stereology, 5 days post kainate injection. A) Cx43 
immunostaining 5 days post kainate injection, in the SR region using two antibodies recognizing 
different epitopes. The signal from Cx43 (360-382) antibody was lost in the contralateral SR. Scale bar, 
25 µm. B) Bar graphs showing the quantification of Cx43 plaques immunostained with Cx43 (250-270) 
antibody. There was no significant difference in the total number of plaques, area occupied by plaques, 
average plaque size and average fluorescent intensity between contralateral and ipsilateral hippocampi. 
N = 3 per group. 
 
4.5.4  Phosphorylation status of Cx43 5 days post kainate injection 
As discussed in section 4.3.5, Cx43 is extensively phosphorylated and its phosphorylation 
profile is altered, 4 h after kainate injection. In case of 5 day time point, Cx43 expression was 
found to be unchanged using immunofluorescence methods (Figure 4.5.3). Therefore, 
phosphorylation of Cx43 was assessed with Western blotting. Plasma membrane associated 
proteins were isolated from ipsilateral and contralateral hippocampi of mice, 5 days post 
kainate injection. SDS PAGE and Western blotting were performed to detect Cx43 and Cx30 
(Figure 4.5.4 A). Using E-cadherin as a loading control, total Cx43 protein levels and protein 
levels of phospho-bands were found to be unaltered (Figure 4.5.4 B & C). In contrast to the 
data from 4 h time point, the absolute levels of the P2 bands between the two hippocampi are 
not changed at 5 day time point. It is likely that the elevated ipsilateral P2 bands levels at 4 h 
decline to normal till day 5 by dephosphorylation.  Similar to the total Cx43 protein levels, 
Cx30 protein levels were also found to be similar between ipsilateral and contralateral 
hippocampi. Thus, neither the phosphorylation status of Cx43 nor the connexin availability at 
the plasma membrane correlates with the astrocytic uncoupling prevalent at the end of the 
latent phase as reported  by Bedner et al., 2015.  
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Figure 4.5.4: Western blot of plasma membrane associated connexins, 5 days post kainate 
injection. A) Plasma membrane associated proteins were selectively isolated from the dorsal 
hippocampi. 5 µg of protein was loaded in each well. Immunoblot displays Cx43, Cx30 and E-cadherin 
(as a loading control). B) The histogram shows E-cadherin-normalized protein levels expressed as a 
percentage of the contralateral group. Total Cx43 and Cx30 levels were not statistically different 
between the contralateral and the ipsilateral hippocampi. C) Phospho-bands P2, P1 and P0 were 
normalized to E-cadherin and then expressed as a percentage of the contralateral group. There was no 
significant change in any of the phospho-bands between the two groups. 
 
4.5.5 BBB disruption and albumin extravasation 5 days post kainate 
injection 
BBB breakdown characterized by albumin extravasation has been implicated in 
epileptogenesis (Vliet et al., 2007)(Ivens et al., 2007). However, was not clear whether this 
aspect was different between ipsilateral and contralateral hippocampi in the mouse model of 
epilepsy. Intraventricular albumin administration has already been shown to cause uncoupling 
in astrocytes (Braganza et al., 2012). Therefore, albumin extravasation was investigated in 
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connection with reduced coupling in the ipsilateral hippocampus. Five days after kainate 
injection, coronal sections of the brain were stained with goat polyclonal anti-albumin 
antibody. Saline injected animals were used as a control. Confocal images from the CA1 region 
revealed that the albumin immunoreactivity was present only in ipsilateral hippocampi of the 
kainate injected mice while contralateral hippocampi in the same mice were devoid of any 
albumin signal. Importantly, albumin immunoreactivity was completely absent in sham 
injected mice indicating that the BBB breakdown was the result of kainate injection (Figure 
4.5.5). Thus, albumin extravasation is a distinct feature of the ipsilateral hippocampus that can 
be associated with reduced coupling. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.5.5: Albumin extravasation 5 days post kainate injection.  Albumin immunostaining 5 
days post kainate injection, in the SR region. Only ipsilateral hippocampi of kainate injected mice 
showed albumin immunoreactivity indicating BBB disruption. Scale bar, 25 µm. 
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4.6 Seizure-induced hippocampal changes in mice with 
astrocytic deletion of connexins  
Hippocampal sclerosis in epilepsy is characterized by the loss of CA1 pyramidal neurons, 
pronounced astrogliosis and granule cell pathologies (Thom, 2014). The granule cell 
pathologies have been correlated with memory disturbances and cognitive dysfunction in 
epilepsy patients (Hester and Danzer, 2014). They include axonal connections with 
inappropriate targets, abnormal dendrite growth, and migration of granule cells to ectopic 
locations resulting in granule cell dispersion (GCD). The latter process was shown to be 
independent of the seizure induced adult neurogenesis (Fahrner et al., 2007). Astrocytic 
connexins (Cx43 and Cx30) are known to regulate neurogenesis in the adult dentate gyrus 
(Kunze et al., 2009a). Interestingly, knock out of these connexins resulted in reduced seizure-
induced GCD (Pavel Dublin, PhD thesis 2012). To investigate this finding further, GCD and 
neuronal proliferation were investigated in mice lacking astrocytic connexins (DKO mice).  
4.6.1 Seizure-induced GCD is attenuated in DKO mice 
GCD is a remarkable feature observed in 40-50% of MTLE-HS patients (Thom, 2014). Granule 
cells have closely packed architecture in the dentate gyrus of control mice. Seizure induced 
dispersion of granule cells in the mouse model 1 month post injection was quantified by 
measuring the thickness of the blades of dentate gyrus. In the ipsilateral hippocampi, the 
granule cells were dispersed in contrast to the compact cellular architecture in contralateral 
hippocampi. The average thickness of the granule cell layer (average of T1, T2, T3 and T4, 
Figure. 4.6.1) was significantly increased in the ipsilateral hippocampus when compared with 
the corresponding contralateral hippocampus. The average thickness of the ipsilateral granule 
cell layer (GCL) was shorter in the DKO mice as compared with wild type (WT) mice (157.90 
± 29.63 vs. 219.47 ± 7.66 µm, N = 3 per group, respectively). These data show that astrocytic 
connexins influence the seizure-induced GCD. 
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Figure 4.6.1:  Seizure-induced GCD is attenuated in DKO mice. A) Prox1 immunostaining 1 month 
after kainate injection. Prox1 is a marker for mature granule cells. In ipsilateral hippocampi, the granule 
cells are dispersed in contrast to the compact cellular architecture in contralateral hippocampi. T1, T2, 
T3 and T4 are the thicknesses of the GCL averaged to obtain a single parameter indicative of GCD. T1 
and T2 are measured along the line D. T3 and T4 are measured at a distance half-way between line D 
and the tip of the hilus. Scale bar, 100 µm. B) Quantification of GCD using the average thickness of 
the GCL (µm). The average thickness of the GCL was significantly higher on the ipsilateral side when 
compared with the corresponding thickness on the contralateral side. Interestingly, the ipsilateral 
dentate gyrus of DKO mouse displayed a lesser GCD as compared with the ipsilateral dentate gyrus of 
the WT mouse. ANOVA followed by post hoc Tukey´s test. N = 3 per group, ** p < 0.01 
 
4.6.2 Seizure-induced cellular proliferation in the hippocampus 
Seizure-induced cellular proliferation in hippocampus has been documented using BrdU 
labelling (Parent et al., 1997) (Bengzon et al., 1997) (Zhu et al., 2005). All of these studies 
involved intraperitoneal injections of BrdU over short intervals. Since BrdU has a very short 
half-life (2 h), only a small population of proliferating cells could be labelled in these studies. 
In order to circumvent this limitation, in the present study the BrdU was administered through 
drinking water. 15 days after kainate injection, the BrdU containing drinking water was 
replaced by normal water for the remaining 15 days. This enabled to assess the survival of the 
cells born during the first 15 days. Kunze et al. with the help of pulse chase BrdU labelling 
showed that neurogenesis was impaired in DKO mice (Kunze et al., 2009a). Therefore, post 
kainate-injection cellular proliferation in DKO mice was compared with that in post kainate 
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WT mice. 30 days after the kainate injection and 15 days after the last dose of BrdU, many 
BrdU-positive cells were seen in the entire hippocampus. These cells were counted in counting 
boxes (290 x 290 x 8 µm3) positioned in the DG and CA1 regions. In the DG, the numbers of 
BrdU-positive cells were similar between ipsilateral and contralateral sides and also between 
the genotypes (Table 4.6.2). In the CA1 region, the ipsilateral side showed more cellular 
proliferation than the contralateral side irrespective of the genotypes (ANOVA followed by 
post hoc Tukey’s test, p < 0.01, N = 3 each group). Here again, the two genotypes did not differ 
in the number of BrdU-positive cells (Table 4.6.1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6.2: Seizure-induced cellular proliferation in the hippocampus. A) Prox1 (green) and 
BrdU (red) immunostaining in WT and DKO mice, 1 month after kainate injection. BrdU was 
administered through drinking water for the first 15 days. Presence of BrdU signal in the cell nucleus 
indicates a newly generated or a proliferating cell.  Counting boxes (290 x 290 x 8 µm3) were positioned 
in CA1 and DG regions.  
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Averages of 3 counting boxes were considered per region and per section. Scale bar, 100 µm. B) and 
C) Number of BrdU-positive cells per counting box in DG and CA1 respectively. In DG (B), there was 
no significant difference between ipsilateral and contralateral side. However, in the CA1 region (C), 
the number of BrdU-positive cells was significantly higher on the ipsilateral side. In both regions, there 
was no difference between the genotypes. ANOVA followed by post hoc Tukey´s test. N = 3 per group, 
** p < 0.01. 
 
Table 4.6.2: Number of BrdU-positive cells per counting box (290 x 290 x 8 µm3) per mouse in the 
DG and CA1. All values are expressed as mean ± SD. N = 3. 
Genotype DG CA1 
Contralateral Ipsilateral Contralateral Ipsilateral 
WT 57.38 ± 18.59 51.36 ± 2.82 60.77 ± 1.17 145 ± 12.66 
DKO 41.33 ± 16.46 44.27 ± 8.21 58.44 ± 11.2 188.55 ± 45.81 
 
4.6.3 Reduced GCD in DKO mice is not caused by impaired neurogenesis 
Post-seizure GCD was reduced in DKO mice as shown by the thickness of granule cells (Figure 
4.6.1). These mice have reduced adult neurogenesis in the DG (Kunze et al., 2009a). Therefore, 
one month post kainate injection; neurogenesis was assessed in the ipsilateral DGs of WT and 
DKO mice for its association with the observed differences in the GCD. Prox1 was used as a 
marker for mature granule cells while Doublecortin (DCX) was used to detect immature or 
newborn neurons. Surprisingly, no DCX-positive cells were detected in the ipsilateral 
hippocampus despite of large proliferative activity. Moreover, no Prox1-BrdU colabelling was 
found, indicating absence of newly generated granule cells. Thus, neurogenesis was completely 
lacking in the ipsilateral DG irrespective of the genotypes. Therefore, the reduced GCD in 
DKO mice cannot be ascribed to the post-kainate neurogenesis. 
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Figure 4.6.3: Reduced GCD in DKO mice is not caused by impaired neurogenesis. Prox1 (white), 
BrdU (red) and DCX (green) immunostaining in WT and DKO mice, 1 month after kainate injection. 
Coronal sections underneath the injection site were used for immunostaining. All images are from the 
ipsilateral DG. No DCX-positive cells were detected in the ipsilateral dentate gyrus, irrespective of the 
genotype. There was no colocalization between Prox1 and BrdU, indicating absence of newly born 
granule cells. Scale bar, 25 µm.  
 
4.6.4 Seizure-induced neurogenesis in the contralateral hippocampus is 
dampened in DKO mice  
Seizure is a strong stimulus for neurogenesis in the dentate gyrus (Marta et al., 2011). Absence 
of Cx43 and Cx30 is known to pose a limitation on the extent of adult neurogenesis in the DG. 
Therefore, by inspecting the post-kainate neurogenesis on the contralateral side, it was 
evaluated whether seizures are able to overcome this limitation. Prox1 was used as a marker 
for mature granule cells while DCXwas used to detect immature or newborn neurons. Cells co-
labelled with Prox1 and BrdU represented newly (post BrdU administration) generated mature 
granule cells while cells co-labelled with DCX and BrdU represented newly generated 
immature neurons. The triple positive cells (not quantified) denoted immature granule cells. 
Both, the Prox1- BrdU colocalized cells and DCX- BrdU colocalized cells were significantly 
reduced in the contralateral dentate gyri of DKO mice (N = 3 per group, t test, * p < 0.05). 
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Figure 4.6.4: Seizure-induced neurogenesis in the contralateral hippocampus. A) Prox1 (white), 
BrdU (red) and DCX (green) immunostaining in WT and DKO mice, 1 month after kainate injection. 
Coronal sections underneath the injection site were used for immunostaining. All images are from the 
contralateral dentate gyrus. Merged images show colocalization of Prox1, BrdU and DCX (arrows). 
Scale bar, 25 µm. B) Quantification of Prox1- BrdU and DCX- BrdU colocalization. Counting boxes 
(290 x290 x 4 µm3) were positioned 250 µm away from the outermost margin of the GCL flexure and 
perpendicularly oriented to the longitudinal axis of the GCL. Number of Prox1 and DCX cells 
colocalizing with BrdU-positive cells per counting box were counted. Prox1-  BrdU positive cells 
represent newly (post BrdU administration) generated mature granule cells while DCX- BrdU cells 
represent newly generated immature neurons. The triple positive cells (not quantified) denote immature 
granule cells. There was a significant decline in Prox1- BrdU positive and DCX- BrdU types of cells in 
DKO mice. Thus, post-kainate neurogenesis was significantly reduced in DKO mice. N = 3 per group, 
* p < 0.05.  
 
 
 
B) 
0
5
10
15
20
25
30
35
40
Prox1+BrdU DCX+ BrdU
  *
N
um
be
r o
f c
el
ls
 p
er
 c
ou
nt
in
g 
bo
x 
  *
WT 
DKO 
A) 
W
T 
(C
on
tra
la
te
ra
l) 
D
K
O
 (C
on
tra
la
te
ra
l) 
Prox1 BrdU DCXDCXBrdUProx1 
   Results  
 
121 
 
Table 4.6.4: Number of Prox1+ BrdU and DCX+ BrdU positive cells per counting box (290 x290 x 4 
µm3)  per mouse in contralateral DG. All values are expressed in mean ± SD. N = 3. 
Prox1+ BrdU DCX+BrdU 
WT DKO WT DKO 
26.11 ± 5.33 12.22 ± 6.46 15.33 ± 3.28 8 ± 3.17 
 
4.6.5 DKO mice have thinner GCL and lower basal neurogenesis  
Kunze at al. reported that DKO mice have less Prox1-positive cells as compared with WT mice 
(Kunze et al., 2009b). Therefore, it was hypothesized that the GCL in DKO mice has lower 
thickness. This hypothesis was evaluated by measuring the GCL thickness in DKO and WT 
mice, which were not subjected to kainate injection. These mice were also assessed for the 
basal neurogenesis using BrdU administration through drinking water (as described in section 
4.6.2, but without kainate injection). GCL thickness was measured at four locations on the 
blades of GCL and then averaged (Figure 4.6.5 A). As expected, the average thickness of the 
GCL in DKO mice was less than that in WT mice (54.5 ± 5.45 µm vs. 69.41 ± 2.92 µm 
respectively, N =3, p < 0.01) (Figure 4.6.5 B).  Almost all of the BrdU- or DCX-positive cells 
were also labelled with Prox1 (Figure 4.6.5 C) indicating that most of the proliferative activity 
in the DG under basal conditions is neurogenic. The basal level of neurogenesis indicated by 
the numbers of BrdU, DCX and BrdU-DCX colocalizing cells was drastically reduced in DKO 
mice (Figure 4.6.5 B, Table 4.6.5). It is important to note here that the counting boxes used in 
this experiment (290 x290 x 24 µm3) were 6 times larger than those used in section 4.6.4 (290 
x290 x 4 µm3). By comparing the BrdU-DCX positive cells (after adjusting for the counting 
boxes) between mice with and without seizures (Table 4.6.4 and 4.6.5), it can be concluded 
that the neurogenesis in epileptic DKO mice (kainate injected DKO mice) was 6 times higher 
than the neurogenesis in non-epileptic DKO mice (non-injected DKO mice) and 3 times higher 
than the neurogenesis in healthy-WT mice (non-injected WT mice). 
Table 4.6.5: Number of DCX, BrdU and DCX+BrdU positive cells per counting box (290 x290 x 24 
µm3) per mouse in contralateral DG. All values are expressed in mean ± SD. N =3. 
DCX BrdU DCX +BrdU 
WT DKO WT DKO WT DKO 
26.49 ± 
4.17 
12.55 ± 4.5 22.87 ± 2.17 11.55 ± 2.27 15.78 ± 2.08 7.83 ± 1.92 
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Figure 4.6.5: GCL thickness and basal neurogenesis in WT and DKO mice. A) Prox1 
immunostaining labelling granule cells in hippocampi from WT and DKO mice. T1, T2, T3 and T4 are 
the thicknesses of GCL averaged to obtain a single parameter that was compared between WT and 
DKO mice. T1 and T2 were measured along the line D passing through the major curvature of the upper 
blade. T3 and T4 were measured at a distance half-way between line D and the tip of the hilus. Scale 
bar, 100 µm. B) The bar graph shows that the average thickness of the GCL was significantly lower in 
DKO mice. ** p < 0.01, N =3. C) Prox1 (white), BrdU (red) and DCX (green) immunostaining in DG 
of WT and DKO mice. Arrows indicate cells colocalizing BrdU and DCX. Almost all of the BrdU or 
DCX cells were also Prox1-positive. D) Quantification of basal neurogenesis. Counting boxes (290 
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x290 x 24 µm3) were positioned 250 µm away from the outermost margin of the GCL flexure and 
perpendicularly oriented to the longitudinal axis of the GCL. Numbers of DCX, BrdU and DCX +BrdU 
colabelled cells were counted. Numbers of all of these cell types were reduced in DKO mice indicating 
reduced basal neurogenesis. N = 3, ** p < 0.01.  
 
4.6.6 DKO mice have reduced post-seizure endothelial proliferation  
Angiogenesis is enhanced in epilepsy and it takes place before the onset of spontaneous 
seizures (Rigau et al., 2007) (Newton et al., 2006). Endothelial cell proliferation is the hallmark 
of angiogenesis (Hellsten et al., 2004). Newly generated endothelial cells were visualized by 
co-immunostaining with the endothelial cell marker CD31 and BrdU (Figure 4.6.6 A and B). 
The ipsilateral hippocampus showed enhanced endothelial proliferation when compared with 
the corresponding contralateral hippocampus. This was evident in both, the DG and the CA1 
region (Figure 4.6.6 C and D). However, the ipsilateral hippocampus of DKO mice showed 
statistically significant lower CD31+ BrdU positive cells when compared with the ipsilateral 
hippocampus of the WT mice (Table 4.6.3). These data indicate that post-seizure angiogenesis 
is modulated by astrocytic connexins. 
Table 4.6.6: Number of CD31+BrdU positive cells per counting box (290 x 290 x 8 µm3)  per mouse 
in DG and CA1, 1 month after kainate injection. All values are expressed as mean ± SD. N = 3. 
Genotype DG CA1 
Contralateral Ipsilateral Contralateral Ipsilateral 
WT 4.56 ± 2.69 14.67 ± 0.58 5.33 ± 2  19.07 ± 1.74 
DKO 3.11 ± 0.77   8.33 ± 2.65      5.33 ± 3.18    12.67 ± 2.6 
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Figure 4.6.6: Endothelial proliferation 1 month after kainate injection. A-B) Endothelial cell 
marker CD31 (green) and BrdU (red) immunostaining in WT and DKO mice, in the DG (A) and CA1 
(B). Co-localization of BrdU with CD31 indicates newly generated or a proliferating endothelial cell 
(examples indicated by arrows). Dotted line demarcates the subgranular zone (SGZ) of the GCL. ML: 
molecular layer, SR: stratum radiatum. Scale bar, 25 µm. C-D) Number of BrdU-positive CD31 cells 
per counting box (290 x 290 x 8 µm3) in the DG (C) and CA1 (D). In both regions, the ipsilateral side 
showed more endothelial cell proliferation than the corresponding contralateral side. However, the 
ipsilateral side of DKO mice showed a lower proliferation when compared with the ipsilateral side of 
WT mice, indicating a modulatory role of astrocytic connexins on angiogenesis. ANOVA followed by 
post hoc Tukey´s test. N = 3 per group, ** p < 0.01.  
 
4.6.7 Connexin-mediated modulation of angiogenesis in epilepsy 
Increased angiogenesis in epileptic tissue was described more than 100 years ago (Sommer, 
1880). Since endothelial proliferation was found to be altered in epileptic DKO mice, the 
vascular density was assessed using CD31 immunostaining. Images for the determination of 
vascular density were obtained from epileptic patients and the mouse model of epilepsy (1 and 
3 months post kainate injection) (Figure 4.6.7 A). A point counting method was employed as 
reported previously (Rigau et al., 2007). A higher density of CD31-positive structures (N = 8, 
p < 0.01) was found in huamn hippocampal specimens with sclerosis (51.94 ± 12.58) as 
compared to those without sclerosis (32.53 ± 11.34) (Figure 4.6.7 B). Interestingly, similar 
differences were observed when comparing the ipsilateral and contralateral hippocampus in 
our mouse model at 3 month (51.16 ± 7.52 in contralateral vs. 69.16 ± 8.28 in ipsilateral, N = 
3, p < 0.05) and 1 month post kainate injection (57.55 ± 6.40 in contralateral vs. 81.55 ± 8.94 
in ipsilateral, N = 3, p < 0.05) (Figure 4.6.7 B). However, deletion of the astrocytic connexins 
abolished the differences in angiogenesis between the ipsilateral and contralateral hippocampi 
(50.55 ± 14.41 in contralateral vs. 60.33 ± 1.76 in ipsilateral, N = 3). This data indicate the 
association of connexins with seizure-induced angiogenesis. 
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Figure 4.6.7: Connexin mediated modulation of angiogenesis in epilepsy. A) CD31 immunostaining 
in human and experimental epileptic specimens. CD31 delineates blood vessels. Note the increased 
vascular density in all sclerotic hippocampi (except DKO mice) when compared with corresponding 
non-sclerotic hippocampi. Scale bar, 100 µm B) The ‘Point counting method’ was applied to the 
confocal images from the CA1 region. The bar graph shows normalized to Non-sclerotic/ Contralateral 
point count values. The vascular density in sclerotic human specimens was 159.7% of non-sclerotic 
specimens (p < 0.01, N = 8 in each group). In the animal model, the vascular density in the ipsilateral 
hippocampus was 135.2% (p < 0.05, N= 3 in each group) and 141.7% (P < 0.05, N= 3 in each group) 
of the contralateral hippocampus at 3 and 1 month post kainate injection, respectively. In DKO mice, 
astrocytic deletion of connexins abolished the vascular density differences between ipsilateral and 
contralateral hippocampi. 
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4.6.8 Altered microglial activation in DKO mice after kainate injection 
Activation of microglia is a primary inflammatory response to seizures (Eyo et al., 2016). This 
involves hypertrophy and process elongation of microglia and their proliferation (Avignone et 
al., 2015) (Avignone et al., 2008). Connexin hemichannels have been shown to regulate 
chemoptaxis and process elongation of microglia via release of ATP (Davalos et al., 2005). 
Therefore, with the help of Iba1-BrdU immunostaining, it was assessed whether the post-
seizure microglial activation differs in DKO mice. The area occupied by microglia, 1 month 
after kainate injection was increased on the ipsilateral side when compared with the 
corresponding contralateral side in both, the CA1 and the DG (Figure 4.6.8 E and F, 
respectively). In the CA1 region, this increase was associated with an increase in the number 
of BrdU-positive Iba1 cells (Figure 4.6.8 D). In the DG, there was no difference in Iba1 
proliferation across all the groups (Figure 4.6.8 C). Interstingly, 1 month post kainate injection 
in the CA1 region, DKO mice showed significantly reduced microglial activation on the 
ipsilateral side when compared with the ipsilateral side of WT mice (Table 4.6.8 A and B). 
Thus, the absence of astrocytic connexins modulated post seizure microglial activation and this 
effect was seen in the CA1 region and not in the DG. 
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Figure 4.6.8: Altered seizure-induced microglial activation in DKO mice.  A-B) Microglial marker 
Iba1 (white) and BrdU (red) immunostaining in WT and DKO mice, in DG (A) and CA1 (B), 1 month 
after kainate injection. Co-localization of BrdU with Iba1 indicates newly generated or a proliferating 
microglial cell (examples indicated by arrows). Dashed-line demarcates the sub-granular zone (SGZ) 
from granule cell layer (GCL). ML: molecular layer, SR: stratum radiatum. Scale bar, 25 µm. C-F) 
Quantification of microglial activation by counting newly generated microglia (C and D) and estimating 
area occupied by Iba1 signal (E and F) in counting boxes (290 x 290 x 8 µm3). In the DG, microglia 
from the ipsilateral side occupied a higher area (E). The proliferation (C) however did not differ between 
the two sides. Microglial proliferation and area occupied by microglia were similar between kainate-
injected WT and DKO mice. In the CA1 region, both the number of newly generated microglia and the 
area occupied by the Iba1 signal were higher on the ipsilateral side. Further, in contrast with the DG, in 
the CA1 region, these two parameters were significantly lower on the ipsilateral side of DKO mice 
when compared with the ipsilateral side of WT mice.  ANOVA followed by post hoc Tukey´s test. N = 
3 per group, ** p < 0.01. 
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Table 4.6.8.1: Number of Iba1- BrdU positive cells per counting box (290 x 290 x 8 µm3) per mouse 
in DG and CA1, 1 month post kainate injection. All values are expressed as mean ± SD. N = 3. 
Genotype DG CA1 
Contralateral Ipsilateral Contralateral Ipsilateral 
WT 17.44 ± 3.83 25 ± 4.37 27.88 ± 3.97 100  ± 11.13 
DKO 15.33 ± 4 23.89 ± 6.7 21.88 ± 9.75 76.77 ± 6.76 
 
Table 4.6.8.2:  Area occupied (µm2) by Iba1-positive cells per counting box (290 x 290 x 8 µm3) in 
DG and CA1, 1 month post kainate injection. All values are expressed as mean ± SD. N = 3. 
Genotype DG CA1 
Contralateral Ipsilateral Contralateral Ipsilateral 
WT 5242.9 ± 829.1 10191.9 ± 
2319.1 
4095.1 ± 834.6 11201.5  ± 1348 
DKO 4971.7 ± 317.3 8729.3 ± 2359.7 2826.6 ± 439.1 7521.7 ± 650.6 
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5 Discussion 
 
5.1 Connexin expression, distribution and 
phosphorylation in hippocampal specimens from epilepsy 
patients 
Astrocytes in the sclerotic human hippocampus display an altered phenotype with atypical 
electrophysiological, morphological and molecular properties (Steinhäuser et al., 2016) 
(Coulter and Steinhäuser, 2015). They are completely devoid of dye coupling in contrast to the 
astrocytes in the non-sclerotic hippocampus (Bedner et al., 2015). The contribution of Cx43 to 
hippocampal astrocytic coupling in mouse exceeds that of Cx30 (Gosejacob et al., 2011). It is 
not known whether this holds true for human hippocampal astrocytes as well. Unlike Cx30, 
Cx43 protein has a very short half-life (1.5 to 5 h) (Kelly et al., 2015) and undergoes extensive 
post-translational modification, for example phosphorylation (Solan and Lampe, 2014).  The 
distribution of Cx43 (plasma membrane vs. intracellular membranes) and its phosphorylation 
status can influence the level of gap junctional coupling. Expression studies of connexins 
(Cx43 and Cx30) in human epileptic specimens have been inconsistent (Mylvaganam et al., 
2014)(Steinhäuser et al., 2016) . Moreover, the cellular distribution and phosphorylation of 
Cx43 in human specimens has not been addressed so far. In order to address these issues and 
explore the Cx43-related mechanisms leading to astrocytic uncoupling, expression, 
distribution and phosphorylation of Cx43 in hippocampal specimens from epilepsy patients 
were investigated in the present study.  
The total Cx43 expression in a specimen is affected by the number of astrocytes present in that 
specimen, provided that Cx43 expression per astrocytes stays constant. As shown in figure 
4.1.1, the number of S100β positive cells (most of which were GFAP positive) is 2.2 times 
higher in sclerotic CA1 region than that in the non-sclerotic one. There was also 1.8 fold 
increase in the average fluorescence intensity of Cx43. Thus, the overall increase in Cx43 
expression paralleled the increase in the number of astrocyte like cells. The increased Cx43 
puncta formed large plaques and occupied overall a larger surface area (Figure 4.1.2). 
Interestingly, there was a non-uniform distribution of Cx43 with preferential localization 
around blood vessels, as denoted by the distribution ratio.  Cx43 is known to form larger 
plaques in endfeet as compared with Cx43 away from the blood vessels (Rouach et al., 2008). 
In fact, in the study by Rouach et al. (2008), Cx43 was found to be enriched in perivascular 
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endfeet of astrocytes and it was found to delineate the blood vessel walls. This study, however, 
did not give a quantitative measure of Cx43-enrichment. The distribution ratio, defined in 
section 3.3.7, measures the relative distribution of Cx43 with respect to the blood vessels. In 
non-sclerotic CA1, the distribution ratio was close to 1 while in sclerotic CA1 the ratio was 
1.8, suggesting enhanced accumulation of Cx43 in the perivascular space (Figure 4.1.2 B). The 
perivascular space comprises of the basement membranes that enclose endothelial cells and 
pericytes. In larger vessels, pericytes are replaced by smooth muscle cells (Abbott et al., 2006). 
Astrocytic endfeet are closely adjacent to the basement membrane encircling the vessel (Serlin 
et al., 2015). In the CNS, Cx43 has been described to be present mainly in astrocytes and to 
some extent in ependymal cells (Rash et al., 2001). However, there have been reports of extra-
astrocytic presence of Cx43 for example in pericytes (Li et al., 2003). Therefore, in the present 
study it was important to ascertain the exact cellular localization of perivascular Cx43. 
Cx43 did not colocalize with the endothelial cell markers lectin and CD31. Its absence in 
pericytes was also confirmed by checking its colabelling with PDGFRβ and NG2 (Figure 4.1.3 
A and B). Thus, the only plausible cellular component of the neurovascular unit that could 
harbor the observed perivascular Cx43 was the astrocytic endfoot. Indeed, Cx43 was closely 
associated with the astrocytic markers, S100β and GFAP (Figure 4.1.4.1). Being a membrane 
protein, its colocalization with any of these astrocytic markers (which are essentially 
cytoplasmic), could not be shown. Moreover, the diffuse GFAP staining in the sclerotic CA1 
and the limited optical resolution obtained by the confocal microscope, made it difficult to 
assign the exact location of Cx43 with respect to the blood vessel-astrocyte interface. These 
limitations were overcome by employing a recently developed expansion microscopy 
technique (Chozinski et al., 2016). In expanded images, most of the Cx43 in the perivascular 
space was found to be present on the parenchymal side of the astrocytic endfoot as GFAP or 
S100β separated the Cx43 signal from the vessel wall (Figure 4.1.4.1). Hence, most of the 
Cx43 proteins obviously do not face vessel walls. Expansion microscopy also made it possible 
to resolve the fine GFAP positive structures. Interestingly, Cx43 was also observed to be 
hemmed between GFAP branches (Figure 4.1.4.2). It could not be resolved whether these 
puncta represented fully formed gap junctions, hemichannels or Cx43 monomers. Even though 
the majority of perivascular Cx43 immunoreactivity was astrocytic, a minor endothelial and 
pericytic expression of Cx43 could not be ruled out.  
After confirming the presence of Cx43 in astrocytes, its distribution in cellular compartments 
was studied by Western blotting. Cx43 is a membrane protein synthesized in the rough 
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endoplasmic reticulum, oligomerized in the trans-golgi network and it reaches the plasma 
membrane in a hexameric and phosphorylated form (Laird, 2006). Only Cx43 in the plasma 
membrane can contribute to gap-junctional coupling. Therefore, the plasma membrane 
associated Cx43 was analyzed by Western blotting. Surprisingly, the levels of plasma 
membrane Cx43 did not differ between sclerotic and non-sclerotic hippocampi (Figure 4.1.5). 
This data contradicted the immunostaining data which showed not only an increase in the 
fluorescence intensity of Cx43 but also increased plaque size and area occupied by Cx43. It is 
important to note here that the immunostaining did not distinguish between Cx43 at the plasma 
membrane and intracellular membrane. It rather represented total Cx43 expression. In order to 
address this discrepancy between plasma membrane Cx43 levels and immunostaining data, 
total (whole-cell) Cx43 protein levels were assessed. Western blot of total Cx43 showed a 
marked increase in the sclerotic hippocampus (Figure 4.1.6). This implied that despite of 
augmented total Cx43 expression, plasma membrane Cx43 did not increase proportionally to 
its synthesis. Thus, the enhanced total Cx43 levels in human sclerotc specimens did not lead to 
increased assembly of Cx43 channels in the plasma membrane, possibly indicating its impaired 
plasma membrane translocation.   
Dye coupling was completely absent in sclerotic specimens (Bedner et al., 2015) despite of the 
presence of Cx43 at the plasma membrane and increased plaque size (Figure 4.1.5 and 4.1.2). 
There could be two reasons behind this contradiction: 1) assembly of gap junctions (i.e. 
docking of two connexons from neighboring astrocytes) was impaired because of altered 
morphology of astrocytes which resulted in the loss of contact between two apposing 
membranes. 2) The gap junctions were closed, for example, due to post-translational 
modifications of Cx43. Assembled gap junctions tend to aggregate across plasma membranes 
of the two cells forming large plaques (Laird, 2006). Thus, the size of assembled gap junctions 
is more than the non-docked connexons. Indeed, plaques were larger in the sclerotic tissue 
(Figure 4.1.2). Moreover, many Cx43 puncta could be seen hemmed between astrocytic 
processes (Figure 4.1.4.2). It could not be concluded from the images whether these puncta 
represented fully formed gap junctions between astrocytic processes. However, it was clear 
from the previous report that there was no functional gap junction coupling between astrocytes 
in sclerosis (Bedner et al., 2015). Thus, if fully formed gap junctions between astrocytes existed 
in the sclerotic tissue, these channels were non-functional. Existence of a fully formed but non-
functional gap junction implies channel closure.  
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Gap junction closure is influenced by both, the open probability and the unitary conductance 
of the channel. Phosphorylation is known to influence both of these channel properties 
(Moreno and Lau, 2007). Among 21 putative sites, phosphorylation on S279/282, S255 and 
S262 has been shown to reduce the open probability of Cx43 channels (Thévenin et al., 2013). 
All of these sites are targets of MAPKs. However, S262 can be phosphorylated by CDK-2 as 
well.  While phosphorylation of S279 and S282 cannot be differentiated from each other with 
currently available techniques, phosphorylation of S255 can be distinguished from that of the 
neighboring sites. Therefore, phosphorylation of S255 was investigated with the help of a 
phospho-specific antibody. The fraction of plasma membrane Cx43 phosphorylated at S255 
was increased in sclerotic specimens, indicating potential drop in the open channel probability 
(Figure 4.1.7). Phosphorylation at S257 or S368 has been suggested to shift the conductance 
of channels to a lower state.  S257 can be phosphorylated by PKG (Kwak et al., 1995) while 
S368 is one of the targets of PKC (Ek-Vitorin et al., 2006). However, the residue 257 in human 
Cx43 is an alanine and not a serine in contrast with mouse or rat Cx43. As a result, 
phosphorylation at position 257 cannot take place in human Cx43. Therefore, only phospho-
S368 was investigated by Western blotting. The fraction of Cx43 phosphorylated on 368 did 
not differ between sclerotic and non-sclerotic hippocampi (Figure 4.1.7). Taken together, 
phospho-specific Western blots revealed altered phosphorylation at least on Serine 255 which 
might have contributed to uncoupling. 
Seizures are known to open the BBB and cause albumin leakage into the brain parenchyma 
(Vliet et al., 2007). Extravascular albumin decreases the gap junctional coupling in astrocytes 
(Braganza et al., 2012). Therefore, albumin extravasation was assessed in human epileptic 
specimens. In both, sclerotic and non-sclerotic specimens albumin was found to be present 
inside the blood vessels. However, perivascular albumin immunoreactivity was seen only in 
sclerotic specimens (Figure 4.1.8) consistent with findings from Ravizza et al., 2008. 
Extravascated albumin is taken up by astrocytes by a TGFβ receptor mediated process (Ivens 
et al., 2007). The process can trigger inflammatory reactions in the brain parenchyma. Albumin 
is known to activate microglia and astrocytes by inducing inflammatory cytokines (Ralay 
Ranaivo and Wainwright, 2010). Remarkably, these effects are mediated by activation of 
MAPKs in astrocytes. Activated MAPKs may in turn phosphorylate Cx43 on the sites 
discussed above and thereby cause uncoupling. In summary, impaired translocation of Cx43 
to the plasma membrane, its preferential distribution around blood vessels and phosphorylation 
at serine 255 possibly as a result of albumin extravasation were associated with astrocytic 
uncoupling in human hippocampal sclerosis. 
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5.2 Three months after kainate injection the mouse 
model recapitulates key features of human epilepsy  
In the unilateral kainate injection model, at 3 months after injection, the ipsilateral 
hippocampus showed pronounced loss of pyramidal neurons in all subfields, astrogliosis and 
granule cell dispersion. Astrocytic coupling was also lacking in SR of the CA1 region. At this 
time point the mice consistently showed spontaneous generalized seizures (Bedner et al., 
2015). These morphological and functional features resemble those in human MTLE-HS. The 
contralateral hippocampus in the mouse model appeared morphologically unaffected and 
served thus as a pseudo control. Since, the human MTLE-HS displayed altered distribution and 
phosphorylation of Cx43 (section 5.1); I investigated whether these features were also observed 
in the mouse model.  
As discussed in section 5.1, increase in the number of astrocytes accompanied enhanced total 
Cx43 expression in the sclerotic human hippocampus. In the mouse model, the ipsilateral 
hippocampus also showed a ~ 2 times increase in the number of astrocytes (Figure 4.2.1 B) 
which was associated with a 1.8 fold increase in average Cx43 fluorescence intensity (Figure 
4.2.2 B). It is likely that in both cases the amount of Cx43 per astrocyte did not change. 
Nevertheless, enhanced Cx43 expression was observed in the form of larger plaques in the 
ipsilateral hippocampus. These plaques were preferentially distributed around blood vessels as 
indicated by the distribution ratio. Cx43-mediated astrocytic coupling around blood vessels 
performs many functions including transport of metabolites and nutrients through gap junctions 
(Rouach et al., 2008) and regulating the vascular tone (Filosa et al., 2016). Neuronal activity 
requires continuous supply of glucose, which is converted to lactate and then released into the 
extracellular space by astrocytes. Astrocytic gap junctions play an important role in the 
distribution of glucose and its metabolites from blood vessels to regions of neuronal activity 
distal from the vasculature. Demand for energy is enhanced during seizure activity (Wu et al., 
2015) posing immense importance on gap junction mediated supply of glucose. Although, 
Cx43 immunoreactivity around blood vessels was enhanced in the ipsilateral hippocampus 3 
months post kainate, there was no astrocytic coupling. Thus, increased Cx43 in the ipsilateral 
hippocampus may not result in increased energy supply to the firing neurons. 
Astrocytes are known to regulate the vascular tone by Ca2+ mediated release of vasoactive 
molecules (Filosa et al., 2016). Cx43 hemichannels, which open up in response to the reduced 
extracellular Ca2+, regulate intercellular Ca2+ waves and ATP release in astrocytes (Stout et al., 
2002).  
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Interestingly, during epileptic discharges, extracellular Ca2+ is markedly reduced creating a 
favourable environment for hemichanel opening (Torres et al., 2012). Thus, directly or 
indirectly astrocytic Cx43 hemichannels might cause the release of vasoactive molecules for 
example ATP, phospholipase A2 and thereby control the vascular tone. These molecules have 
also been implicated in BBB disruption (Abbott et al., 2006). Indeed, albumin 
immunoreactivity indicative of BBB disruption was seen around blood vessels in the ipsilateral 
hippocampus (Figure 4.2.6). Notably, Cx43 upregulation was also seen in the same region 
(Figure 4.2.2 A). However it was not clear from the immunofluorescence images whether the 
perivascular Cx43 was in a hemichanel or gap junction configuration. In order to investigate 
this, BN PAGE, a method that allows separating proteins according to their native 
conformation, was used. Cx43 showed three bands at around 146, 240 and 480 kDa, indicating 
configurations as trimer, hexamer and dodecamer (Figure 4.2.7). Remarkably, the band 
representing a putative dodecamer configuration had less intensity in the ipsilateral 
hippocampus. There was no difference in the hexamer bands. Thus, most of the perivascular 
Cx43 in ipsilateral hippocampus is seemed to be in a hemichanel configuration.   
Owing to its short half-life, Cx43 is continuously removed from the plasma membrane and 
new channels are recruited in the plaques (Laird, 2006). The rate of Cx43 synthesis has to 
match the rate of channel removal in order to maintain the pool of connexons at the plasma 
membrane. When the rate of Cx43 synthesis far exceeds the rate of channel recruitment at the 
plasma membrane, most of the Cx43 is seen in intracellular stores, for example, Golgi 
apparatus and endoplasmic reticulum. This intracellular Cx43 is not available for coupling. 
Indeed, a disparity between plasma membrane Cx43 levels and Cx43 immunostaining data was 
observed in the ipsilateral hippocampus, implying that most of the Cx43 resided in intracellular 
stores (Figure 4.2.2 and 4.2.3). Moreover, although total Cx43 levels were increased (Figure 
4.2.4), Cx43 levels at the plasma membrane were not, indicating impaired translocation of 
Cx43 to the plasma membrane, an observation similar to that made in human sclerotic 
hippocampus. Interestingly, there was a shift towards the P2 band on the Western blot (Figure 
4.2.3), signifying an altered phosphorylation of Cx43. Our data from human specimens 
revealed augmented phosphorylation at serine 255 but unchanged phosphorylation at serine 
368. Therefore, phosphorylation on these sites was also investigated in the mouse model. The 
fraction of Cx43 phosphorylated at serine 255 was two times higher in the ipsilateral 
hippocampus compared with the contralateral hippocampus. On the other hand, there was a 
fourfold upsurge in serine 368 phosphorylation (Figure 4.2.5). As discussed earlier, 
phosphorylation at both of these sites results in reduced coupling albeit by different 
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mechanisms. Serine 255 phosphorylation causes reduced open probability (Thévenin et al., 
2013) while serine 368 phosphorylation results in lower channel conductance (Ek-Vitorin et 
al., 2006). Phosphorylations at these two sites are expected to have a synergistic effect 
manifesting in uncoupling. Taken together, 3 months after kainate injection, the mouse model 
recapitulated many features of Cx43 expression, distribution and phosphorylation observed in 
human sclerotic hippocampus. In order to see if these changes take place during early 
uncoupling potentially causing epileptogenesis, 4 h time point after kainate injection was 
investigated. 
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5.3 Altered phosphorylation of Cx43 is an early event in 
epileptogenesis 
MTLE-HS involves, among other features, loss of pyramidal neurons in the hippocampus. This 
loss is a result of a progressive process with its beginning in the status epilepticus (Thom, 
2014). Intracortical injection of kainate above the hippocampus induces status epilepticus in 
mice. This phase is characterized by synchronous rapid firing of principal hippocampal neurons 
for 6 to 12 h. As early as 4 h after kainate injection, astrocytic coupling is reduced 
approximately by 50%. However, no TUNEL positive apoptotic neurons were seen in the 
hippocampus (Bedner et al., 2015). Therefore, changes in astrocytes may be associated with 
the mechanisms of subsequent neuronal death. Reduction in coupling is an important astrocytic 
change potentially causative to epileptogenesis. In order to investigate mechanisms causing 
uncoupling in the early phase of epileptogenesis, modifications of Cx43 were investigated. 
Cx43 showed a punctate staining pattern in both contralateral and ipsilateral CA1 regions 4 h 
after kainate injection (Figure 4.3.3 A). Plaque size and number as well as the area occupied 
by Cx43 were not modified by kainate injection (Figure 4.3.3 B). However, in the Western blot 
ipsilateral Cx43 displayed a shift towards the P2 band (Figure 4.3.4), similar to that seen at 3 
months post kainate (Figure 4.2.3). The total Cx43 levels, however, were unchanged at 4 h post 
kainate. This shift in the P2 band was the result of kainate and not mere an injection artifact as 
demonstrated by Western blot performed with lysates from sham injected mice (Figure 4.3.4 
B and D). The P2 band is the slowest migrating band of Cx43 resulting from complex 
conformational changes in the phosphorylated Cx43 protein (Solan and Lampe, 2009). 
Phosphorylation at S325, S328 and S330 is believed to mediate the shift to the P2 band 
conformation (Lampe et al., 2006). Phosphorylation at these sites is a signal for the assembly 
of gap junctions (Cooper and Lampe, 2002). However, phosphorylation at S262 also results in 
slower migrating Cx43 bands (Solan and Lampe, 2008). There are 21 putative phosphorylation 
sites described for Cx43 (Pogoda et al., 2016). Bands in the Western blot do not reveal exactly 
which of these sites have been phosphorylated. Moreover, not all phosphorylations result in 
changes of mobility in SDS PAGE. Therefore a method dissecting the phosphorylation profile 
of Cx43 was sought. Mass spectrometry based phosphoproteomics has been proposed to 
resolve the phosphorylation profile of Cx43 (Chen et al., 2013). 
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Sample preparation is the critical step in the mass spectrometry workflow. Its efficiency is 
determined by purity and quantity of the isolated protein of interest. Proteins in the lysate tend 
to bind non-specifically to magnetic beads used for immunoprecipitation. Hence, it was 
important to keep the quantity of the beads as low as possible. Optimization of the bead-
antibody proportion revealed that a minimum ratio of 0.023 between beads and antibody was 
sufficient to cause the complete adsorption of the antibody on to the beads (Figure 4.4.1.1). 
Similarly, the minimum volume of the antibody required to extract all of the Cx43 from 1 mg 
of the lysate was estimated to be ~100 µl (Figure 4.4.1.2). By means of these two estimates, 
the immunoprecipitation reaction was scaled up and efficiency of the immunoprecipitation was 
confirmed using antibody targetting the N-terminus of Cx43. Interestingly, total membrane 
preparations gave better yield of phospho-Cx43 and hence were used in the subsequent 
experiments (Figure 4.4.1.3). The optimized protocol for sample preparation was applied to 
lysates from mice 4 h post kainate.  
In total, 14 sites (1 tyrosine, 2 threonines and 11 serines) with phosphorylation were detected 
(Table 4.4.3.1). Of these sites, phosphorylation at T290 and Y301 has been described for the 
first time. Statistical analysis of the normalized chromatographic peak areas of the phospho-
peptides revealed differential phosphorylation at 4 sites namely S328, S330, S257 and S262 
(Table 4.4.3.2). The fact that there was no difference between ipsilateral and contralateral 
hippocampi of saline-injected mice proved that the changes in the phosphorylation in kainate 
injected mice were caused by kainate and were not mere an injection artifact.  
Among the differentially phosphorylated sites, phosphorylation at S328 and S330 (and also at 
S325) by casein kinase 1 has been shown to enhance assembly of gap junctions (Cooper and 
Lampe, 2002). These phospho-sites therefore can be viewed as promoters of gap junction 
formation. Indeed, in ischemic hearts, which show decreased gap junctions in the intercalated 
discs, S328, S330 (and S325) phosphorylation was reduced 8 fold (Lampe et al., 2006).  
Replacing serines at these sites by glutamate (mimicking phosphorylation, S3E mice) resulted 
in slower migrating Cx43 bands, which were abolished after substitution by alanine 
(resembling dephosphorylation, S3A mice) (Remo et al., 2011). Consequently, S3E mice were 
resistant to ischemia-induced gap junction remodeling and arrhythmias (Remo et al., 2011). 
Interestingly, S3A constructs in cell culture showed decreased dye coupling and channel 
conductance (Lampe et al., 2006). All these findings highlight the importance of 
phosphorylation at S328 and S330 for coupling. In the present study, phosphorylation at these 
sites was reduced in kainate-injected mice as compared with saline-injected mice (Figure 
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4.4.3.2 A and B). However, there was no difference between ipsilateral and contralateral 
hippocampus of kainate-injected mice. It is worth noting here that the ipsilateral hippocampus 
showed reduced coupling not only in comparison with the contralateral hippocampus but also 
in comparison with both hippocampi of saline injected mice (Bedner et al., 2015). Therefore, 
it is unlikely that dephosphorylation at S328 andS330 alone might have caused the observed 
uncoupling. 
S257 can be phosphorylated by CamKII and PKG. Phosphorylation by CamKII has been 
shown only in an in vitro assay (Huang et al., 2011) while PKG-mediated in vivo 
phosphorylation of S257 has been induced by cGMP (Kwak et al., 1995). In the latter study, 
8-bromoguanosine 3': Y-cyclic monophosphate (a membrane-permeant activator of PKG), 
shifted the conductance of wild-type Cx43 channels to a lower state. The effect was abolished 
when serine at 257 was replaced by alanine (Kwak et al., 1995). Our mass spectrometric 
analysis revealed increased phosphorylation at S257 in the ipsilateral hippocampus of the 
kainate injected mice as compared with sham injected mice (Figure 4.4.3.2 C). This indicated 
a possible activation of the nitric oxide- cGMP-PKG pathway in ipsilateral astrocytes. S100β, 
which is released by astrocytes upon kainate injection (Figure 4.3.1.1 A, discussed in section 
5.4), is known to increase nitrite production in astrocytes (Hu et al., 1996). Thus, S100β could 
be a mediator of kainate-induced phosphorylation of Cx43 at S257. Alternatively, activation 
of CamKII in ipsilateral astrocytes might have resulted in increased S257 phosphorylation.  
S262 was the only phospho-site which in the kainate-injected mice showed increased 
phosphorylation ipsilaterally (Figure 4.4.3.2 D). Increased S262 phosphorylation was further 
confirmed by Western blot using a specific antibody against Cx43 phosphorylated at S262 
(Figure 4.4.4).  S262 is the target of CDK-2 and MAPKs (Pogoda et al., 2016). CDK-2  is 
believed to be active during mitosis and causes gap junction internalization by S262 and S255 
phosphorylation (Lampe et al., 1998)(Doble et al., 2004). MAPKs, on the other hand, have 
been shown to be upregulated in astrocytes following kainate-induced seizures (Choi et al., 
2003). They can phosphorylate Cx43 at S255, S262 and S279/282 (Thévenin et al., 2013). In 
general, phosphorylation of Cx43 by MAPKs decreases the open probability of gap junctions 
and thereby attenuates coupling (Thévenin et al., 2013). In endothelial cells, MAPK-mediated 
phosphorylation of Cx43 upon VEGF stimulation has been shown to result in gap junction 
internalization (Nimlamool et al., 2015). Both of these mechanisms (reduction in open 
probability and internalization of the gap junctions) can lead to uncoupling.  
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MAPKs are known to be downstream effectors in inflammatory cascades (Kaminska et al., 
2009)(Kyriakis and Avruch, 2012). Stimulation of astrocytic TLR-4 resulted in a 
proinflammatory environment involving MAPK activation (Gorina et al., 2011). MAPKs are 
also activated by cytokines, for example TNFα (Takada and Aggarwal, 2004). Indeed, cytokine 
mediated uncoupling in cultured astrocytes was prevented by a MAPK inhibitor (Retamal et 
al., 2007). Incubation of acute slices with cytokines also resulted in astrocytic uncoupling 
(Bedner et al., 2015). Interestingly, this cytokine mediated uncoupling was rescued by co-
treatment with the soluble TNFα blocker, XPRO 1595 (Dupper, 2014). Expression of cytokines 
is known to be upregulated following seizures (Vezzani and Granata, 2005). For example, 6 h 
after electrically induced limbic seizures, TNFα and IL-1β transcripts reached their peak levels 
(De Simoni et al., 2000). Another study has reported the activation of MAPK at 6 h after kainate 
injection (Choi et al., 2003). With this background information, S262 phosphorylation was 
investigated in acute hippocampal slices incubated with the cytokines TNFα and IL-1β. The 
increased S262 phosphorylation upon cytokine incubation was attenuated by co-treatment with 
XPRO 1595 (Figure 4.4.5 A, B and C). Intriguingly, cytokine treatment also resulted in a Cx43 
band shift similar to that seen after kainate injection. This shift towards the P2 band was 
prevented by XPRO 1595 (Figure 4.4.5 D). This data and the supporting literature propose a 
mechanistic link between cytokine mediated Cx43 phosphorylation at S262 and astrocytic 
uncoupling following kainate injection. Importantly, this alteration in Cx43 phosphorylation 
takes place quite early after kainate injection (4 h post injection), highlighting its potential 
causative role in epileptogenesis.  
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5.4 Changes in astrocytic immuno-labelling 4 h post 
kainate injection 
GFAP and S100β are the most commonly used markers to identify astrocytes. S100β is a 
member of cytosolic EF hand calcium binding proteins (Rothermundt et al., 2003) and plays a 
crucial role in intracellular Ca2+ homeostasis, cell morphology and motility (Donato et al., 
2013). GFAP is a type III intermediate filament protein mainly responsible for the cyto-
architecture of astrocytes (Hol and Pekny, 2015).   
There was a drastic reduction in S100β immunoreactivity in the ipsilateral CA1 region 4 h after 
kainate injection (Figure 4.3.1.1). In order to assess whether this was caused by any 
modification in the epitope targeted by the antibody, another antibody with different clonality 
was employed. Both of these antibodies failed to show S100β signal in the ipsilateral CA1 area, 
while the signal was persistent in the corresponding contralateral area and ipsilaterally distant 
from the injection site. This implied that the reduction in immunoreactivity was confined to the 
ipsilateral CA1 area underneath the injection site (dorsal hippocampus). S100β is known to be 
released by astrocytes by various stimuli. Upon activation, astrocytes release S100β to regulate 
extracellular Ca2+ which in turn influences neuronal rhythmic firing (Morquette et al., 2015).  
S100β is also one of the ‘damage associated molecules’ whose presence in the CSF indicates 
substantial CNS damage (Sorci et al., 2010). Presence of S100β in the CSF has also been 
associated with the degree of cerebral infarction in stroke patients (Brouns et al., 2010). In 
general, the basal level of extracellular S100β is low in the hippocampus. Interestingly, in acute 
hippocampal slices, kainate potentiated the release of S100β in a neural-activity-dependent 
way (Sakatani et al., 2008).  Further, it was shown that kainate-induced astrocytic S100β 
release was dependent on presynaptic glutamate discharge. This glutamate then activated 
metabotropic glutamate receptors (mGluR 3) on astrocytes which prompted S100β release by 
a mechanism independent of Cx43 hemichannels. The concentration and the volume of kainate 
used were 400 nM and 500 µl respectively. As described in section 3.1.2, intracortical injection 
of 70 nl of 20 mM kainate was used to induce status epilepticus in our mouse model. Thus, the 
amount of kainate used in our animal model was 7 times higher than that used in the study by 
Sakatani et al., 2008. This amount of kainate is expected to cause a massive release of S100β 
into the extracellular space, virtually emptying cellular S100β. This could be the reason why 
S100β immunoreactivity was almost negligible in the ipsilateral CA1 as compared with the 
contralateral CA1, when imaged under same microscope settings. GFAP immunostaining 
however was retained (Figure 4.3.1.2 A). In summary, the apparent disappearance of S100β 
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immunoreactivity did not indicate the absence of astrocytes. Release of S100β could be a 
plausible explanation behind the loss of signal. 
In the absence of ipsilateral S100β labelling, counting of astrocytes was based on GFAP 
positive cells co-labelled with the nuclear marker Hoechst. The total number of GFAP positive 
cells was reduced by 27.9% in the ipsilateral SR as compared with contralateral SR (Figure 
4.3.1.2 B). The result was confirmed by employing two antibodies targetting different epitopes. 
There was also a 24.4% reduction in the number of nuclei corroborating the decline in the 
number of astrocytes (Figure 4.3.1.2 B). This reduction might indicate astrocytic death. The 
known pathways for cell death comprise of apoptosis, necrosis, autophagy, oncosis and 
pyroptosis (Fink and Cookson, 2005). Apoptosis is a programmed cell death that involves 
initiator caspases stimulating effector caspases to cleave cellular structures (Elmore, 2007). 
Apoptotic cells display cytoplasmic and nuclear condensation, DNA fragmentation, and 
formation of apoptotic bodies. However, the plasma membrane usually remains intact 
displaying surface molecules targetting for phagocytosis. In the absence of phagocytosis, 
apoptotic bodies may proceed to lysis and secondary or apoptotic necrosis (necroptosis) (Fink 
and Cookson, 2005). Signals like intracellular Ca2+, oxidative stress, nitric oxide (NO), 
mitochondrial dysfunction and endoplasmic reticulum stress can initiate apoptosis in astrocytes 
(Takuma et al., 2004). Of these, rise in the intracellular Ca2+ and activation of NO (by the 
action of S100β) pathway are expected to take place in kainate-exposed astrocytes. During 
epileptiform activity, an increase in the frequency of Ca2+  oscillations in astrocytes has been 
reported (Tian et al., 2005). S100β release (for example induced by kainate) from astrocytes 
can activate a NO pathway in a paracrine manner (Hu et al., 1996). Both of the above-
mentioned events (Ca2+  increase and activation of NO pathway) are inducers of apoptosis 
(Takuma et al., 2004). Indeed, kainate-induced emptying of astrocytic S100β stores was 
observed during this study (Figure 4.3.1.1 A). Moreover, S100β has been found to induce 
apoptotic cell death in cultured astrocytes via a nitric oxide-dependent pathway (Hu and Van 
Eldik, 1996).  Therefore, the possibility of astrocyte death via apoptosis was checked with A 
TUNEL assay. This assay detects DNA breaks caused by apoptosis.  Surprisingly, there were 
no TUNEL positive nuclei in the CA1 region, 4 h after kainate injection (Figure 4.3.2). This 
implied that any cell death via apoptotic pathway could be ruled out. It is important to note 
here that DNA breaks (detected by TUNEL) are features of late stage apoptosis. Any cell in 
the early phases of apoptosis cannot be detected by TUNEL. Further, apoptosis is followed by 
phagocytosis by innate or adaptive immune cells. If this takes place for instance before the 4 h 
time point post kainate, then it is not possible to detect apoptosis at this time point. In this case, 
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it is desirable to perform the TUNEL assay at an earlier time point, for example 2 h after kainate 
injection. 
There are other pathways of cell death, mainly necrosis, autophagy, oncosis and pyroptosis 
(Fink and Cookson, 2005). Necrosis is defined as a passive, non-programmed (non-apoptotic) 
cell death. It refers to the morphological remains seen after a cell has already died and reached 
equilibrium with its surroundings. Thus, necrotic features are indicative of an end-stage death 
rather than any mechanism leading to the death. Further, any programmed cell death pathway 
can secondarily lead to necrosis. Autophagy is characterized by the degradation of cellular 
components within the intact dying cell in autophagic vacuoles. The morphological 
appearances of autophagy comprise vacuolization, degradation of cytoplasmic contents, and 
chromatin condensation. Oncosis involves cellular and organelle swelling in addition to 
membrane breakdown, with the eventual release of inflammatory cellular contents. Pyroptosis 
is mediated by the activation of caspase-1 leading to cell lysis and release of inflammatory 
cellular contents. This pathway is therefore inherently pro-inflammatory.  All of these 
pathways might present indistinguishable morphological features. Therefore, it is important to 
have specific markers for these pathways. Moreover, as discussed in the earlier paragraph, any 
mechanistic investigation of astrocytic death 4 h post kainate should be performed at an earlier 
time point, for instance 2 h after kainate injection. 
GFAP immunostaining showed altered morphology of astrocytes in the ipsilateral CA1 as 
suggested by the reduced number of primary branches (Figure 4.3.1.2. C). The thickness of the 
branches also appeared to be increased ipsilaterally (not quantified). However, there was no 
change in the area occupied by GFAP, indicating unaltered GFAP expression (Figure 4.3.1.2 
C). This was further confirmed by Western blotting (Figure 4.3.1.2 D). As the number of 
astrocytes was also reduced, the data indicated that there was an increase in the GFAP-content 
per astrocyte. In summary, ipsilateral astrocytes 4 h after kainate injection displayed depletion 
of S100β, altered morphology, reduced number but no evidence of late stage apoptosis (i.e. 
TUNEL labelling). It could not be resolved whether these changes were directly linked with 
uncoupling. 
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5.5 Astrocytic proliferation and Cx43, 5 d post kainate 
injection 
Status epilepticus in the mouse model is followed by a latent phase that lasts approximately 5 
days (Bedner et al., 2015). Four h post kainate, the number of astrocytes was found to be 
reduced ipsilaterally (Figure 4.3.2). However, 5 d post kainate the number of astrocytes were 
similar between ipsilateral and contralateral hippocampi (Figure 4.5.1). This recovery of 
astrocytic number indicated possible proliferation. Indeed, newly generated astrocytes, as 
indicated by BrdU labelling, were observed in both hippocampi (Figure 4.5.2 A). Surprisingly, 
the number of BrdU positive S100β cells was ~2 times higher in the contralateral SR region 
although the total number of astrocytes was not different from the ipsilateral SR region (Figure 
4.5.2 B). It is important to note here that BrdU not only labels newly generated cells but also 
cells which are currently having DNA synthesis implying that some of the BrdU positive cells 
might represent cells in the state of division or DNA repair (Taupin, 2007). Moreover, a small 
proportion (~ 13% in the SR region of adult mice) of NG2 cells also express S100β (Moshrefi-
Ravasdjani et al., 2016). NG2 cells, whether S100β positive or negative, have potential to 
proliferate (Moshrefi-Ravasdjani et al., 2016). Remarkably, seizures have been shown to 
induce proliferation in NG2 cells (Wennström et al., 2003). Nevertheless, BrdU labelling 
confirmed the proliferation of S100β cells most of which were astrocytes as indicated by 
colabelling with GFAP (Figure 4.5.1). 
Cx43 immunostaining using an antibody targeting aa 360 to 382 of Cx43 revealed apparent 
loss of signal in the contralateral SR relative to the ipsilateral SR 5 d post kainate (Figure 4.5.3 
A). This apparent loss, however, did not indicate the absence of Cx43 as another antibody 
targeting aa 250-270 of Cx43 showed Cx43 positive puncta. Such a change in antibody binding 
efficiency has been reported in kainate-induced seizures (Hossain et al., 1994)(Ochalski et al., 
1995).  The authors termed this phenomenon epitope masking and proposed that kainate-
induced change in the conformation of the antibody epitope was responsible for loss of 
antibody binding to it. In these studies, various sequence specific antibodies were used for 
immunostaining and Western blotting after intracortical kainate injection.  
Immunohistochemical signal from the antibody targeting aa 346-363 was lost as early as 2 days 
after kainate injection while immunohistochemical signal from the antibody targeting aa 241-
260 was still present. Surprisingly, both antibodies showed similar reactivity in Western blot, 
indicating that epitope masking was present only in immunostaining (Hossain et al., 1994). 
Immunolabelling shown by the antibody targeting aa 250-270 was quantified in the present 
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study. Plaque size, number of plaques, area occupied by Cx43 and Cx43 fluorescence intensity 
did not differ between ipsilateral and contralateral SR regions indicating similar expression 
pattern of Cx43 (Figure 4.5.3 B). 
Western blots of Cx43 showed an increase in P2 band at 3 months’ and 4 h time points. At the 
5 d time point, however, there was no change in the phospho-bands (Figure 4.5.4). This 
indicated that the increased phospho band levels 4 h after kainate returned to baseline after 5 
d, possibly by the action of phosphatases. Phosphatase-mediated dephosphorylation of Cx43 
has been shown in heart tissue (Remo et al., 2011). These phosphatases colocalized with Cx43 
in the intercalated discs in heart failure (Ai and Pogwizd, 2005). Mice expressing glutamate at 
S325, S328 and S330 of Cx43 were resistant to ischemia-induced Cx43 dephosphorylation and 
subsequent arrhythmia (Remo et al., 2011). Dephosphorylation of Cx43 has also been shown 
in the acute phase of seizures induced by intraperitoneal 4-aminopyridine (Zádor et al., 2008). 
This dephosphorylation was proposed to be regulated by neuronal and/or glial NMDA 
receptors.  
At the 5 d time point, there was no difference in astrocytic coupling between ipsilateral and 
contralateral hippocampi (Julia Mueller, unpublished data). This result is in apparent 
contradiction with that reported in Bedner et al. (2015), because of the selection criterion used 
for the inclusion of animals in the study (Bedner et al., 2015). In Bedner et al., (2015), one of 
the objectives was to investigate astrocytic coupling in the latent phase. Therefore, those mice 
showing spontaneous seizure activity in EEG (and hence chronic seizure onset) were excluded 
from the analysis. However, in the study by Julia Mueller (and also in the present study), no 
such exclusion criterion was employed. All the kainate injected mice at the end of 5 days were 
considered for coupling or Cx43 phosphorylation analysis. It is likely that some of the mice 
included for coupling or Cx43 phosphorylation analysis might not have been in the latent 
phase. Consequently, the contralateral and ipsilateral hippocampi did not differ in astrocytic 
coupling and also in Cx43 phospho bands. Considering the Western blot and coupling data 
from 3 months, 4 h and 5 d time points, changes in the phospho bands of Cx43 can be associated 
with changes in astrocytic coupling. 
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5.6 Seizure-induced granule cell dispersion and 
neurogenesis in connexin-DKO mice 
About 60% of the human MTLE HS cases show GCD in the DG while ~ 40% show substantial 
granule cell loss (Blümcke et al., 2009). Granule cell pathologies in epilepsy have been found 
to correlate with the duration of epilepsy but not with the extent of pyramidal cell loss in the 
CA1 region (Blümcke et al., 2009). The animal model of epilepsy used in the present study 
also showed noticeable GCD in the ipsilateral hippocampus 1 and 3 months post kainate 
injection. Granule cells in the contralateral DG on the other hand showed a compact cellular 
architecture with distinct borders between the granule cell and the molecular layer, similar to 
what is observed in non-injected control mice. A reduced GCD in kainate-injected DKO mice 
was first reported in the PhD thesis by Pavel Dublin (Pavel Dublin, 2012). In the present study 
this finding was investigated further.  
Quantification of GCD has been based on the width of the blades of the granule cell layer 
(Schmeiser et al., 2016). The seizure-induced increase in this width was lower in DKO mice 
as compared with WT mice (Figure 4.6.1). Granule cells labelled with Prox1 also occupied 
smaller area in DKO mice. Since DKO mice were earlier shown to have reduced adult 
neurogenesis (Kunze et al., 2009), the contribution of this process to seizure-induced GCD was 
explored.  Seizure-induced neurogenesis in DKO mice has not been investigated before.  Fate 
mapping of the new born cells was enabled by BrdU which was administered through drinking 
water for the first 15 days post kainate injection. Neurogenesis was assessed 15 days after the 
last BrdU administration (Figure 3.3.5). Therefore, any BrdU positive neuron that was detected 
at this time point had survived at least 15 days after its generation. Surprisingly, no BrdU-
positive Prox1 cells could be observed in the ipsilateral DG underneath the injection site. BrdU-
positive DCX cells were also absent (Figure 4.6.3). On the other hand many BrdU-positive 
DCX cells could be detected in contralateral hippocampi of both WT and DKO mice, albeit to 
a lesser extent in the latter (Figure 4.6.4). Nevertheless, these results ruled out the hypothesis 
that the reduced GCD in DKO mice was caused by reduced seizure-induced neurogenesis.  
Lack of newborn granule neurons in the ipsilateral DG underneath the injection site has been 
reported earlier in the intrahippocampal model of epilepsy (Häussler et al., 2012). The authors 
found no BrdU-positive DCX or Prox1 neurons in the ipsilateral DG below the injection site. 
However, seizure induced neurogenesis could be detected in the contralateral DG and also in 
the ipsilateral DG distal to the injection site. This study differed from the present study in two 
aspects: 1) The animal model involved intrahippocampal injection that causes mechanical 
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damage to the CA1 as compared with intracortical injection used in the present study that 
spares mechanical injury to the CA1 region 2) BrdU was administered intraperitoneally only 
on the 6th day post injection while in the present study BrdU was administered through drinking 
water continuously for first 15 days. The different design of the present study was intended to 
detect the maximum of post seizure neurogenesis which is known to take place mostly in the 
first 15 days after status epilepticus and declines severely in the chronic phase (Hattiangady et 
al., 2004). Despite of the differences in the design, the present study confirmed the findings of 
Häussler et al., 2012. 
One possible reason behind the attenuated GCD in DKO mice could be the already lower 
number of granule cells in DKO mice as reported earlier (Kunze et al., 2009b). In the study by 
Kunze at al., DKO mice were found to have less Prox1 positive cells as compared with WT 
mice. Thus, upon seizure induction spread of granule cells owing to their small number 
appeared to a lower extent in DKO mice. Indeed, the non-injected DKO mice had thinner 
granule cell layers as compared with those of the non-injected WT mice (Figure 4.6.5 A and 
B). DKO mice also have a lower basal level of neurogenesis. However, Nitta et al., showed 
that the extent of GCD does not depend on the basal level of neurogenesis (Nitta et al., 2008). 
The authors found that seizure-induced GCD in aged and irradiated mice, which are known to 
have reduced neurogenesis, does not differ from GCD in those mice which have normal adult 
neurogenesis.  
Connexins are essential for the proliferation of RG-like cells in the DG (Kunze et al., 2009b). 
As a result, seizure induced neurogenesis in the contralateral DG of DKO mice was lower than 
in the contralateral DG of the WT mice. However, neurogenesis in kainate-injected DKO mice 
was still higher than the non-injected DKO and the non-injected WT mice (Table 4.6.4 and 
4.6.5). This implies that the seizures overcome the limitations on neurogenesis posed by the 
absence of connexins. Thus, seizure-induced neurogenesis is actually independent of astrocytic 
connexins. The differences in seizure-induced neurogenesis observed between DKO and WT 
mice can be attributed to the lower level of basal neurogenesis in the former.  
Kainate injection caused increased proliferation of endothelial cells in the ipsilateral 
hippocampi 1 month post kainate (Figure 4.6.6). This was further reflected in vascular density 
that showed higher values in ipsilateral hippocampi when compared with the corresponding 
contralateral hippocampi at 1 month and 3 month post injection in WT mice (Figure 4.6.7 A 
and B). The sclerotic human hippocampus also showed an increased vascular density, in 
contrast with the non-sclerotic one. This difference in vascular densities was not observed in 
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DKO mice 1 month post injection (Figure 4.6.6 B). Interestingly, DKO mice presented reduced 
ipsilateral seizure-induced proliferation of endothelial cells when compared with WT mice 
(Figure 4.6.7 C and D). This pattern of reduced endothelial cell proliferation was similar in 
both DG and the CA1 region. The pattern of microglial proliferation, however, was different 
in these two regions. While the ipsilateral CA1 region of DKO mice showed reduced microglial 
area and proliferation as compared with WT mice, the DG of these mice did not differ (Figure 
4.6.8). Both, microglial proliferation (Vezzani and Granata, 2005) and enhanced angiogenesis 
(Rigau et al., 2007) have been proposed to contribute to epileptogenesis. The differential 
modulation of these processes in DKO mice indicates that astrocytic connexins influence 
seizure-induced proliferation of non-neuronal cells.  
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6 Summary 
 
The dynamic regulation of connexins throughout its life cycle has profound impact on the level 
of gap junctional coupling in astrocytes. Astrocytic uncoupling in epilepsy can be viewed in 
the context of modifications in their connexins. The present work sheds a light on seizure-
induced alterations in connexins associated with uncoupling in astrocytes.  
This study unequivocally proves that post seizure uncoupling in astrocytes is not caused by the 
scarcity of connexins. In fact, in hippocampal specimens from epilepsy patients and in the 
mouse model of epilepsy 3 months post injection, an increase in the total Cx43 protein levels 
was found. This increase in the total Cx43 levels, however did not result in the increase in 
plasma membrane Cx43 levels indicating impaired translocation of this protein. Nevertheless, 
plasma membrane Cx43 levels in the human sclerotic hippocampus were comparable to those 
in non-sclerotic hippocampus. Expansion microscopy utilized for the first time to resolve the 
gap junction-blood vessel interface in human hippocampal specimens, further enabled to 
localize Cx43 with respect to blood vessels. Interestingly, in the sclerotic hippocampus, a 
preferential distribution of Cx43 around blood vessels was observed, which coincided with 
albumin extravasation.  
All these features of Cx43 expression and distribution were also observed in the mouse model 
of epilepsy at the 3 months’ time point highlighting its clinical relevance. At this time point, a 
significant change in the phosphorylation of Cx43 was detected. Remarkably, as early as 4 h 
after kainate injection, altered Cx43 phosphorylation, indicated by a shift of Cx43 bands 
towards P2, was noticed. This phosphorylation of Cx34 was further characterized in detail with 
the help of mass-spectrometry reported for the first time in an epilepsy model. In total, 14 Cx43 
phosphorylated sites were detected of which, phosphorylated T290 and Y301 have not been 
described before. Phosphorylation at S257, S262, S328 and S330 was found to be differentially 
regulated after kainate-induced seizures. Phosphorylation at S262 could be associated with 
astrocytic uncoupling in the ipsilateral hippocampus. Interestingly, this phosphorylation could 
also be induced by TNFα and IL-1β and could be blocked by XPRO1595, a blocker of the 
soluble form of TNFα. It is noteworthy that both of these cytokines have been reported to be 
upregulated after kainate-induced seizures (Vezzani and Granata, 2005). 
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The 4 h time point also showed dramatic changes in the morphology and markers of astrocytes. 
S100β immunoreactivity in the ipsilateral hippocampus was drastically reduced while GFAP 
immunoreactivity showed reduced astrocytic branching. Although the total number of GFAP 
positive astrocytes was reduced ipsilaterally, there was no evidence of apoptotic cell death. The 
possibility of other mechanisms of cell death, however cannot be ruled out.  Furthermore, 5 d 
post kainate injection the numbers of astrocytes in the ipsilateral and contralateral hippocampi 
were similar.  These numbers were still higher than those at the 4 h time point, indicating 
astrocytic proliferation. Indeed, BrdU labelling 5 d post injection revealed newly generating 
and/or proliferating astrocytes in both hippocampi. The higher molecular weight shift in Cx43 
bands observed at 4 h post kainate was absent at the 5 days’ time point agreeing with the state 
of astrocytic coupling at these time points. 
All these results exemplified how seizures affected astrocytic connexins and thereby the gap 
junctional coupling. In the second part of my thesis, I checked how the deletion of astrocytic 
connexins influenced seizure-induced granule cell dispersion and neurogenesis. I found that 
the attenuated granule cell dispersion in connexin DKO mice could not be ascribed to the 
newborn neurons. It could however be attributed to the lower number of granule cells (Prox1 
positive cells) resulting into thinner granule cell layers under basal conditions. The ipsilateral 
dentate gyri of both WT and connexin DKO mice were devoid of seizure-induced neurogenesis 
1 month post injection. On the other hand, neurogenesis was present in the contralateral dentate 
gyri although lower in the connexin DKO mice than WT mice.  Interestingly, neurogenesis in 
connexin DKO mice with seizures (kainate-injected connexin DKO mice) was 6 times higher 
than the neurogenesis in connexin DKO mice without seizures (non-injected connexin DKO 
mice) and 3 times higher than the neurogenesis in WT mice without seizures (non-injected WT 
mice). It can be concluded that seizure-induced neurogenesis is independent of astrocytic 
connexins. 
In summary, the present study provides vital insights into the mechanisms of astrocytic 
uncoupling in epilepsy. These can be utilized to devise strategies to prevent astrocytic 
uncoupling in experimental and clinical epilepsies. 
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7 Perspective 
 
Astrocytic uncoupling has profound implications for epileptogenesis. Prevention of the 
uncoupling has potential therapeutic benefits. Therefore, it would be appropriate to identify the 
exact molecular pathways responsible for uncoupling at various stages of epilepsy.  
The present study has identified altered phosphorylation of Cx43 as a probable mechanism 
leading to uncoupling. Phosphorylation of Cx43 at S262, which in the present study was 
observed to be increased in the ipsilateral hippocampus, is known to reduce gap junctional 
coupling. In this context, a proof of principle study ascertaining the contribution of S262 
phosphorylation to seizure-induced uncoupling in astrocytes is very much desirable. Such a 
proof can be obtained by evaluating the post seizure astrocytic coupling in mice in which S262 
of Cx43 has been replaced either by glutamate (mimicking phosphorylation) or by alanine 
(mimicking dephosphorylation). If the latter mice are resistant to uncoupling, causal 
relationship between S262 phosphorylation and post seizure astrocytic uncoupling can be 
established.  
The next step would be then to identify the kinase or kinases responsible for this 
phosphorylation. MAPKs and CDK-2 are known to phosphorylate Cx43 at S262 (and also at 
some other sites) (Thévenin et al., 2013). Inhibitors of these kinases can be employed to impede 
S262 phosphorylation and subsequent astrocytic uncoupling. In this case, MAPKs are 
particularly of importance as they are known to be activated in inflammatory conditions. TLR-
4 stimulation in astrocytes has been shown to create a proinflammatory environment involving 
MAPKs activation (Gorina et al., 2011). MAPKs are also activated by cytokines for example 
TNFα (Takada and Aggarwal, 2004). Indeed, the data in the present study implicated a role of 
the inflammatory cytokines TNFα and IL-1β in phosphorylation of Cx43 at S262. Although 
various previous reports have shown upregulation of these cytokines after seizures (Vezzani 
and Granata, 2005), their contribution to astrocytic uncoupling is not clearly known. This 
contribution can be determined by assessing post seizure S262 phosphorylation and astrocytic 
coupling in mice deficient in TNFα and/or IL-1β. Alternatively, inhibitors of these cytokines 
can be employed to judge their role in uncoupling. Furthermore, phosphorylation of S262 can 
be checked in TLR-4 knock out mice, which have already been shown to be resistant to seizure-
induced uncoupling (Bedner et al., 2015).  
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Another important finding from the present study is the abundance of plasma membrane Cx43 
in the human sclerotic hippocampus and also in the ipsilateral hippocampus of mice 3 months 
after kainate injection. Expansion microscopy further revealed the presence of Cx43 puncta in 
between GFAP-positive processes in the human sclerotic hippocampus. It could not be deduced 
whether these puncta represented fully formed gap junctions (dodecamers) or undocked 
connexons (hexamers). Extracellular loop antibodies, which bind only to undocked connexons 
(and also to connexin monomers) can be used to distinguish between gap junctions and other 
Cx43 structures by immunohistochemistry (Riquelme et al., 2013). The opening of connexons 
known as hemichannel activity can be assessed ex-vivo by ethidium bromide uptake. The 
configuration of Cx43 into hexamers and dodecamers can also be determined based on their 
molecular weight in native conditions. Another approach to unravel the Cx43 configuration 
would be visualization of Cx43 at higher resolution obtained by techniques like atomic force 
microscopy. It is also probable that the abundant Cx43 immunolabelling in sclerotic conditions 
might represent fully formed but closed gap junctions. The permanent closure of gap junctions 
implies drastic reduction in its open probability and /or unitary conductance. Interestingly, both 
of these properties are influenced by phosphorylation. Indeed, in the present study 
phosphorylation at S255 of Cx43 has been found to be increased in human sclerotic 
hippocampus. On the other hand, in the mouse model employed in this study, phosphorylations 
at both S255 and S368 were found to be augmented. Therefore, it will be pertinent to assess 
the global changes in Cx43 phosphorylation in the chronic phase of epilepsy. Such an 
assessment can be done either by using phospho-specific antibodies or by using mass 
spectrometry.
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